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ANTERIOR CRUCIATE LIGAMENT RUPTURE AND TREATMENT
ACL rupture is a common sports-related injury potentially causing instability of the 
knee joint. In the general population, annual incidence rates reach up to 5 - 8 per 
10.000 persons1, 2. On the contrary, incidence rates reported for professional athletes 
are substantial higher: 8 to 52 per 10.000 per persons per year in various populations 
including Sweden, Norway, Denmark, The United States of America, Australia and 
Germany1. However, the exact incidence in The Netherlands is unknown. ACL injuries 
are most frequently observed in pivoting sports, such as down-hill skiing, soccer, handball 
and basketball3. Women are at 2 to 8 times greater risk as men of suffering this injury4, 5.
Currently, the treatment options are either a conservative regime with exercise therapy 
or a surgical reconstruction of the injured ACL. The Dutch ACL guidelines recommend 
surgical reconstruction only when knee instability exists. Otherwise, a conservative 
treatment is indicated6. When despite adequate conservative therapy complaints of 
instability remain, one might consider operative treatment too. Other factors that 
contribute to the final treatment decision are additional injuries and patient’s requirements 
in terms of activity levels and participation in pivoting sports6, 7. The number of ACL 
reconstruction procedures performed globally and in The Netherlands is increasing8, 9. 
The estimated number of ACL reconstructions in The Netherlands in 2003 was 3.0009, 
whereas today’s estimations reach up to 7.000 reconstructions annually10.
An important aspect of the ACL reconstruction procedure is the graft choice. Today, 
several graft options exist, including autografts, allografts and synthetic grafts. Because of 
unlimited access and no donor-site morbidity, synthetic grafts were popular in the past. 
However, these grafts presented serious drawbacks such as immunological responses, 
recurrent instability and knee osteoarthritis11. Therefore, artificial grafts are hardly used 
in current clinical practice12. There are various allografts available for reconstruction 
purposes, such as tibialis posterior tendon, tibialis anterior tendon, Achilles tendon, 
peroneus longus tendon and bone-patellar tendon-bone (BPTB). A potential disadvantage 
of the use of allografts is the risk of infection, graft rejection and graft elongation. These 
disadvantages are less likely to occur in autografts. Autografts are therefore the most 
preferred graft for ACL reconstruction procedures. The most commonly used autografts 
are the hamstring tendons and bone-patellar tendon-bone (BPTB)13. As BPTB grafts 
are associated with donor-site morbidity in 80% of the patients14 and patellar tendon 
rupture occurs in 0.24%15, the hamstring tendon autografts are the graft of choice to 
replace injured ligaments in the Netherlands as well as globally. Orthopaedic surgeons 
tend to harvest two hamstring tendons and subsequently fold them to create the typical 
4-stranded graft. This ensures that an optimal graft size is obtained and so that optimal 
biomechanical function is reached16.
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LIGAMENTS AND TENDONS
Anatomy
The anterior cruciate ligament (ACL) is a ligament that courses from the femur to the tibia. 
More precisely, the ACL arises from the posteromedial side of the lateral femur condyl and 
attaches on the anteromedial side of the tibia plateau (Figure 1). The ACL is comprised 
of two bundles named for their insertion sites on the tibia plateau: anteromedial (AM) 
bundle and posterolateral (PL) bundle17. Its main function is considered the primary 
restraint to anterior displacement of the tibia and to provide rotational stability18.
Patella 
Tibia 
Fibula 
Anterior cruciate ligament 
Posterior cruciate ligament 
Femur
Patellar tendon
Medial collateral ligament 
Lateral collateral ligament 
Figure 1: Anatomical representation of the right knee (modified from Kennedy et al.19).
The two tendons that are harvested for reconstructive purposes are the semitendinosus 
and gracilis tendons. The semitendinosus is located in the postero-medial side of the 
thigh and has its origo at the inferior-medial aspect of the ischial tuberosity. The proximal 
tendon shares a tendon with the biceps femoris. The long distal tendon, which is harvested 
for reconstruction of the ACL, starts caudal from the mid-thigh.
The gracilis tendon has it origo at the ramus inferior ossis pubis and descends along 
the medial thigh. From an anatomical and functional perspective, the m. gracilis is 
considered to be an adductor of the leg. The tendons of the semitendinosus, gracilis and 
sartorius eventually conjoin to form the pes anserinus. The pes then turns around the 
medial aspect of the tibia and inserts at the tuberositas tibiae.
It should be noted that in the light of autografts for ACL reconstructions, the m. 
semitendinosus and m. gracilis are often referred to as hamstring tendons.
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Structure
Tendons and ligaments are hierarchically organised. The main structural component 
is collagen, which is a triple helix. The assembly of five collagen molecules is termed a 
microfibril. These microfibrils are arranged into larger longitudinal bundles. Depending 
on their size, these bundles are called subfibrils, fibrils and fascicles (Figure 2). Each 
fascicle is separated by a layer of loose connective tissue that is known as the endotenon. A 
group of fascicles form the entire tendon, which is enclosed by the epitenon: a connective 
tissue-sheath containing the vascular, lymphatic and nerve supply. The ligamentous 
equivalent for endotenon is endoligament, whereas epitenon is referred to as epiligament. 
In general, the collagen fibers are organised in the direction of the applied force. As forces 
in tendons are applied in a uniaxial direction, a parallel alignment of the collagen fibrils is 
found in tendons. However, collagen fibrils are not as uniformly orientated in ligaments 
because forces are applied in more than one direction.
100-500µm 50-300µm 50-500nm 10-20nm 3.5nm 1.5nm
Tendon Fascicle Fibril Subfibril Microfibril Collagen 
Figure 2: Schematic image of the hierarchical structure of tendons and ligaments (modified from Encyclo-
pedia Britannica20).
Composition
The extracellular matrix (ECM) of tendons and ligaments is approximately composed of 
65-80% collagen (dry weight)21-23. Collagen type I is with 95% of the total collagen the 
predominant collagen in both ligaments and tendons. Additionally, at least 28 more collagen 
types are found in minimal concentrations24, 25. Collagens contribute to the structural 
framework in tendons and ligaments as they form both intramolecular and intermolecular 
covalent cross-links. This stabilises the ECM and determines its tensile strength. Forms 
of cross-linking that are generally found in tendons and ligaments are the hydroxylysine 
aldehyde derived and the lysine aldehyde derived cross-links26. These are established after 
enzymatic modifications27. Another mechanism of cross-linking is via non-enzymatic 
modifications using glucose, with pentosidine as a well-identified end product28.
CHAPTER 1
12
Although collagen fibrils are the main component in the ECM of tendons and ligaments, 
several other non-collagenous constituents also contribute to its overall function. 
Proteoglycans, a special class of glycoproteins, represent 3% of the dry weight in tendons 
and ligaments29, 30. These proteoglycans contain glycosaminoglycan (GAG) subunits 
that, due to their high concentration of negative charge, generate an osmotic pressure by 
attracting water. The water content of the matrix is about 70% of the wet weight of the 
ECM. This leads to lubrication and spacing allowing fibers to glide over each31.
Highly specialized fibroblasts are sparsely present in the ECM, but represent the main 
cell type in tendons and ligaments comprising 90-95% of the cell population32, 33. These 
fibroblasts in tendons are referred to as tenocytes and in ligaments as ligamentocytes. 
These cells are involved in the degradation and synthesis of ECM components.
TISSUE HEALING AND INFLAMMATION
It has been reported that hamstring tendons harvested for ACL reconstruction are able 
to regenerate after surgical resection34. These regenerated tendons clinically appear 
as a well-defined fibrous band that could be palpated on the posteromedial aspect of 
the popliteal fossa35. Macroscopically, regenerated tendons have the same colour 
and glossiness as those of normal hamstring tendons35, 36. In addition, several studies 
microscopically examined the regenerated tissue. No significant differences were found 
in terms of collagen type, fiber structure, cellularity, vascularity and amount of GAGs 
when comparing the regenerated tendon with native tendon35-38. This illustrates the 
remarkable extent of tendon healing following harvesting procedures.
Tissue healing is a complex and multistage process, involving the recruitment of various 
cells. These cells typically produce their own cytokines or growth factors contributing to 
the process of tissue healing. Tissue healing can be subdivided in four stages39:
1. Haemostasis: the blood clotting system is activated in the first minutes to hours after 
(iatrogenic) injury. More specifically, thrombocytes and platelets aggregate in a fibrin 
network40. Additionally, these platelets release cytokines and growth factors to attract 
other cells.
2. Inflammation: during this phase inflammatory cells are recruited to remove dead 
cells, bacteria and other pathogens. Together with macrophages, mast cells and 
T-lymphocytes are attracted and subsequently secrete multiple factors to influence 
the process of tissue healing41. This process typically takes a few days to a few weeks.
3. Proliferation: following the inflammatory phase, cells will start to proliferate and 
synthesize structural and fibril-associated components of the extracellular matrix. 
This step can take a few days up to weeks after injury.
13
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14. Remodelling: in this final stage, the new tissue will be rearranged into normal tissue structure. In particular the orientation of collagen fibers is reorganised along the 
tension lines. Furthermore, superfluous cells will undergo apoptosis during this 
phase. In general, this phase might take weeks to months following tissue injury.
Macrophages are a major component of the mononuclear phagocyte system and are 
key role players in the inflammatory phase of the process of tissue healing42. These 
specialized cells of the immune system are derived from monocytes. Depending on the 
microenvironmental cues, macrophages are able to obtain a whole spectrum of different 
phenotypes with distinct functional and phenotypical characteristics43, 44. The tissue-
remodelling process is orchestrated by these macrophages, but more specifically by their 
produced cytokines and chemokines41.
Pro-inflammatory macrophages, or M1, represent one end of the spectrum. Their main 
function is to debride affected sites by phagocytosis of pathogens, foreign materials and 
damaged cells45. Also, pro-inflammatory macrophages are responsible for the production 
of numerous pro-inflammatory cytokines including interleukin (IL)-1β, IL-6 and tumor 
necrosis factor (TNF)-α. Conversely, on the other end of the spectrum, anti-inflammatory 
macrophages, or M2, are found. They are involved in tissue repair and healing processes 
by the secretion of anti-inflammatory cytokines, such as IL-4, IL-10 and transforming 
growth factor (TGF)-β43, 44. These cytokines, interleukines and growth factors are known 
to activate different pathways;
Apoptosis Inflammatory factors are known to stimulate the production of reactive oxygen 
species, resulting in the production of caspases46, 47. Caspases are known to induce 
apoptotic cell death23. A decrease in cell numbers directly compromises maintenance and 
repair of the ECM, as cells are responsible for the production of ECM components.
Fibrosis Other inflammatory factors contribute to an upregulation of TGF-β leading to 
an increased production of collagens and proteoglycans48-51. Ultimately, this might lead to 
fibrosis. In addition, TGF- β induces the synthesis of tissue inhibitors of metalloproteinases 
(TIMPs), preventing the degradation of matrix components52.
ECM degradation The production of prostaglandin E2 is induced following exposure to 
inflammatory cytokines and leads to an upregulated production of metallaproteinases 
(MMPs)53-55. These proteins are known to enhance the degradation of ECM components.
Taken together, the inflammatory response is a complex combination of pro- and anti-
inflammatory factors that needs to be tightly regulated. An imbalance between the pro- 
and anti-inflammatory response leaves the inflammation unchecked resulting in either 
too much matrix degradation or too much fibrotic tissue.
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AIMS AND OUTLINE OF THIS THESIS
Anterior cruciate ligament (ACL) reconstruction has become standard orthopaedic 
practice worldwide and often requires harvest of the hamstring tendons. However, the 
harvest of functional and healthy tissue might lead to donor-site morbidity and functional 
deficits. In 1992, Cross et al. were the first ones to describe the remarkable feature of 
these tendons to regenerate following harvesting procedures, potentially solving the 
post-harvest morbidity34. Therefore, the general aim of this thesis is to improve the 
outcome after hamstring tendon harvesting through a better understanding of tendon 
regeneration.
In Chapter 2 we conduct a systematic review to summarize the available literature about 
hamstring tendon regeneration following harvesting procedures.
Regeneration of the hamstring tendons has been associated with various clinical 
symptoms, such as pain in the posterior thigh, cramping and muscle weakness56. 
These symptoms might be explained by failure of the regeneration process or altered 
morphological properties of the regenerated tendons. Chapter 3 describes the process of 
hamstring tendon regeneration at one- and two-years follow-up after ACL reconstruction 
entailing the hamstring tendons using magnetic resonance imaging. More specifically, it 
reports regeneration rates, changes in cross-sectional areas and tendon lengths.
Considering the clinical symptoms, it might be interesting to preoperatively identify 
patients that are likely to lack a regenerative capacity of the hamstring tendons. Knowledge 
about modulators for hamstring tendon regeneration might alter the graft choice. 
Therefore, chapter 4 identifies predictive factors for hamstring tendon regeneration. In 
addition, patient-reported outcome measurements between patients with and without 
hamstring tendon regeneration are reported.
Inflammation is a well-known factor that contributes to tissue repair. However, a better 
understanding of the effects of inflammatory factors on the production of extracellular 
matrix components is required to direct the inflammatory process and to improve tendon 
regeneration. Currently, it remains unclear how polymorphisms within genes encoding 
inflammatory proteins such as interleukin (IL)1B and IL6 affect the production of 
structural and fibril-associated components of the extracellular matrix. Chapter 5 focuses 
on the effect of polymorphisms within genes encoding for two inflammatory factors 
(IL1B and IL6) on gene expression levels of collagens and proteoglycans in fibroblasts 
with an increased or decreased injury risk.
Immune cells, in particular macrophages, are the key role players in inflammation and are 
known to produce inflammatory factors such as IL-1β and IL-6. The production of these 
proteins is known to be stimulated following activation of a specific signaling pathway. 
Chapter 6 describes the effects of specific inhibition of this inflammatory signaling 
pathway on macrophage phenotypes.
15
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1Finally, chapter 7 summarizes and discusses the main findings and limitations of the studies described in this thesis. In addition, it combines the knowledge of the studies to 
discuss potential directions for future research in order to improve the outcome following 
hamstring tendon harvesting procedures.
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ABSTRACT
Background: Hamstring tendons are often used as autografts for anterior cruciate 
ligament (ACL) reconstruction. However, no systematic review has been performed 
describing consequences, such as hamstring tendon regeneration rate and determinants 
of hamstring tendon regeneration.
Purpose: To summarize the current literature regarding hamstring tendon regeneration 
rate, the time course of regeneration, and determinants of hamstring regeneration.
Study design: Systematic review.
Methods: A search was performed in the Embase, Medline (OvidSP), Web-of-Science, 
Cochrane, PubMed and Google Scholar databases up to June 2014 to identify relevant 
articles. A study was eligible if it met the following inclusion criteria: tendons were 
harvested, regeneration at harvest site was assessed, population size was at least 10 human 
subjects, full-text article was available and the study design was either a randomized 
controlled trial, prospective cohort study, retrospective cohort study or case control 
study. A risk of bias assessment of the eligible articles was determined. Data describing 
hamstring tendon regeneration rates were pooled per time period.
Results: A total of 18 publications met the inclusion criteria. The mean regeneration rate 
for the semitendinosus and gracilis was, in all cases, 70%, or higher. More than 1 year 
after harvesting, 79% (median [IQR], 80 [75.5-90]) of the semitendinosus tendons and 
72% (median [IQR], 80 [61-88.5]) of the gracilis tendons were regenerated. No significant 
differences in regeneration rate could be found considering patient sex, age, height, 
weight or duration of immobilization. Results did not clearly show whether absence of 
regeneration disadvantages the subsequent hamstring function. Five studies measured 
the regeneration rate at different moments in time.
Conclusion: Hamstring tendons regenerated in the majority of patients after ACL 
reconstruction. The majority of the hamstring tendon regeneration was found to occur 
between 1 month and 1 year after harvest. No significant determinants for hamstring 
tendon regeneration could be identified because of a lack of research. The function and 
strength of the regenerated hamstring remained unclear.
Clinical relevance: Insight into hamstring tendon regeneration is of clinical relevance as 
it may influence the choice of ACL graft and it may alter the current rehabilitation after 
harvesting the tendon.
Key terms: hamstring tendon regeneration; determinants; time course; clinical outcome.
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INTRODUCTION
The hamstring has become one of the most often harvested tendons used to reconstruct 
the anterior cruciate ligament (ACL) after rupture18. Hamstring tendon autografts are used 
more often for primary ACL reconstruction compared with bone-patellar tendon-bone 
(BPTB) autografts1,12,17. This may be the result of several advantages to using hamstring 
tendons, such as less donor-site morbidity, fewer kneeling problems, and fewer patellar 
tendon ruptures8,9,32,33.
In 1992, Cross et al5 were the first to describe the potential of hamstring tendons to 
regenerate after harvesting for ACL reconstruction. However, in the following years, 
after observing neotendons by histology or visual means, investigators found that some 
hamstring tendons seemed to lack the ability to regenerate16,27.
Several predictive factors have been identified for tendon regeneration in general. Some 
examples of determinants that may negatively influence tendon regeneration are the use 
of nonsteroidal anti-inflammatory drugs25, the use of nicotine22, and diabetes mellitus10,11. 
However, no systematic review has described determinants for hamstring tendon 
regeneration before.
Knowledge of regeneration of hamstring tendons is of clinical importance, as it may 
influence the choice of ACL graft and may even change rehabilitation programs after 
surgery13. In addition, some patients voice concerns about the consequences of removing 
native tendons and the functional deficits that may result as a consequence. This systematic 
review aimed to answer these questions.
No systematic review has been performed concerning the regeneration of harvested 
hamstring tendons previously, nor has a review been performed to describe determinants 
for hamstring tendon regeneration. The aim of this systematic review was to summarize 
(1) hamstring regeneration rate after harvesting, (2) the time course of regeneration, 
(3) the morbidity and function loss of nonregenerated harvested hamstrings, and (4) 
determinants that may influence the process of regeneration.
METHODS
Search strategy
The search strategy (Supplementary Table 1) was carried out on published literature 
from the following electronic databases: Embase, Medline (OvidSP), Web-of-Science, 
Cochrane, PubMed and Google Scholar. These databases were searched from their 
inception to June 1, 2014. Additionally, the reference list of each included study was 
reviewed.
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Eligibility criteria
A publication was eligible if (1) a surgical procedure that entailed hamstring tendon 
harvesting was used, (2) an evaluation of hamstring regeneration at harvest site was 
performed, (3) the study population consisted of a minimum of 10 patients, (4) the study 
was performed on humans, (5) full-text article was available, and (6) the study design 
was a randomized controlled trial, prospective cohort study, retrospective cohort study, 
or case control study.
Studies were excluded when (1) the outcome was other than specified in the inclusion 
criteria (e.g. evaluation of the hamstring tendon autograft), (2) there was no information 
about the regeneration, or (3) previous hamstring injuries were reported.
Animal studies were also excluded. The search was limited for language (English, Dutch, 
French, German, or Spanish).
Identification of eligible studies
Identified studies were screened, based on title and/or abstract, independently by 2 
reviewers (M.S., D.M.). Full-text versions of the selected studies were reviewed, and if 
they met the eligibility criteria, the study was included in the current systematic review. 
Disagreements were solved by consensus.
Data extraction
Three independent reviewers (M.S., S.L., and J.P.) performed data extraction from each 
included publication. Extracted characteristics of the included studies were as follows: 
number of included subjects, sex, average age, time between surgery and evaluation, 
imaging technique and experience of examiner. The outcome measures were percentages 
of tendon regeneration, the time course of regeneration, the morbidity of harvested 
hamstrings not regenerated, and determinants predicting the regeneration potential of 
the hamstring tendon. Hamstring tendon regeneration rates are displayed in percentages 
based on their follow-up periods (less than or more than 1 year).
Risk-of-bias assessment
We assessed the risk of bias of studies using a quality assessment list (Table 1), based 
on modified questions of existing quality assessment tools6, 7, 29. The purposes of 
this systematic review were of a different nature. Studies reporting the rate of tendon 
regeneration were considered to have a low risk of bias if consecutive patients were 
included and if the imaging technique used was valid and reliable. Next to these criteria, 
in order to be considered to have a low risk of bias, articles investigating a relationship 
between tendon regeneration and determinants of regeneration or clinical outcome had 
to use valid determinants as well as an unbiased assessment of the study outcome and 
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determinants. Two independent researchers performed the risk-of-bias assessment. 
Disagreement was solved by consensus.
Table 1. Criteria for the risk-of-bias assessment.
Question Response
1. Is there a clearly stated aim? The study must have a study question, main aim or objective. 
The question addressed must be precise and relevant in light 
of the available literature. To be judged as adequate, the aim of 
the study must be consistent with the description given in the 
introduction of the paper.
2. Were consecutive patients included?a, b The investigators must state ‘consecutive patients’ or ‘all patients 
during period from X to X.’
3. Are inclusion and exclusion criteria described? Inclusion and exclusion criteria must be reported.
4. Is the inclusion of patients described? The number of eligible patients who agreed to participate (ie. 
gave consent) must be reported.
5. Was data collection prospective? That is, were 
data collected according to a protocol established 
before the beginning of the study?
The investigators should state ‘prospective’ or ‘follow-up’. A 
study is not prospective when the study design is a chart review 
or database review.
6. Was the imaging technique used to confirm 
regeneration valid and reliable?a, b
To be judged as adequate, at least 1 of the following imaging 
techniques must be used: histological biopsy, magnetic 
resonance imaging, echo / ultrasound, computed tomography. 
All other imaging techniques are judged as inadequate.
7. Was assessment of the study outcome and 
determinants unbiased?b
To be judged as adequate, outcome(s) and determinants have to 
be measured independently of each other.
8. Were the determinants measures used 
accurate (valid and reliable)?b
To be judged as adequate, the determinant measures must be 
shown to be valid and reliable, or the investigators must refer to 
other work that demonstrates the determinant measures to be 
accurate.
9. Was the follow-up period appropriate for the 
aim of the study?
To be judged as adequate, the study must report the follow-up 
period, and a study must entail 3 months’ minimal follow-up.
10. Was loss of follow-up reported and 
acceptable?
To be judged as adequate, the study must report the loss of 
follow-up, and the loss of follow-up must be ≥20%.
11. Was the sample size calculated before the 
study was initiated?
To be judged as adequate, calculation of the sample size must 
have been made before the study was initiated.
12. Were the statistical analyses adequate? To be judged as adequate, the following aspects must be met:
-  The relationship between the determinant and the primary 
outcome was described.
-  There was an adjustment for age and/or sex. A study was 
inadequate if the effect of the main confounders was not 
investigated or confounding was demonstrated but no 
adjustment was made in the final analyses.
-  The variance of the outcome was reported (e.g. standard 
deviation, confidence interval)
aJudged as adequate for studies investigating the rate of hamstring tendon regeneration.
bJudged as adequate for studies investigating a relationship between hamstring tendon regeneration and 
determinants or clinical outcome.
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When the article met the criterion, 1 point was granted, if the criterion was not met, 0 
points were given. If the information concerning the specific criterion was not available 
in the study and information was not available after contacting the authors, 0 points were 
given.
Statistical analysis
In this systematic review, data for hamstring tendon regeneration were pooled. 
Regeneration rates less than 1 year after harvesting were pooled, and regeneration rates 
more than 1 year after harvesting were pooled. Distribution of the pooled data are 
displayed as median and interquartile range (IQR).
RESULTS
Literature search
From initial 2957 relevant articles identified, 2939 publications were excluded based on 
title and abstract, because they did not meet the inclusion criteria. Consequently, a total 
of 18 studies were included. A flow chart of the literature search is presented in Figure 1.
Hamstring tendon regeneration rates were reported in 17 of the included studies, and 
6 of the included studies reported possible determinants for hamstring regeneration or 
clinical outcome. Chapter 2 figuur 2                
 
Records identified through database search (n=11.7666) 
Removal of duplicates (n=8.809) 
Records screened  (n=2.957)  Records excluded  (n=2.939)  
Studies included in systematic review (n=18)  
Figure 1. Flow chart.
Risk-of-bias assessment
According to the predefined criteria, 6 articles that considered the rate of hamstring 
tendon regeneration had a low risk of bias4, 11, 15, 26, 27, 30. Three studies investigating 
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possible determinants for hamstring regeneration or clinical outcome had a low risk 
of bias4, 11, 26 (Supplementary Table 2). Other studies did not meet the criteria and were 
therefore considered to have a high risk of bias.
Study characteristics
The study sizes ranged from 10 to 50 patients. The average age of the included patients 
varied from 20 to 37 years. Male participation ranged from 27% to 100%. Follow-up 
time ranged from 1 week to 10 years. Table 2 shows the data extraction of the studies 
evaluating hamstring tendon regeneration after harvesting.
Measuring methods
The included studies used different imaging techniques to determine regeneration of the 
hamstring tendons. Magnetic Resonance Imaging (MRI) was the most common used 
technique (12/18)2, 4, 9, 11, 15, 19, 23, 24, 28, 30, 34, 35. Other techniques used were 3-dimensional 
computed tomography (2/18)20, 21, histological biopsy (3/18)9, 26, 31 and ultrasound 
(3/18)3, 27, 31.
To be assessed as regeneration, all the included studies demanded at least regrowth 
of tendon tissue. Next to this, different studies used their own scoring system with 
additional points of interest (e.g. cross-sectional area of muscles and tendons, muscle 
volume, muscle length, proximal shift of the musculotendinous junction, pixel value, and 
insertion site) to assess the presence or absence of regeneration.
Tendon regeneration
All included studies reported their exact regeneration rates except from Rispoli et al28. 
The regeneration rates varied overall from 50% to 100% for the semitendinosus tendon 
and from 46% to 100% for the gracilis tendon (Table 3). Regeneration of the gracilis 
tendon was only measured by use of MRI. After the data were pooled, the overall mean 
regeneration rate in the first year after harvesting was 91% (median [IQR], 97[74-100]) 
for the semitendinosus and 100% for the gracilis tendon. The overall mean regeneration 
rate more than 1 year after harvesting was 79% (median [IQR], 80 [75.5-90]) for the 
semitendinosus and 72% (median [IQR], 80 [61-88.5]) for the gracilis.
Time path of tendon regeneration
Five studies determined the regeneration rate at different points in the first year after 
ACL reconstruction. Eriksson et al.11 described that no tendon regeneration could be 
observed 2 weeks after surgery, but 6 months after surgery, the majority of the patients 
(73%) showed regeneration.
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Nakamae et al.21 reported that no regeneration could be observed 1 month after surgery. 
However, 90% of the patients showed regeneration at 9 months after ACL reconstruction, 
and all the patients showed regeneration after 1 year21.
In accordance with Eriksson et al.11, Papandrea et al.27 did not report any regeneration 
after 2 weeks. Papandrea et al.27 reported that after 12 months, all fibers of the regenerated 
tendon were attached to the medial popliteal fascia.
Rispoli et al.28 made no differentiation between regeneration of the semitendinosus 
and gracilis tendon, but the authors reported fluid or edema in the semitendinosus and 
gracilis tract 2 weeks after harvesting. Although a neotendon seemed to be present after 
12 months, the most distal 3 to 4 cm of this neotendon remained ill defined28.
Murakami et al.19 used an inducer technique meaning that the gastrocnemius branch of 
the harvested semitendinosus was used as a graft to improve the regeneration process. 
This study reported tendon regeneration in all patients 1 month after ACL reconstruction.
Table 3. Regeneration rates before and after 1 year of follow-up.
Regeneration rate, % (n/N)
≤1-y follow-up >1-y follow-up
Author (Year) Imaging technique Semitendinosus Gracilis Semitendinosus Gracilis
Eriksson et al.11 (1999) MRI 73 (8/11)
Papandrea et al.27 (2000) US 100 (40/40)
Eriksson et al.9 (2001) MRI/ Histology 75 (12/16)
Rispoli et al.28 (2001) MRI 100 (20/20)
Tadokoro et al.34 (2004) MRI 79 (22/28) 46 (13/28)
Nakamae et al.21 (2005) 3D-CT 100 (20/20)
Nishino et al.23 (2006) MRI 91 (21/23)
Okahashi et al.26 (2006) Histology 82 (9/11)
Takeda et al.35 (2006) MRI 100 (11/11) 82 (9/11)
Åhldén et al.1 (2012) MRI 89 (17/19) 95 (18/19)
Bedi et al.3 (2012) US 50 (9/18)
Choi et al.4 (2012) MRI 80 (36/45) 76 (34/45)
Janssen et al.15 (2012) MRI 64 (14/22) 100 (22/22)
Murakami et al.19 (2012) MRI 100 (16/16)
Nakamae et al.20 (2012) 3D-CT 97 (38/39)
Snow et al.30 (2012) MRI 80% (8/10)
Stevanović et al.31 (2013) US/ Histology 72 (18/25)
Nomura et al.24 (2014) MRI 88 (21/24)
Total
Median (Interquartile range)
91 (177/195)
97 (74-100)
100 (22/22) 79 (142/179)
80 (75.5-90)
72 (74/103)
80 (61-88.5)
aData are reported as percentage (absolute values) unless otherwhise indicated. 3D-CT, three-dimensional com-
puted tomography; MRI, magnetic resonance imaging; US, ultrasound.
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These five studies show that the process of regeneration took place the first year after 
harvesting and that the regeneration rate could be 100% after one year. However, none of 
these studies reported a clearly defined time period of regeneration. Other studies, with 
only one evaluation moment, reported regeneration rates for the semitendinosus ranging 
from 64% to 97%15, 20.
Determinants for tendon regeneration
Six publications reported possible determinants, such as sex, demographic data, and 
duration of immobilization4, 9, 11, 20, 26, 35.
Patient sex Only 5 publications made a distinction in regeneration rated based on 
sex4, 9, 11, 26, 35. In these publications collectively, regeneration in men could be observed in 
85.5% of the cases and in women in 83.3% of the cases. No study reported a significant 
difference in regeneration rate between men and women.
Demographic data Choi et al.4 and Nakamae et al.20 investigated the effect of several 
demographic factors on hamstring tendon regeneration. No significant difference in 
hamstring tendon regeneration could be found based on age, weight, or height.
Duration of immobilization Nakamae et al. described the effect of duration of 
immobilization after ACL reconstruction on tendon regeneration. They divided the study 
population into 2 groups: a control group with a standard rehabilitation protocol with 
3 days of immobilization (short immobilization) and the intervention group with of 10 
to 14 days of immobilization (long immobilization). In the short immobilization group, 
all patients but one showed tendon regeneration. In the long immobilization group, a 
tendon-like structure was confirmed in all cases. The difference in regeneration rate was 
not statistically significant (p=0.42)20.
Tendon regeneration in relationship with clinical outcome
Seven studies determined whether tendon regeneration influenced the clinical 
outcome4, 9, 15, 19, 20, 23, 34. Clinical outcome was defined as hamstring function and hamstring 
strength.
Choi et al.4 noted that patients without regenerated tendons had more than 4 times as 
much flexor strength deficit compared with patients with 2 regenerated tendons (p<0.05). 
Furthermore, a correlation (ρ=-0.443) was noted between the number of regenerated 
tendons and the amount of functional deficit. This contradicts the results of Janssen et 
al.15 who did not report a significant difference in flexion and extension strength between 
the patients with both hamstring tendons regenerated and the patients with 1 regenerated 
tendon.
Eriksson et al.9 performed several functional performance tests. The Lysholm scores 
showed no statistical difference between the regeneration and no-regeneration group. 
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Furthermore, regarding hamstring strength, no statistical difference between the 
regenerated group and non-regenerated group could be found.
Nakamae et al.20 considered hamstring strength and reported no significant correlation 
between hamstring peak torque and the types of regenerated tendon.
Nishino et al.23 showed that hamstring strength was greatest when the semitendinosus 
tendon regenerated and had a normal length. Hamstring strength was lowest when no 
semintendinosus tendon-like structure could be identified. Unfortunately, no p-values 
were reported.
Using ultrasound, Tadokoro et al.34 were able to differentiate between different 
morphologic regeneration (hypertrophic, atrophic, and unidentifiable regeneration) of 
semitendinosus and gracilis tendons. The hamstring strength of the operated leg was 
compared with the hamstring strength in the nonoperated side. The nonoperated side 
had significantly greater hamstring strength in all cases, except for the hypertrophic 
gracilis tendon group (p=0.077).
DISCUSSION
This systematic review aimed to provide an overview of the current evidence regarding 
hamstring tendon regeneration after harvesting.
The mean regeneration rate less than 1 year and at least 1 year after harvesting for the 
semitendinosus tendon was 91% (median [IQR], 97 [74-100]) and 79% (median [IQR], 
80 [75.5-90]), respectively; for the gracilis tendon, it was 100% and 72% (median 
[IQR], 80 [61-88.5]), respectively. The majority of the hamstring tendon regeneration 
was found to occur between 1 month and 1 year after harvest. No determinants for 
tendon regeneration are described. Six studies determined whether tendon regeneration 
influenced the clinical outcome. However, results of these studies are contradictory.
The included studies reported a wide range of regeneration rates. Several explanations 
can be found for this variation. First, all the included studies used other points of interest 
to assess the rate of regeneration. Second, the assessments are mostly dichotomous, which 
is not in accordance with a gradual, continuous process expected in tendon regeneration. 
Third, studies used different imaging techniques to visualize tendon regeneration. It 
is unlikely that these techniques are equal in all aspects to determine the hamstring 
regeneration. Fourth, patient characteristics such as sample size, age, and sex differed. In 
short, the wide range in reported regeneration rates might be due to the heterogeneity in 
study designs and how tendon regeneration was assessed.
We found counterintuitive results when comparing the high regeneration rates less 
than 1 year after harvesting and the relatively low regeneration rates more than 1 year 
after harvesting. Our aim is to identify the time course of regeneration. This could be 
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established best if only prospective studies were included, measuring regeneration rates 
at different points in time. Studies measuring regeneration only once are less accurate, 
as it is unknown whether regeneration was present before. Considering the included 
studies in this systematic review, it becomes clear that a majority of the studies reporting 
regeneration rates in the first year only had 1 measurement moment9, 19, 21, 27, 28. This may 
have contributed to an overestimation in studies measuring regeneration rates less than 
1 year after harvesting.
The current systematic review aims to clarify the time course of regeneration. Janssen 
and Scheffler14 described in a systematic review 3 different stages of a regenerating 
hamstring; however, the time course of these stages remained unclear. Five studies 
assessed the regeneration rates in patients at different chronological moments the first 
year after harvesting for ACL reconstruction11, 19, 21, 27, 28. Four of these studies reported a 
regeneration rate of 100% after one year19, 21, 27, 28. This result was contradictory to studies 
that used one measure point in time, as several studies reported regeneration rates less 
than 100% in the first year after surgery. Therefore, it remains unclear when regeneration 
is completed and whether reported regeneration rates in the first year after harvesting 
are an overestimation or an underestimation, respectively, due to studies with several 
measurement moments and with a single measurement moment. Studies that used more 
than 1 evaluation point measured a different number of patients at each evaluation point. 
It was not reported whether these patients were the same individuals as the ones who 
were evaluated before11, 21, 28. So the exact time course of regeneration could not be exactly 
clarified, but the majority of hamstring tendon regeneration was found to occur between 
1 month and 1 year after harvest.
Another aim of this systematic review was to identify predictive factors for regeneration. 
Some studies mentioned regeneration rates in men and women separately, but sex as a 
determinant for hamstring tendon regeneration has never been researched. Vourazeris 
et al. considered the possibility of fatty infiltration as an inhibiting factor for tendon 
regeneration in rabbits. However, no fatty infiltration could be found over time after 
hamstring tendon harvesting36. Fatty infiltration cannot be considered as a determinant. 
Altogether, we conclude that neither positive nor negative predictors for hamstring 
tendon regeneration have been described in current literature.
Only 7 studies investigated the relationship between regeneration and clinical 
outcome4, 9, 15, 19, 20, 23, 34. However, these results were contradictory. Choi et al.4 reported 
that the number of regenerated tendons influenced hamstring function. Thus, the clinical 
consequences of the absence of regeneration remain unclear.
In future, more research is required to identify determinants of hamstring tendon 
regeneration. This is important, because if any determinants can be specified, a risk profile 
for regeneration failure could be developed. Based on this risk profile, it will be possible 
to assess whether reharvesting may be possible in the future. Further, more knowledge 
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about the clinical outcome in terms of hamstring strength and hamstring function after 
regeneration may influence the type of surgery chosen. However, because the clinical 
consequences of absence of regeneration remain unclear, better studies are needed to 
clarify this. Rehabilitation programs should be redesigned if it is found that mechanical 
load is a positive or negative predictive factor for regeneration. Further, knowledge about 
the time course of regeneration can change rehabilitation programs, because without 
hamstring regeneration these muscles cannot be rehabilitated or exercised.
The risk-of-bias assessment that we performed showed that the probability of bias is 
high. Six studies that examined hamstring tendon regeneration were considered to have 
a low risk of bias4, 11, 15, 26, 27, 30. Only Choi et al.4, Eriksson et al.11, and Okahashi et al.26, 
investigating the relationship between hamstring tendon regeneration and determinants 
of regeneration and clinical outcome, met the criteria described in the methods 
section4, 11, 26. The strength of evidence is therefore limited because of the quality of the 
available studies. Another weakness of this systematic review is the population size in the 
included studies. Only 2 studies performed a calculation of sample size, and other studies 
were underpowered to allow firm conclusions. However, this systematic review pooled 
data concerning hamstring regeneration and therefore approximated real regeneration 
rates. For this reason, we conclude that hamstring tendons regenerate after harvesting in 
at least 70% of the cases.
In conclusion, the results of this systematic review indicate that the semitendinosus 
and gracilis tendon regenerate in the majority of the patients after harvesting for ACL 
reconstruction. The pooled regeneration rate for the semitendinosus tendon and for the 
gracilis tendon is at least 70% in all cases. While the exact time couse of regeneration 
could not be determined exactly due to heterogeneity of the study designs, the majority 
of hamstring tendon regeneration was found to occur between 1 month and 1 year 
after harvest. No positive or negative determinants for tendon regeneration have been 
described yet. Because of conflicting evidence, no correlation could be described 
between tendon regeneration and clinical outcome. Considering the possible potential 
clinical effect, it is of vital importance to perform more prospective research concerning 
hamstring tendon regeneration after harvesting, its functional deficit, and determinants 
that influence regeneration.
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SUPPLEMENTARY DATA
Supplementary Table 1. Search terms.
(Hamstring/de OR ‘semitendinous muscle’/de OR ‘gracilis muscle’/de OR (hamstring*
OR semitendin* OR gracilis* OR ((single OR double) NEAR/3 bundle*)):ab,ti) AND
(harvesting/de OR autograft/de OR ‘tendon graft’/de OR ‘anterior cruciate ligament
reconstruction’/de OR ‘anterior cruciate ligament’/de/dm_su OR ‘anterior cruciate
ligament injury’/de/dm_su OR ‘anterior cruciate ligament rupture’/de/dm_su OR
((‘anterior cruciate ligament’/de) AND (‘ligament surgery’/de)) OR (harvest* OR
autograft* OR autotransplant* OR gathering* OR transect* OR ((acl OR ‘anterior
cruciate’) NEAR/3 (surg* OR repair* OR reconstruct*))):ab,ti) AND (regeneration/exp
OR evaluation/de OR ‘muscle function’/de OR strength/de OR ‘muscle strength’/de OR ‘tensile strength’/de OR 
torque/de OR ‘knee function’/de OR ‘neuromuscular
function’/de OR ‘range of motion’/de OR ‘muscle contraction’/de OR ‘physical
examination’/de OR ‘medical examination’/exp OR ‘function test’/de OR ‘joint
laxity’/de OR ‘knee instability’/de OR ‘joint instability’/de OR biomechanics/de OR
(recover* OR regenerat* OR evaluat* OR function* OR strength* OR torque* OR torsion* OR force* OR flexion* 
OR (range NEAR/3 motion*) OR (physical* NEAR/3 examin*) OR stabilit* OR instab* OR laxit* OR rotat* OR 
biomechanic*):ab,ti) NOT ([animals]/lim NOT [humans]/lim) AND ([english]/lim OR [dutch]/lim) NOT ([meta 
analysis]/lim OR [systematic review]/lim OR [editorial]/lim OR [letter]/lim OR [note]/lim OR [review]/lim)
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SUPPLEMENTARY DATA
Supplementary Table 2. Risk-of-bias assessment.
Author (Year) 1 2a, b 3 4 5 6a, b 7b 8b 9 10 11 12 Risk of bias
Eriksson et al.(1999) 1 1 0 0 1 1 1 1 0 0 0 0 Low
Papandrea et al. (2000) 1 1 0 0 1 1 0 0 1 0 0 0 Low
Eriksson et al. (2001) 1 0 1 0 1 1 1 1 1 1 0 0 High
Rispoli et al. (2001) 1 0 0 1 1 1 0 0 1 0 0 0 High
Tadokoro et al. (2004) 1 0 1 0 0 1 0 0 1 0 0 0 High
Nakamae et al.(2005) 1 0 1 0 1 1 0 0 1 0 0 0 High
Nishino et al. (2006) 1 0 0 0 1 1 0 0 1 0 0 0 High
Okahashi et al. (2006) 0 1 0 1 1 1 1 1 1 0 0 0 Low
Takeda et al. (2006) 1 0 0 0 1 1 0 1 1 0 0 0 High
Ahlen et al. (2012) 1 0 0 0 0 1 0 0 1 0 1 0 High
Bedi et al. (2012) 1 0 1 0 1 1 0 0 0 0 0 0 High
Choi et al. (2012) 1 1 1 0 1 1 1 1 1 0 0 1 Low
Janssen et al. (2012) 1 1 1 0 1 1 0 0 1 0 1 0 Low
Murakami et al. (2012) 1 0 0 0 1 1 0 0 1 0 0 0 High
Nakamae et al. (2012) 1 0 1 0 0 1 0 0 1 0 1 0 High
Snow et al. (2012) 1 1 1 0 1 1 0 0 1 0 0 0 Low
Stevanovic et al.(2013) 1 0 1 1 1 1 0 0 1 0 0 0 High
Nomura et al. (2014) 1 0 1 0 1 1 0 0 1 0 1 0 High
The numbers 1 to 12 represent questions from the risk of bias assessment.
astudies reporting about hamstring tendon regeneration rate should obtain 1 point to decrease the risk of bias.
bstudies investigating relationship between tendon regeneration and determinants should obtain 1 point to decrease 
the risk of bias.
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ABSTRACT
Background: Patients often report pain in the posterior thigh following harvest of the 
hamstring tendons. This is potentially caused by impaired regeneration of the tendons or 
altered morphological features of the regenerated structures. Therefore, this study aims to 
describe the regeneration and remodeling process of the hamstring tendons on magnetic 
resonance (MR) imaging.
Methods: Patients with anterior cruciate ligament (ACL) injury who underwent 
reconstruction using the hamstring tendons were included in the current study. MR 
imaging was preoperatively acquired and at 1- and 2-year follow-up after surgery. 
Hamstring tendon regeneration and sizes were evaluated at knee joint line level.
Results: 76 out of 93 patients had sagittal and transversal MR images available at 1- and 
2-year follow-up. Two years after surgery, semitendinosus (ST) tendons regenerated 
in 65.8% and gracilis (G) tendons in 82.9%. At 2-years follow-up 10.5% of the patients 
showed an altered regeneration status compared to the first year after surgery. The sizes 
of native ST tendons (mean, interquartile range [IQR], 11.6 mm2 [9.1-13.3]) and gracilis 
tendons (mean [IQR], 7.3 mm2, [6.0-8.5]) significantly increased 2 years after surgery 
to 22.7 mm2 (IQR 11.2-24.4, p=0.02) and 13.6 mm2 (IQR 7.8-18.4, p=0.01) respectively. 
Additionally, musculotendinous junctions shifted proximally in 57.1% of the ST and in 
78.6% of the G tendons.
Conclusions: The regeneration status of ST and G tendons changed in 10.5% of the 
patients over time, resulting in 65.8% and 82.9% respectively at 2-year follow-up. 
Regenerated tendons are hypertrophic and longer compared to their native ones.
Key words: Anterior Cruciate Ligament Reconstruction; Regenerative Medicine; 
Translational Research; Hamstring Tendons; Sports Medicine.
43
Remodeling of regenerated hamstring tendons
3
INTRODUCTION
Hamstring tendon autografts are widely used to anatomically reconstruct a variety of 
structures, such as the anterior cruciate ligament (ACL), the medial patellofemoral 
ligament, lateral ankle ligaments and the coracoclavicular ligament. More specifically, 
the semitendinosus (ST) tendon and/or gracilis (G) tendon are harvested for these 
reconstruction procedures. A particularly interesting feature of hamstring tendons 
is their potential to regenerate after harvest, which is observed in at least 70% of the 
patients15. This regeneration process of the hamstring tendons is less likely to occur with 
aging and in smokers16. Although hamstring tendon regeneration has been investigated 
extensively, knowledge about the tendon remodeling process is limited.
Hamstring tendon remodeling should be considered as a dynamic and continuous 
process that changes morphologic characteristics of the tendons over time, such as the 
cross-sectional area (CSA) and tendon lengths. In addition, impaired or delayed tendon 
remodeling might influence regeneration rates at different follow-up periods. However, 
the vast majority of the current literature assesses hamstring tendon regeneration 
dichotomously and only uses a single follow-up period15. Therefore, the process of tendon 
remodeling following tendon regeneration remains unclear.
Knowledge about hamstring tendon remodeling is of clinical importance for several 
reasons. First, impaired tendon remodeling and premature rupture of the regenerated 
structure might cause retraction of the muscle belly, resulting in clinical symptoms such 
as posterior thigh pain, weakness and cramping7. Second, many patients voice concerns 
about the resection of functional tendons and possibly accompanying functional deficits, 
potentially caused by impaired remodeling mechanisms. Although it has been suggested 
before that regenerated tendons could be used as grafts14, 21, this might partially depend 
on the quality of the tendon remodeling process.
The current magnetic resonance (MR) study aims to describe the hamstring tendon 
remodeling process. In order to assess the remodeling process, the current study focuses 
on three specific outcomes that were repeated at 1-and 2-year follow-up. First of all, 
impaired or delayed remodeling potentially influences hamstring tendon regeneration 
rates. Therefore, hamstring tendon regeneration rates were measured at both 1- and 2-year 
follow-up to assess the quality of the remodeling process. Additionally, the remodeling 
process is likely to influence morphologic features of tendons, such as CSAs and tendon 
lengths.
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METHODS
Study population
The patients were recruited between January 2009 and November 2010 in a prospective 
multicenter follow-up study from three hospitals in The Netherlands: Erasmus MC – 
University Medical Center Rotterdam, Medical Center Haaglanden (The Hague) and 
Reinier de Graaf Gasthuis (Delft)18. In the current study, we included patients that 
participated in the KNALL (KNee osteoarthritis anterior cruciate Ligament Lesion) 
study and underwent a surgical ACL reconstruction entailing both the ST and G tendons. 
Inclusion criteria for this study were (1) ACL rupture diagnosed by physical examination 
and MRI, (2) MRI was preoperatively acquired within 6 months after trauma, (3) patients 
were between 18 and 45 years old. Patients who did not speak Dutch, those with previous 
ACL injury or intra-articular knee trauma or surgery, those with disabling co-morbidity 
and those with osteoarthritic changes on radiography (Kellgren and Lawrence grade > 
0) were excluded. Written informed consent was obtained from all included patients 
and the institutions’ Medical Ethics Committees approved the study (NL 21778.078.08, 
MEC-2008-068).
MRI measurements
MR examinations were performed before surgical reconstruction (baseline), at 1-and 
2-year follow-up. At baseline, MR scans were acquired using three different MR scanners 
(Philips, Siemens or General Electric). The follow-up MR scans were acquired on the 
same MR scanner at 1.5 Tesla. Patients’ knees were imaged in a neutral position using a 
dedicated knee coil. Included MR scans have the following MR pulse sequences: sagittal 
and coronal proton density weighted turbo spin echo (TSE) sequence (slice thickness 
3 mm, TR/TE: 2700/27ms), coronal T2-weighted TSE sequence with fat saturation 
(slice thickness 3 mm, TR/TE: 5030/71 ms), axial proton density and T2-weighted TSE 
sequence (slice thickness 3 mm, TR/TE: 3500/25/74ms) and sagittal 3D water excitation 
double-echo steady state (slice thickness 1.5 mm, TR/TE 21.35/7.97ms).
Assessment of regenerated tendons on MRI
To assess presence of regenerated hamstring tendons, both axial and sagittal MR planes at 
1- and 2-year follow-up had to be available. Based on previous findings, hamstring tendon 
regeneration in the current study was subdivided into three different categories: complete, 
incomplete or no regeneration15. If regenerated ST and G tendons could be visualized 
at the level of the joint line on axial and sagittal planes MR images, the regeneration 
was considered as complete. Tendon regeneration was considered as incomplete when a 
tendon-like structure was absent at the joint line level, but could be identified cranially 
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thereof. If no neotendon could be visualized on any MR image on any level, this was 
considered as no regeneration.
The cross-sectional area (CSA) of the hamstring tendons was assessed in patients with 
complete regeneration of both the ST and G tendons and with MR imaging available 
at baseline (native tendon), 1- and 2-year follow-up (regenerated tendons). CSAs were 
measured in the axial plane at the joint line level using a commercially available MR 
image analysis software (AW Server 2.0, GE Health care).
The location of the musculotendinous junction of the ST and G was determined on 
axial MR images as the most caudal image on which tissue with muscle signal intensity 
was visualized. This anatomic position was then co-localized on the sagittal plane and 
the distance between this location and the extension of the joint line was measured. 
Musculotendinous junctions could be determined in patients with complete regeneration 
of both hamstring tendons and with MR imaging visualizing the distal musculotendinous 
junction at all three time points.
All MR measurements were performed by a trained researcher (M.S.) under supervision 
of a musculoskeletal radiologist (E.O.) and a sports medicine trained orthopaedic surgeon 
(D.M.) with both more than ten years of experience. Baseline and follow-up MR scans 
were assessed concurrently and the order of MR measurements was known. Equivocal 
cases were discussed and solved by consensus.
Statistical analysis
All statistical analyses were performed with IBM SPSS Statistics for Windows (version 
21.0, IBM Corp., Armonk, NY). To test for normality, a Shapiro-Wilk’s test (p>0.05) and 
inspection of the histograms, normal Q-Q plots and box plots were performed. Interquartile 
range (IQR) was obtained for non-normally distributed variables. Furthermore, data 
was tested on skewedness and kurtosis. To determine the interobserver variability 20 
randomly chosen scans were re-assessed by a blinded second observer (E.O.), and an 
inter- and intraclass correlation coefficient (two-way random effects model, absolute 
agreement) was calculated.
RESULTS
Study population
A flow chart of selection of eligible patients is shown in Figure 1. 93 patients met the 
inclusion criteria for the current study. Axial and sagittal MRI planes of 76 patients at 
both post-operative follow-ups were available for analysis. Baseline patient characteristics 
are presented in Table 1. Mean age at trauma was 25.8 years (SD 6.6) and 65.3% were men.
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Total included patient with ACL reconstruction entailing the hamstring tendon (n=93) Excluded (n=17). No sagittal and/or transversal MR images available - - at T1 (n=6) 
- - at T2 (n=5) 
- - at T1 and T2 (n=6) 
MR images available at 1- and 2-year follow-up (n=76) Excluded (n=32). No sagittal and/or transversal MR images available at baseline.  Pre- and postoperative MR images available (n=44) 
Figure 1. Overview of included patients.
aACL, Anterior Cruciate Ligament; MR, Magnetic Resonance; T1, 1-year follow-up; T2, 2-year follow-up.
Table 1. Patient characteristicsa.
n=76
Age at trauma, y 25.8 ± 6.6
Sex (male) – n (%) 49 (65.3)
Body mass index, kg/m2 24.2 ± 3.3
Time from surgery to MRI at 1-year follow-up, m 9.5 ± 2.7
Time from surgery to MRI at 2-year follow-up, m 21.1 ± 4.2
aData are presented as mean ± SD unless otherwise specifi ed.
Regeneration rates
At 1-year follow-up aft er harvesting of the hamstring tendons, 43.3% of the patients 
showed complete regeneration of both tendons. On the contrary, 10.5% of the patients 
showed no regeneration at all. Complete regeneration of the ST tendon was visualized 
in 53.9% of the patients, whereas incomplete regeneration was found in 17.1% of the 
patients. No signs of ST regeneration were found in 28.9% of the patients. Th e G tendon 
regenerated in 59.2% of the patients and showed incomplete regeneration in 25.0% of 
the patients. In 10 patients, complete regeneration of one tendon was accompanied with 
no regeneration of the other tendon. Regeneration rates 9.5 months aft er harvest are 
displayed in Table 2A.
At 2-year follow-up, both tendons regenerated in 42.1% and 11.8% of all patients had no 
tendon regeneration (Table 2B). Complete regeneration of the ST tendon took place in 
53.9% of the patients two years aft er surgery and incomplete regeneration was found in 
11.8%. At 2-year follow-up, the G tendon regenerated completely in 59.2% of the patients 
and did not regenerate in 17.1% of the patients.
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Interestingly, the regeneration status changed in 8 patients (10.5%) over time. The 
regeneration status of the semitendinosus tendon deteriorated in 50% (4 out of 8), 
whereas the gracilis tendon deteriorated in only 12.5% (1 out of 8) of the patients. The 
regeneration status of the semitendinosus and gracilis improved in 37.5% (3 out of 8) and 
25% (2 out of 8) respectively at 2-year follow-up. This implies that 6.7% (5 out 76) of the 
patients improved their regenerated structure over time (Table 3).
At 1-year follow-up, the regeneration starting point was in all 33 cases of incomplete tendon 
regeneration found at the distal muscle sites. This was confirmed in all 28 cases of incomplete 
regeneration at 2-year follow-up. No concurrent regeneration sites could be identified.
Table 2. Regeneration rates.
A. Regeneration at 1-year follow-up.
Semitendinosus
Complete Incomplete No
Gracilis Complete 33 (43.4) 5 (6.6) 7 (9.2) 45 (59.2)
Incomplete 5 (6.6) 7 (9.2) 7 (9.2) 19 (25.0)
No 3 (3.9) 1 (1.3) 8 (10.5) 12 (15.8)
41 (53.9) 13 (17.1) 22 (28.9) 76 (100.0)
n (%).
B. Regeneration 2-year follow-up.
Semitendinosus
Complete Incomplete No
Gracilis Complete 32 (42.1) 3 (3.9) 10 (13.2) 45 (59.2)
Incomplete 6 (7.9) 5 (6.6) 7(9.2) 18 (23.7)
No 3 (3.9) 1 (1.3) 9 (11.8) 13 (17.1)
41 (53.9) 9 (11.8) 26 (34.2) 76 (100.0)
n (%).
Table 3. Patients with altered regeneration statusa.
Patient number 1-year
follow-up
2-year
follow-up
Change in regeneration status
ST G ST G ST G
1 + + + ± = ↓
2 + + - + ↓ =
3 + + - - ↓ ↓
4 + ± - + ↓ ↑
5 ± + - + ↓ =
6 ± + + + ↑ =
7 ± ± + ± ↑ =
8 ± ± + + ↑ ↑
aST, semitendinosus; G, gracilis; +, complete regeneration; ±, incomplete regeneration; -, no regeneration, ↑ im-
provement of regeneration status; ↓ deterioration of regeneration status; =, no change in regeneration status.
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Cross-sectional areas
Of the 30 patients with complete regeneration of both tendons, a total of 15 patients had 
MR imaging available at baseline, 1- and 2-year follow-up. Representative images are 
displayed in Figure 2A-C.
Th e mean CSA of the native ST tendons was 11.6 mm2 (IQR 9.1-13.3), whereas 9.5 months 
aft er tendon harvesting the mean CSA of regenerated ST tendons was increased to 25.1 
mm2 (IQR 15.0-27.0) (p=0.04). Compared to the native tendon, the mean CSA of the ST 
tendons increased to 22.7 mm2 (IQR 11.2-24.4, p=0.02) at 2-year follow-up (Figure 3A).
Th e average CSA of native G tendons was 7.3 mm2 (IQR 6.0-8.5). Th is CSA increased to 
an average of 17.5 mm2 (IQR 11.2-21.5, p<0.01) 9.5 months aft er surgery and to 13.6 mm2 
(IQR 7.8-18.4, p=0.01) at 2-year follow-up (Figure 3B).
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Figure 2. Representative MR images of same patient.
A-C: Images of the cross-sectional area of the left knee before surgery (A), at one 
year follow-up (B), and 2-year follow-up (C). Red color indicates semitendinosus 
tendon, green color indicates gracilis tendon.
D-F: images of the musculotendinous junction of the semitendinosus tendon in a 
single patient A) before harvesting, B) at 1-year follow-up, C) at 2-year follow-up. Red 
dotted line indicates extension of the joint line, white dotted line indicates distance 
between musculotendinous junction and extension of joint line
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Tendon lengths
Of the 30 patients with complete regeneration of both tendons, musculotendinous 
junctions of the ST and G could be visualized at all follow-up measurements in 8 and 
14 patients, respectively. A shift in the location of musculotendinous junction of the ST 
could be determined in 8 patients: the junction was found to be located more proximally 
at both post-operative time points compared to that of the native ST tendons. Similarly, of 
14 patients in whom the musculotendinous junction of the G tendon could be visualized 
pre-operatively, a proximal shift occurred in 11 patients at both post-operative time-
points. Representative images are displayed in Figure 2D-F.
A. B.
Figure 3. Remodeling of cross-sectional areas.
Boxplots displaying the absolute values of CSA (in mm2) at different time points of the (A) semitendinosus and (B)
gracilis tendon.
Mean with second and third quartile. Wickets representing the lowest and highest value.
aT0, baseline; T1, 1-year follow-up; T2, 2-year follow-up; ns, not significant.
Inter- and intraclass correlation coefficients
The two observers agreed on presence of complete regeneration and absence of 
regeneration in every case. Assessment of incomplete regeneration was concordant in 
95% of the cases.
The interclass correlation coefficient of CSA at 1-year follow-up in the regenerated ST 
tendons ranged from 0.97 to 0.99 and for regenerated G tendons from 0.92 to 0.96.
The intraclass correlation coefficient of CSA at 2-year follow-up in the regenerated ST 
tendons ranged from 0.97 to 0.99 and for regenerated G tendons from 0.93 to 0.97.
DISCUSSION
Due to the prospective follow-up, we were able to increase knowledge about how hamstring 
tendons remodel. At a 2-year follow-up period ST tendons regenerated in 65.8% and 
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G tendons regenerated in 82.9%. Interestingly, we reported that the initial regeneration 
status alters in 10.5% of the patients. Additionally, we reported that regenerated hamstring 
tendons are hypertrophic and longer compared to their native ones.
With regeneration rates of 65.8% for the ST and 82.9% for the G tendons at a 2-year 
follow-up period, our findings are in line with previous work15. Compared to the ST 
tendon, the G tendon was more capable of at least partial regeneration. Surprisingly, 5 
tendons that showed signs of regeneration one year after surgery, did not have signs of 
regeneration at the 2-year follow-up time point. We hypothesize that disappearance of 
the initial visualized structure at 1-year follow-up may be caused by the rupturing of 
the regenerated structure10. Another explanation for this phenomenon is that the human 
body may have a certain “time point of no success” and that after this time point, the 
body suspends its own regenerating efforts in the case of non-functionality leading to 
removal of the newly formed, but dysfunctional tissue. On the other hand, five patients 
with initially incomplete regenerated tendons, showed complete regeneration at 2-year 
follow-up.
Over time, various theories have been postulated aiming to explain the capacity and 
direction of hamstring tendons to regenerate after harvest. Analogous to repair of nerve 
lesions along an intact neural sheath, several authors considered the anatomic space 
between the fascial planes of the medial thigh as pathway for regenerating tendons4, 12, 19. 
Based on this, it has been previously hypothesized that tendons regenerate in a proximal 
to distal fashion along the fascial plane7. With presence of the partially regenerated 
tendons on the distal muscle ends, this study might indirectly support this hypothesis. 
As more fascial layers cover the ST tendon, regeneration rates of ST tendons could be 
expected to be higher than those of the G tendon17. However, in the current study we 
found that regeneration rates of the G are increased compared to regeneration rates of 
the ST. These findings are in line with previous studies13, 20. Furthermore, the anatomic 
space between medial layer I and II is not tubular in shape2. Taken this into account, we 
conclude that this pathway cannot result in a similar shape of the regenerated tendon 
compared to the native tendons.
A second theory is that after harvest some peritendinous tissue and tendon sheath is left 
at the most distal end of the ST and G tendon5, 11. Fibroblast precursor cells in this tissue 
then migrate towards the haematoma that is formed in the void space after harvest. The 
precursor cell then start to proliferate and start to produce collagen. In this hypothesis, 
the haematoma acts as a scaffold for tendon regeneration5, 11.
In the current study, we also investigated the CSAs and musculotendinous junction shift 
in regenerated tendons and these findings were compared with native tendons. We found 
significantly increased CSAs of the regenerated tendons at both post-operative time 
points compared to the native tendons. This is in contradiction with Choi et al. who 
reported no statistical significant difference in CSA in regenerated hamstring tendons 
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compared with the native tendons3. However, the average follow-up period of their study 
was 3 years. This fits with the observed trend in the current study that showed an initial 
increase in CSA of the regenerated tendons and gradual decrease over time. Another 
important finding is that the range of CSAs of the regenerated tendons is increased 
compared to the range of the native tendons. The phenomenon of tendon hypertrophy 
after tendon lesion has been described before1. The range of increased CSAs is wide, as 
some regenerated tendons are hypertrophic, whereas others hardly are. This suggests 
that the extent of hypertrophy depends on patient characteristics. Our finding that the 
musculotendinous junction of both tendons shifted proximally is in line with previous 
studies3, 9. This finding is of clinical relevance as it has been previously suggested that the 
extent of muscle retraction might correlate with symptoms, such as cramping, weakness 
and pain of the posterior thigh6-8. Although smaller retractions might be relatively 
common in asymptomatic patients, patients with higher retractions might report the 
previous mentioned symptoms. In addition, this study reports that both hamstring 
tendons can regenerate independently from each other. The extent of retraction might 
be less if one of both tendons regenerates. Also, the fact that all kind of variations in 
regeneration are possible might affect clinical outcome.
The primary strength of our study is the large number of included patients. This is, to 
our knowledge, the first study that has investigated hamstring tendon regeneration 
in a prospective MRI study in 76 patients. An additional strength of our study is that 
hamstring tendon regeneration could be assessed at 1- and 2-year follow-up, which 
has never been performed before. Besides, this is the first study that did not describe 
regeneration as a dichotomous process, but differentiated between complete, incomplete 
and no regeneration.
Our study has some limitations. Some patients already underwent an MRI scan before 
assessment of eligibility for the study, resulting in the use of different MRI scanners. 
Secondly, a relatively low number of patients could be included for the analysis of the 
CSA and the musculotendinous junction shift. Although one might suggest that the 
multicenter aspect of the study and subtle surgical differences affect regeneration rates, 
this argument has been invalidated by our previous study16.
Although 65.8% of the ST tendons and 82.9% of the G tendons regenerate, it remains 
unclear why tendons in some patients only regenerate partially or do not regenerate at 
all. Therefore, future studies should focus on identifying determinants and molecular 
mechanisms underlying regeneration processes. Furthermore, the current literature 
is unclear about the clinical consequences of absence of regeneration15 and therefore 
possible symptoms reported by patients without regeneration should be investigated.
In conclusion, the results of this prospective multicenter MR imaging study indicate that 
the ST tendons regenerate in 65.8% and the G tendons in 82.9% of the patients. There 
was a change in extent of regeneration in 10.5% of the patients over times, in which 
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both improvement and deterioration were seen. Additionally, regenerated tendons are 
hypertrophic and longer compared to their native ones. Future research should focus 
understanding the cellular and molecular mechanisms of the tendon regeneration and 
remodeling process.
Perspective
This study provides insight in the dynamics of tendon regeneration processes, in terms 
of regeneration rates, morphological characteristics and possible molecular pathways of 
regeneration. An important finding is that an initial regenerated structure may fail over 
time10. Although regenerated tendons might be used for re-reconstruction purposes, the 
failure of regenerated tendons questions its quality and therefore the use of regenerated 
hamstring tendons in re-reconstruction procedures21. Another interesting observation 
is that regenerated hamstrings tendons are hypertrophic compared to native tendons, as 
has been described before for the patellar tendon1. The reason for this remains unclear. 
However, one may hypothesize that this is a protection mechanism of the human body 
regarding previous injuries. On the other hand, it may be postulated that the quality of the 
regenerated tendons may be inferior to native tendons and one needs the hypertrophic 
tendons to resist similar strengths as before. Also, this study contributes to the direction of 
future translational research in the field of tendon repair processes. As regeneration starts 
proximally in any case, fibroblast precursor cells in the muscles may migrate towards the 
hematoma that is formed in the void space after harvest5, 11.
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ABSTRACT
Background: Semitendinosus and gracilis tendons may regenerate after harvesting for 
ligament reconstruction procedures. However, predictive factors of tendon regeneration 
and the extent of functional recovery remain unclear.
Purpose: To identify predictive factors for hamstring tendon regeneration and to examine 
the morbidity of nonregenerated hamstring tendons.
Study design: Cohort study; Level of evidence, 3.
Methods: Of the 154 patients who were included in a prospective follow-up study, 79 
underwent reconstruction of the anterior cruciate ligament entailing the hamstring 
tendons and met the following inclusion criteria: (1) anterior cruciate ligament rupture 
diagnosed by physical examination and magnetic resonance imaging (MRI), (2) MRI 
within 6 months after trauma, (3) age between 18 and 45 years, and (4) 2-year follow-
up MRI data available. Hamstring tendon regeneration was assessed as complete if a 
tendon-like structure could be visualized at level of joint line or more cranially. Patient 
characteristics - such as age, gender, body mass index, alcohol/nicotine use, activity 
level (Tegner scores) and functional instability (1-legged hop test) – were evaluated 
preoperatively and at 2 years to determine predictive factors for tendon regeneration or 
examine functional recovery of hamstring tendon regeneration.
Results: At 2 years’ follow-up, 67.1% of the patients showed regeneration of 
semitendinosus tendons, 81.0% of gracilis tendons and 59.5% of both tendons. The 
likelihood of semitendinosus regeneration significantly decreased with aging (odds ratio 
[OR], 0.92 change per year of age; 95% CI, 0.84-0.99; p=0.03) and smoking (OR, 0.20; 95% 
CI, 0.05-0.77; p=0.02). No predictive factor was found for gracilis tendon regeneration. 
Regeneration of the semitendinosus and gracilis tendons was negatively related with 
smoking (OR, 0.22; 95% CI, 0.06-0.79; p=0.02). Patients without regeneration showed 
similar postoperative visual analog scale scores during physical activity, similar Tegner 
scores, and a significant decrease of the upper leg circumference, as compared with 
their preoperative results. Regardless the regeneration status, 1-legged hop test results 
significantly increased at 2-year follow-up.
Conclusions: Hamstring tendon regeneration occurs less frequently in older patients and 
in smokers. However, absence of regenerated tendons does not seem to cause a loss of 
function.
Key Terms: hamstring tendon regeneration; predictive factors; functional outcome; 
recovery; anterior cruciate ligament reconstruction.
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INTRODUCTION
Anterior cruciate ligament (ACL) rupture is a common sports-related injury of the 
knee. Estimations of annual incidences reach up to approximately 5 to 8 per 10,000 
persons26, 31. Numerous graft choices exist for ACL reconstruction, such as hamstring 
tendons autografts and bone-patellar tendon-bone (BPTB) autografts. Because of donor 
site morbidity and patellar tendon ruptures with the use of BPTB autografts, hamstring 
tendon autografts are a commonly employed option1, 15, 22, 42.
Cross et al. were the first to describe the potential of hamstring tendons to regenerate after 
harvesting procedures for ACL reconstructions12. In a previous study, semitendinosus 
and gracilis tendons regenerated in at least 70% of the patients after harvesting37. 
Currently, it is unknown why some tendons lack the capacity to regenerate37. Mechanical 
load and controlled mobilization are related to a beneficial effect on tendon recovery 
after injury4, 41, 44. On the contrary, smoking23, aging29, 33, and alcohol use16 are related 
with tendon healing failure. The role of non-steroid anti-inflammatory drugs (NSAIDs) 
in healing processes remains unclear14, 32. However, the available literature does not 
describe predictive factors specifically for hamstring tendon regeneration, which could 
be considered an altogether different process from tendon healing.
A systematic review reported on the morbidity and function loss of nonregenerated 
hamstrings37. The exact mechanism of the absence of hamstring tendon regeneration is 
presently unclear. Several cases were described in which patients experienced a persistent 
sharp pain in the dorsal aspect of the thigh in the early stage after surgery, perhaps caused 
by rupturing of the regenerated structure28. Another explanation might be that the 
human body suspends its regenerating efforts in case of nonfunctional tissue, resulting 
in a removal of the newly formed but dysfunctional tissue. Although different studies 
investigated the clinical response to hamstring tendon regeneration, its consequences 
remain unclear because of conflicting evidence. A systematic review summarized studies 
that examined the effect of tendon regeneration on hamstring strength and function37, 
reporting conflicting evidence regarding the relationship between regeneration status and 
deep knee flexion. Some studies cited a deep knee flexion deficit among patients without 
regeneration11, 30, whereas other studies contradicted this finding13, 19, 27. In addition, there 
is no consensus about the clinical relevance of the number of regenerated hamstring 
tendons. Some studies suggested that the extent of deep knee flexion deficits is limited if 
both tendons regenerate11. Other studies did not find a relationship between the number 
of regenerated tendons and strength deficits19.
Nevertheless, insight into determinants of hamstring tendon regeneration and its clinical 
consequences is relevant for several reasons. First of all, patients voice concerns about 
harvesting the tendons of functional muscles and the possible accompanying functional 
deficits. If predicting factors are identified, the chances of hamstring tendon regeneration 
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could be estimated more accurately. This may affect the choice of hamstring tendons as an 
autograft and provide insight in the clinical consequences of regenerated hamstring tendons. 
After all, knowledge of determinants for hamstring tendon regeneration may lead to life 
style modification before surgery and changes in rehabilitation programs after surgery.
The aim of the current study was to (1) identify predictive factors for hamstring tendon 
regeneration and (2) examine the effect of tendon regeneration on hamstring strength 
and function.
METHODS
Study Population
Between January 2009 and November 2010, patients were included in the Knee 
Osteoarthritis Anterior Cruciate Ligament Lesion (KNALL) study: a prospective 
multicenter cohort study with 2 years of follow-up. Patients were recruited from 3 hospitals 
in The Netherlands: Erasmus MC-University Medical Center Rotterdam, Medical Center 
Haaglanden (The Hague) and Reinier de Graaf Gasthuis (Delft). Inclusion criteria for the 
KNALL study were (1) ACL rupture diagnosed by physical examination and magnetic 
resonance imaging (MRI), (2) MRI made within 6 months after trauma, and (3) age 
between 18 and 45 years. Patients who did not speak Dutch, those with previous ACL 
injury or intra-articular knee trauma or surgery, those with disabling comorbidity and 
those with already osteoarthritic changes on radiographs (Kellgren and Lawrence grade 
> 0) at baseline were excluded. Patients were treated operatively or nonoperatively 
independent of the study, according to the decision of the treating physician in accordance 
with the Dutch ACL guideline24. In the current study, operatively treated patients were 
included when 2-year follow-up MRI, completed questionnaires, and data of physical 
examination at baseline and 2-year follow-up were available. Patients were excluded if the 
initial treatment was other than an ACL reconstruction entailing the hamstring tendons. 
Written informed consent was obtained from all included patients, and the institutions’ 
medical ethics committees approved the study.
Measurements
Two-year follow-up MRI scans were acquired on a 1.5-T MRI scanner. The patient’s legs 
were set in a neutral position through a dedicated knee coil. Details of MRI parameters 
are shown in Table 1.
Hamstring tendon regeneration was evaluated by an intensively trained researcher 
(M.S.) who was blinded for clinical information. Hamstring tendon regeneration was 
assessed at 2 years’ follow-up for patients who underwent surgical ACL reconstruction 
with the hamstring tendons. Equivocal cases were discussed with a musculoskeletal 
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radiologist (E.O.) and a sports medicine-trained orthopaedic surgeon (D.M.), both 
with more than ten years of experience, and solved with consensus. Hamstring tendon 
regeneration was assessed at 2-year follow-up for patients who underwent surgical ACL 
reconstruction with the hamstring tendons. If regenerated tendons could be visualized 
at the level of the joint line or more cranially, regeneration was assessed as complete. If 
no neotendons could be visualized on any MRI scan on any level, this was considered no 
regeneration. Therefore, 4 subgroups of regeneration were distinguished: regeneration of 
the semitendinosus tendon and gracilis tendon, regeneration of only the semitendinosus 
tendon, or regeneration of only the gracilis tendon, and no regeneration of either tendon.
Table 1. Parameters of magnetic resonance imaginga.
Pulse Sequence Slice thickness, mm TR/TE, ms
Sagittal and coronal proton density TSE sequence 3 2700/27
Coronal T2-weighted TSE sequence with fat saturation 3 5030/71
Axial proton density and T2-weighted TSE sequence 3 3500/25/74
Sagittal 3D water excitation double-echo steady state 1.5 21.35/7.97
aTE, echo time; TR, repetition time; TSE, Turbo Spin Echo.
Harvesting procedure
After an oblique skin incision just medial to the tibial tuberosity, the subcutaneous tissue 
was dissected to expose the sartorius fascia. A reversed L-shaped incision on this fascia 
was made to free the whole pes anserinus. The gracilis and semitendinosus tendons were 
divided from the conjoined tendon of the pes anserinus and whip stitched. Both tendons 
were harvested with a closed tendon stripper. The sartorius fascia was then sutured in its 
anatomic position. No drains were used.
Rehabilitation
Rehabilitation consisted of full weightbearing and use protective crutches use for 6 weeks. 
No immobilisation or brace was applied. Return to play was considered appropriate in 
concurrence with the advice of the physiotherapist, on average at 8-9 months after surgery. 
No specific functional or quantitative protocol, such as isokinetic testing, was obligatory.
Data collection
All included patients were requested to complete several questionnaires. One trained 
medical doctor (B.M.) who was blinded for the regeneration status, performed a 
standardized physical examination and history taking at baseline and 2 years’ follow-up. 
To evaluate determinants for hamstring tendon regeneration and the clinical consequence 
of nonregenerated tendons, the following factors and outcome measurements were 
documented:
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•	 Patient	 characteristics:	 sex,	 age	 and	 body	mass	 index	 at	 baseline.	The	 role	 of	 the	
patient’s sex in the process of tendon regrowth remains unclear37. Aging seems to 
affect tendon regeneration negatively29, 33. No data about the correlation of body mass 
index and tendon regeneration were available. Therefore, patient’s body mass index 
was determined and categorized into 1 or 3 groups: <25, 25-30, and > 30 kg/m2.
•	 Mechanical	load:	mechanical	load	is	associated	with	a	beneficial	effect	on	hamstring	
tendon regeneration4, 41, 44. Therefore, preinjury and 2-year follow-up Tegner scores 
were analyzed as a reflection of mechanical load.
•	 Hospital:	 some	 studies	 suggested	 an	 effect	 of	 surgical	 proceedings;	 therefore,	 the	
surgeon may be a factor that affects regeneration capacity37.
•	 Toxins:	smoking23 and alcohol use16 seem to negatively affect regeneration changes.
The effect of NSAIDs on regeneration remains unclear14, 32.
•	 Vascular	status:	diabetes	mellitus	(DM)	complicates	wound	healing	and	has	negative	
effects on tendon-healing processes in animal studies3, 10. Moreover, adequate blood 
supply has been shown to be an important factor for ligament healing5.
•	 Clinical	consequences
 o  All patients completed the following questionnaires regarding pain, sports 
activity and knee function: visual analogue scale for knee pain (rest and physical 
activity)20, Tegner scale (pretrauma level)20, Lysholm6, 7, 21, and International Knee 
Documentation Committee (IKDC) questionnaire18, 34, 40.
 o  One-legged hop test (OLHT) was performed, and the upper leg circumference of 
the affected knee was determined.
Statistical analysis
All statistical analyses were performed with SPSS Statistics for Windows (v 21.0; IBM 
Corp). Descriptive statistics were used to describe baseline characteristics. Selection 
of variables was based on the available literature. To analyze predictive factors for 
hamstring tendon regeneration, the study population was subdivided into 3 groups 
based on the regeneration status. Multivariable binomial logistic regressions were 
used to calculate odds ratios (ORs) and 95% CIs for determinants of regeneration of 
hamstring tendon. Qualitative variables were coded in the following way: sex (man, 0; 
woman, 1), smoking (no, 0; yes, 1), alcohol use (no, 0; yes, 1), NSAID use (no, 0; yes, 
1). Positive predictive values were calculated for the determinants that had a significant 
relationship in the multivariable model for hamstring tendon regeneration. Factors were 
tested for multicollinearity. To determine clinical recovery, outcomes of 4 questionnaires 
and physical examination were compared among the 4 regeneration subgroups (both 
tendons, semitendinosus tendon only, gracilis tendon only, none) and the nonoperatively 
treated group (control). Patients who were treated non-operatively were used as controls 
to examine clinical performance of native tendons after a ruptured ACL. Differences 
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between baseline and 2-year follow-up scores were statistically tested with paired t-tests. 
Significance was tested for p-value<0.05. To determine the interobserver variability, 20 
randomly chosen scans were reassessed by a blinded second observer (E.O.), and an 
intraclass correlation coefficient (ICC; 2-way random effects model, absolute agreement) 
was calculated.
RESULTS
Study population
Of the 143 patients for whom MRI at 2-year follow-up was available, the baseline 
characteristics are presented in Table 2.
Table 2. Patient characteristics at baselinea.
Median (IQR) or No. (%)
Age, y 25.2 (21.4 – 32.6)
Male 94 (65.7)
Body mass index, kg/m2 23.9 (22.0 – 26.2)
Injured side: right 76 (53.1)
Pretrauma Tegner score 9 (7 – 9)
Upper leg circumference of index knee, cm 46.7 (43.0 - 48.0)
One leg hop test of index leg, cm 55.0 (25.0 – 85.0)
aIQR, interquartile range.
During the 2-year follow-up period, 93 patients underwent an ACL reconstruction 
procedure. A surgical procedure entailing hamstring-tendon grafts was performed in 87 
patients (93.5%), BPTB in 4 patients (4.3%), and a combination of hamstring tendon 
and allograft in 2 patients (2.2%). Postoperative MRI was available for 79 patients who 
underwent an ACL reconstruction with hamstring tendons. At 2 years’ follow-up, 
semitendinosus and gracilis tendons regenerated in 53 (67.1%) and 64 (81.0%) patients, 
respectively. No tendon regeneration was reported for 9 (11.4%) patients. Figure 1 
displays an overview of the regeneration subgroups. Figure 2 provides a flow chart of 
inclusion for eligible patients.
Predictive factors
Predictive factors were examined in cases of regeneration of the semitendinosus 
tendon (n=53), gracilis tendon (n=64), and both tendons (n=47). Regeneration of the 
semitendinosus tendon was significantly related with age (OR, 0.92 per change per year; 
95% CI, 0.84-0.99; p=0.03) and smoking status (OR, 0.20; 95% CI, 0.05-0.77; p=0.02). 
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Isolated gracilis tendon regeneration was not related with any of the analyzed predictive 
factors. Regeneration of both tendons was negatively related with patient’s smoking status 
(OR, 0.22; 95% CI, 0.06-0.79; p=0.02). Table 3 represents an overview of the ORs. Because 
only 2 patients had diabetes mellitus and no patients were known to have abnormal 
cardiovascular status, we did not analyze those determinants for hamstring tendon 
regeneration outcome. Coeffi  cients of determination varied from 26% (semitendinosus 
tendons) to 31% (semitendinosus and gracilis tendons). No multicollinearity was 
detected.
For the signifi cant determinants aft er multivariable analyses, see Table 4, which presents 
the positive predictive values for tendon regeneration.
Based on the multivariate binomial logistic regression analysis, an approximation of 
regeneration can be assessed for the semitendinosus tendon and both tendons. For the 
chance of semitendinosus tendon regeneration,
A. B.
 ST G  
 
G  ST 
 ST G  
 
G  ST 
C. D.
 ST G  
 
G  ST 
 ST G  
 
G  ST 
ST, semitendinosus; G, gracilis.
Figure 1: Representative magnetic resonance images at joint-line level aft er hamstrings harvesting.
A Left  knee with regeneration of the semitendinosus and gracilis tendon.
B Left  knee without regeneration of the semitendinosus and gracilis tendon.
C Left  knee with only regeneration of the gracilis tendon.
D Right knee with only regeneration of the semitendinosus tendon.
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P (regeneration semitendinosus) = e
2.245−(0.094×age)+1.4(smoking)
1+ e2.245−(0.094×age)+1.4(smoking).
For the chance of regenerating both tendons,
P (regeneration semitendinosus and gracilis) = e
−0.619+1.363(smoking)
1+ e−0.619+1.363(smoking).
In both formulas, e represents the Euler number. If a patients smokes, the number 1 
should be filled in the formula, whereas if the patients does not smoke, the number 0 
should be filled in.
Clinical consequences
To analyze the clinical consequences of tendon regeneration, the study population 
was divided into 4 groups based on regeneration and 1 nonoperative group as control: 
semitendinosus tendon (n=53), gracilis tendon (n=64), both tendons (n=47), neither 
tendon (n=9), and control (n=50). When compared with preoperative scores, visual 
analog scale scores at physical activity significantly decreased for all groups at two years’ 
follow-up (all p-values <0.001), except for the patients who showed no regeneration of 
 
ST+, G- (n=6) ST+, G+ (n=47) ST-, G+ (n=17) ST-, G- (n=9) 
ST +  (n=53) G+  (n=64) 
Patient diagnosed with ACL injury between January 2009 and November 2010 (n=154)  MRI data unavailable at T2 (n=11) - pregnancy (n=1) - foreign stay (n=3) - not available (n=5) - not willing to participate (n=2)     Inclusion in current study (n=143)  
BPTB graft  (n=4)  Combination graft (n=2)  Hamstring tendon graft (n=87)  
Conservative treatment (n=50)  Excluded (n=8) - no transversal MRI planes (n=5) - T2 < 1 year after surgery (n=3)    Regeneration assessment (n=79)  
Figure 2. Flowchart.
ACL, anterior cruciate ligament; BPTB, bone-patellar tendon-bone; G, gracilis; MRI, magnetic resonance imag-
ing; ST, semitendinosus. +, regeneration; -, no regeneration.
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either tendon (p=0.14). Before trauma, Tegner scores were significantly higher for all 
groups versus 2-year follow-up, except for the patients with no regeneration of either 
tendon. Furthermore, the circumference of the upper leg decreased significantly from 
47.1 cm to 45.5 cm (difference, 1.6; 95% CI of difference, 0.46-2.8; p=0.01) for patients 
with no regeneration of the semitendinosus and gracilis tendons, whereas patients with 
regeneration of at least one tendon did not show a similar decrease. One-legged hop 
test, Lysholm, and International Knee Documentation Committee scores significantly 
increased over time for all groups as compared with their preoperative scores. Table 5 
presents an overview of the functional consequences and hamstring tendon regeneration.
Table 4 Positive predictive values of tendon regenerationa.
Smoking
ST+ ST+/G+
Yesb No PPV Yesc No PPV
Yes 9 11 0.45 7 13 0.35
No 44 15 40 19 
aG, gracilis; PPV, positive predictive value; ST, semitendinosus.; +, regeneration.
bPrior chance: 67.1% (53 of 79).
cPrior chance: 59.5% (47 of 79).
Table 3. Multivariable analysis of possible predictive factors for hamstring tendon regeneration (n=79)a.
ST+ (n=53) G+ (n=64) ST+/G+ (n=47)
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Sex 1.7 (0.54 – 5.6) 0.35 1.4 (0.38 – 5.4) 0.60 0.69 (0.23 – 2.0) 0.50
Age 0.92 (0.84 - 0.99) 0.03b 1.0 (0.92 – 1.1) 0.92 0.95 (0.88 – 1.0) 0.16
NSAID use 0.57 (0.15 – 2.2) 0.42 1.1 (0.23 – 5.1) 0.93 0.52 (0.15 – 1.9) 0.31
BMIc, kg/m2
25-30 1.6 (0.43 – 6.3) 0.47 2.1 (0.46 – 9.3) 0.35 1.8 (0.52 – 6.1) 0.36 
>30 0.27 (0.02 – 3.8) 0.33 1.0 (0.06 – 17) 0.99 0.27 (0.02 – 3.6) 0.32 
Smoking 0.20 (0.05 – 0.77) 0.02b 0.40 (0.10 – 1.6) 0.19 0.22 (0.06 – 0.79) 0.02b
Alcohol 1.3 (0.36 – 4.9) 0.67 0.86 (0.21 – 3.5) 0.83 1.7 (0.50 – 5.7) 0.41
Surgeond
2 1.1 (0.17 – 7.1) 0.91 3.0 (0.31 – 30) 0.34 2.4 (0.41 – 14) 0.33 
3 0.67 (0.08 – 5.4) 0.71 2.6 (0.21 – 33) 0.45 1.6 (0.22 – 11) 0.65 
4 0.21 (0.01 – 6.2) 0.37 N/A  0.60 (0.02 – 15) 0.75 
5 0.54 (0.11 – 2.6) 0.44 1.3 (0.24 – 6.7) 0.79 1.3 (0.31 – 5.5) 0.71 
6 1.7 (0.20 – 15) 0.62 N/A  3.5 (0.45 – 27) 0.23 
aBMI, body mass index; G, gracilis; N/A, not available; NSAID, nonsteroid anti-inflammatory drug; OR, odds 
ratio; ST, semitendinosus; +, regeneration.
bp-value<0.05.
cReference: <25 kg/m2.
dReference: surgeon 1.
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Table 5. Functional consequences and hamstring tendon regenerationa.
 
 
Mean (SD) Difference
(95% CI) p-valueT0 T2
VAS (at rest)b ST+ (n=53) 1.1 (1.6) 0.47 (0.9) 0.65 (0.20 – 1.1) 0.005c
G+ (n=64) 1.2 (1.8) 0.52 (1.0) 0.69 (0.22 - 1.2) 0.005c
ST+/G+ (n=47) 1.1 (1.7) 0.52 (0.95) 0.61 (0.11 – 1.1) 0.017c
ST-/G- (n=9) 0.83 (0.85) 0.34 (0.45) 0.49 (-0.26 – 1.2) 0.17
control (n=50) 0.71 (1.2) 0.41 (0.75) 0.29 (-0.07 - 0.66) 0.11
VAS (during 
movement)
ST+ 2.8 (2.5) 0.73 (0.99) 2.1 (1.4 - 2.8) <0.001c
G+ 2.8 (2.6) 0.86 (1.2) 1.9 (1.2 – 2.6) <0.001c
ST+/G+ 2.7 (2.5) 0.80 (1.0) 1.9 (1.1– 2.6) <0.001c
ST-/G- 2.5 (2.0) 1.1 (1.3) 1.3 (-0.52 - 3.2) 0.14
control 2.3 (2.2) 1.0 (1.5) 1.3 (0.55 - 2.0) <0.001c
Tegner ST+ 8.3 (1.4)d 7.1 (1.9) 1.2 (0.68 - 1.6) <0.001c
G+ 8.3 (1.4)d 6.8 (1.9) 1.5 (1.0 – 1.9) <0.001c
ST+/G+ 8.3 (1.4)d 7.1 (1.9) 1.1 (0.66 – 1.6) <0.001c
ST-/G- 7.8 (1.4)d 6.4 (1.5) 1.3 (-0.10 – 32.8) 0.65
control 7.5 (1.6)d 5.5 (2.0) 2.0 (1.4 - 2.6) <0.001c
Lysholm ST+ 77.2 (13.1) 93.0 (7.2) 15.8 (12.5 – 19.2) <0.001c
G+ 75.4 (16.0) 92.8 (7.3) 17.4 (13.5 – 21.2) <0.001c
ST+/G+ 76.9 (13.7) 92.8 (7.4) 15.9 (12.1 – 19.6) <0.001c
ST-/G- 64.6 (11.7) 87.8 (15.8) 23.2 (9.1 – 37.3) 0.005c
control 74.6 (16.8) 91.6 (12.3) 17.0 (11.6 - 22.4) <0.001c
IKDC ST+ 54.4 (14.9) 87.6 (10.4) 33.2 (28.9 – 37.5) <0.001c
G+ 52.9 (16.3) 87.8 (11.2) 34.9 (30.4 – 39.3) <0.001c
ST+/G+ 54.2 (14.9) 87.9 (10.3) 33.7 (29.0 – 38.4) <0.001c
ST-/G- 50.8 (11.3) 85.2 (16.0) 35.4 (18.7 – 50.0) 0.001c
control 59.2 (19.0) 84.3 (14.7) 25.1 (10.2 – 30.9) <0.001c
One-legged hop test 
(cm)
ST+ 53.2 (38.7) 110.8 (29.4) 57.6 (46.8 – 68.3) <0.001c
G+ 52.5 (38.9) 113.1 (30.9) 60.5 (50.7 -70.4) <0.001c
ST+/G+ 54.1 (38.6) 111.2 (30.1) 57.1 (46.2 – 68.1) <0.001c
ST-/G- 37.4 (40.2) 94.6 (26.6) 57.1 (31.1 – 83.1) 0.001c
control 57.9 (37.9) 101.3 (36.5) 43.3 (33.4 - 53.3) <0.001c
Circumference 
upper leg (cm)
ST+ 45.6 (4.8) 45.4 (3.7) 0.19 (-0.83 – 1.2) 0.71
G+ 47.3 (12.8) 45.7 (3.6) 1.6 (-1.5 – 4.8) 0.31
ST+/G+ 45.8 (5.0) 45.6 (3.8) 0.23 (-0.90 – 1.4) 0.68
ST-/G- 47.1 (4.7) 45.5 (4.5) 1.6(0.46 – 2.8) 0.01c
control 46.6 (5.5) 46.3 (4.4) 0.31 (-0.62 - 1.3) 0.50
aG, gracilis; IKDC, International Knee Documentation Committee; ST, semitendinosus; T0, preoperative; T2, 
2-year follow-up; VAS, visual analog scale; + regeneration; -, no regeneration.
bSample sizes apply to each grouping.
cp<0.05.
dPretrauma Tegner.
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Inter- and intracorrelation coefficients
The 2 observers agreed on presence of complete regeneration and absence of regeneration 
in every case. Assessment of incomplete regeneration was concordant in 95% of the cases.
The interclass correlation coefficient of cross-secitonal areas in the regenerated 
semitendinosus tendons ranged from 0.97 to 0.99 and for regenerated gracilis tendons 
from 0.92 to 0.96.
The intraclass correlation coefficient of cross-sectional areas in regenerated semitendinosus 
tendons ranged from 0.97 to 0.99 and for regenerated gracilis tendons from 0.93 to 0.97.
DISCUSSION
Hamstring tendon regeneration occurs in at least 70% of the patients37. The results of 
this prospective observational follow-up study show that hamstring tendon regeneration 
occurs significantly less frequent in patients who smoke. Furthermore, semitendinosus 
tendons are less likely to regenerate in older patients. If none of the harvested tendons 
regenerated, patients did not report improved physical activity and a significant decrease 
of their upper leg circumference was observed.
In the current study, semitendinosus tendons regenerated more often than gracilis 
tendons. This finding is in line with previous studies37-39. To explain the difference in 
regenerative capacity, we developed the following hypothesis: that hamstring tendon 
regeneration occurs behind the deep layer of the thigh fascia. Regarding this fascia, the 
gracilis tissue plane is covered and protected to a lesser extent than to the semitendinosus 
tendon. This anatomic difference may explain inferior gracilis tendon regeneration rates 
versus those of the semitendinosus tendons.
Although previous literature described several determinants for tendon healing, potential 
predictive factors for hamstring tendon regeneration have not been investigated; 
therefore, this study is the first to evaluate potential predictive factors for hamstring 
tendon regeneration based on known factors for tendon healing. For regeneration of the 
semitendinosus tendon, we identified age and smoking as predictive factors. Age-related 
changes in tendons include loss of cellularity, loss of vascularity, and fatty infiltration17. The 
latter two are mainly thought to be responsible for less regenerative capacity in tendons. 
The exact mechanism of smoking on hamstring tendon regeneration remains unclear. It 
could be that nicotine, as a known major vasoconstrictor, affects tendons’ regeneration 
chances by decreasing the blood supply to former harvest sites25. However, nicotine use 
could also be a marker for unhealthy lifestyles. Nonetheless, based on these results, it 
remains hard to predict an individual’s capacity for hamstring tendon regeneration after 
harvest procedure. As with common orthopaedic conditions, we suggest a model of 
intrinsic and extrinsic factors that produce an indication of susceptibility for regenerating 
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processes. However, identifying the cause and genetic linkage of orthopaedic phenotypes 
has proven to be complex and requires further investigation. Therefore, the current study 
points out that regeneration of the semitendinosus is related to patient’s age and smoking 
habits, but it may be that genetic factors also contribute to one’s regeneration capacity.
This study is the first to examine functional consequences of hamstring tendon 
regeneration in 5 subgroups: regeneration of 1 tendon only, regeneration of both tendons, 
no regeneration of either tendon, and a nonoperatively treated group (control). Although 
the primary function of the hamstring muscles is to flex the knee or to decelerate its 
extension, the hamstring muscles control anterior translation of the tibia, sharing the 
stress with the ACL. However, we found that all patients experience better knee stability 
at 2 years’ follow-up, regardless of regeneration status of the hamstring tendons. Second, 
several previous studies used the 1-legged hop test for distance to examine strength and 
confidence in the tested leg34, 35. In the current study, all groups showed a significant 
increase in the 1-legged hop test results, suggesting that the number of regenerated 
tendons does not affect clinical performance. An increase of 1-legged hop test results 
has been reported2; however, this study did not differentiate between patients with and 
without regenerated tendons. In addition, Choi et al. reported no statistically significant 
difference between the number of regenerated tendons and 1-legged hop test results11. 
This is in line with the findings of the current study.
Furthermore, we found that the circumference of the operated upper leg is significantly 
decreased among patients without regeneration versus patients showing regeneration of 
one or more hamstring tendons. A previous study reported that the majority of the upper 
leg atrophy involves the semitendinosus and gracilis muscles36, although this could not be 
confirmed with measurements in the current study.
A previous study of 45 patients investigated the relationship among tendon regeneration, 
flexor strength, and functional tests at a minimum follow-up of 2 years, reporting that 
individual tendon regeneration was associated with fewer knee flexion deficits at 70o and 
with improved performances on the carioca test11. Taken together, the results may suggest 
that lack of regeneration results in knee flexion deficits because of muscle atrophy of the 
harvested tendons.
The current study confirms previous studies’ findings of a significant decrease of upper leg 
circumference in the case of no tendon regeneration, which suggests muscle atrophy8, 43. 
These studies showed a compensatory hypertrophy of the biceps femoris. However, this 
could not adequately compensate the loss of muscle volume measured in the harvested 
medial hamstrings9, 36. Unfortunately, most of these studies compared clinical outcomes 
postoperatively regardless of an individual’s regeneration status. In addition, only 
relatively short-term follow-up studies are available. So, despite some strong indications 
to the clinical relevance of hamstring tendon regeneration, it remains to be seen if different 
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degrees of muscle atrophy and tendon regeneration will have any clinically relevant effect 
on patients at longer-term follow-ups.
The strengths of the current study are its prospective design, availability of baseline 
and follow-up MRI, extensive physical examination, and questionnaires at baseline and 
follow-ups. Because of these strengths, we were able to identify predictive factors and 
clinical consequences of hamstring tendon regeneration for different subgroups.
This study also has some limitations. The parameters used to evaluate the clinical 
consequences of regeneration may be debatable, as they may be not specific for hamstring 
tendons. However, there is currently no test to evaluate the function of the semitendinosus 
and gracilis muscles. Although there are no functional consequences, determining 
muscle function with Biodex measurements may be useful. Another limitation of our 
study is that patients showing regeneration of both t tendons were included in analysis 
for semitendinosus and gracilis regeneration separately; therefore, those 3 groups have a 
certain overlap.
In conclusion, the current study reported that semitendinosus and gracilis tendons 
regenerated in 67.1% and 81.0% of patients, respectively. Furthermore, it points out 
that regeneration of the semitendinosus tendon is related with an individual’s age and 
smoking habits. Likewise, regeneration of both hamstring tendons is negatively related to 
smoking habits. However, absence of regenerated tendons does not seem to cause a loss 
of function.
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ABSTRACT
Objectives: To investigate the functional effect of genetic polymorphisms of the 
inflammatory pathway on structural extracellular matrix components (ECM) and the 
susceptibility to an anterior cruciate ligament (ACL) injury.
Design: Laboratory study, case-control study.
Methods: Eight healthy participants were genotyped for interleukin (IL)1B rs16944 C>T 
and IL6 rs1800795 G>C and classified into genetic risk profile groups. Differences in type 
I collagen (COL1A1), type V collagen (COL5A1), biglycan (BGN) and decorin (DCN) 
gene expression were measured in fibroblasts either unstimulated or following IL-1β, 
IL-6 or tumor necrosis factor (TNF)-α treatment.
Moreover, a genetic association study was conducted in: (i) a Swedish cohort comprised 
of 116 asymptomatic controls (CON) and 79 ACL ruptures and (ii) a South African 
cohort of 100 CONs and 98 ACLs. Participants were genotyped for COL5A1 rs12722 
C>T, IL1B rs16944 C>T, IL6 rs1800795 G>C and IL6R rs2228145 G>C.
Results: IL1B high-risk fibroblasts had decreased BGN (p=0.020) and COL5A1 (p=0.012) 
levels after IL-1β stimulation and expressed less COL5A1 (p=0.042) following TNF-α 
treatment. Similarly, unstimulated IL6 high-risk fibroblasts had lower COL5A1 (p=0.012) 
levels than IL6 low-risk fibroblasts.
In the genetic association study, the COL5A1-IL1B-IL6 T-C-G (p=0.034, Haplo-score: 
2.1) and the COL5A1-IL1B-IL6R T-C-A (p=0.044, Haplo-score: 2.0) combinations were 
associated with an increased susceptibility to ACL injury in the Swedish cohort when 
only male participants were evaluated.
Conclusions: This study shows that polymorphisms within genes of the inflammatory 
pathway modulate the expression of structural and fibril-associated ECM components 
in a genetic risk dependent manner, contributing to an increased susceptibility to ACL 
injuries.
Key words: Anterior cruciate ligament injury; Extracellular Matrix; Genetics; 
Polymorphisms; Personalized Medicine.
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INTRODUCTION
Anterior cruciate ligament (ACL) rupture is a common sports-related injury of the knee1. 
The ability of the ACL to maintain its extracellular matrix (ECM) integrity is critical to 
its function to effectively resist mechanical loads and prevent injury2. Loading activates 
matrix-remodeling pathways to maintain ECM homeostasis, such as the inflammatory 
pathways (Figure 1). Therefore, it is not surprising that polymorphisms within these 
pathways contribute to the susceptibility of ACL injuries3, 4.
Figure 1. Schematic representation of the proposed downstream effects of cytokines IL-1β and IL-6 which 
are upregulated in response to mechanical loading of a ligament 3, 4, 28, 32.
Activation/upregulation is represented by a pointed arrow head (→) and inhibition/down regulation is represented 
by a perpendicular line at the end ( ---| ). The boxed molecules are the ones investigated in the current study. Ab-
breviations: ECM, extracellular matrix; IL-1β, interleukin-1β; IL-6, interleukin-6; IL-6R, interleukin-6 receptor; 
MMPs, matrix metalloproteinases; ROS, reactive oxygen species; TGF-β, transforming growth factor β; TNF-α, 
tumor necrosis factor.
Type V collagen is a functionally important collagen for the maintenance of tissue 
structure and integrity. The major isoforms consists of two α1 (V) and one α2 (V) chains 
encoded by COL5A1 and COL5A2 respectively5. Polymorphisms within the 3’UTR of 
COL5A1 were previously implicated in ACL rupture6 and tendinopathy7. In addition, 
polymorphisms within genes encoding the α1(I) chain of type I collagen (COL1A1)8, 
biglycan (BGN)9 and decorin (DCN)9 were associated with ACL injury susceptibility. 
Together, these molecules form the basic building blocks of the ECM and are involved in 
collagen fibrillogenesis.
Interleukin (IL) -1β is a pro-inflammatory cytokine encoded by IL1B and up-regulates 
the production of matrix metalloproteinases, regulating the degradation of specific 
ECM components, such as collagen types V and X10. In addition, IL-1β induces its own 
expression and the expression of other pro-inflammatory cytokines such IL-6 (Figure 
1)11. The C-allele of the IL1B promoter polymorphism rs16944 C>T increases IL-1β 
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mRNA expression levels12 and is hypothesised to increase susceptibility to tendinopathy 
and ACL injury3, 4.
IL-6 is known to induce apoptotic cell death15 affecting the production of extracellular 
matrix components and thereby the ECM integrity. Polymorphisms within the IL6 
gene that increase IL-6 expression, such as the G-allele of the IL6 rs1800795 G>C 
polymorphism, can therefore potentially be associated with increased risk of ligament 
injuries. IL-6 needs to bind and form complexes with the interleukin-6 receptor (IL-6R) 
in order to exert its biological function. IL-6R exists as two isoforms: a membrane-bound 
receptor and a soluble receptor. IL6R rs2228145 A>C is located in the cleavage site and 
is thought to affect cleavage efficiency. The A-allele is associated with decreased levels 
of soluble IL-6R and an increased response to IL-613. Therefore, we hypothesize that the 
IL6R rs2228145 AA genotype is associated with an increased susceptibility to ligament 
injury.
Although currently no genetic loci within the gene encoding tumor necrosis factor α 
(TNF-α) have been associated with either ACL injuries or tendinopathies, this pro-
inflammatory protein is considered to be key in the inflammatory pathway14. The 
biological function of TNF-α is executed after binding to its receptor, the tumor necrosis 
factor receptor superfamily member 1A (TNFRSF1A). Similar to IL-6, TNF-α is involved 
in apoptosis and thereby possibly contributes to matrix remodeling capacity14.
The main aim of the current study was to investigate the effects of specific genetic loci 
within the inflammatory pathway on the production of ECM components in an injury 
risk model. Additionally, the association of these genetic loci with susceptibility to ACL 
injury was evaluated in two independent populations of different ancestry. Based on the 
a priori hypothesis it was proposed that the IL1B rs16944 CC and the IL6 rs1800795 GG 
downregulate the production of ECM components and should therefore be associated 
with an increased susceptibility to ligament injuries.
METHODS
All participants completed questionnaires regarding personal details, medical history, 
sporting history and a family history of tendon and ligament injury. Written informed 
consent was obtained from all participants according to the Declaration of Helsinki. 
Ethics approval was attained from the Human Research Ethics Commission (HREC) 
of Faculty of Health Sciences, University of Cape Town, South Africa (HREC 164/2006 
and 645/2014) and the Regional Ethical Review Board in Umeå, Sweden (dnr. 2011-200-
31M), where relevant.
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For the in vitro work eight healthy, unrelated South African participants of self-reported 
Caucasian ancestry with no history of musculoskeletal soft tissue injuries were recruited. 
Venous blood and skin biopsies were taken from each participant.
For the Swedish cohort 195 physically active and unrelated participants (age 19-65 years) 
were recruited between 2011 and 2013 from either the Västerbotten or Norrbotten 
regions of Sweden, via the orthopedic clinics in two major hospitals in the cities of Umeå: 
Västerbotten and Luleå: Norrbotten. The majority of the participants were recruited from 
a long-term follow-up of ACL injury15. This cohort consisted of 79 participants with ACL 
rupture (SWE-ACL) and 116 asymptomatic participants without any history of ACL or 
tendon injury (SWE-CON). ACL ruptures were diagnosed based on physical examination, 
magnetic resonance imaging and arthroscopically confirmed at the University hospital in 
Umeå. Mechanism of injury data was categorized into direct contact, indirect contact, 
non-contact and skiing sports as previously defined16. All 79 cases reported a non-contact 
mechanism (SWE-NON) of injury.
For the South African cohort 198 physical active and unrelated participants were recruited 
from South Africa as previously described17. This cohort comprised of 100 asymptomatic 
controls (SA CON) and 98 participants with an ACL rupture (SA ACL) of which 51 
reported a non-contact mechanism of injury.
A previously described protocol with slight modifications18 was used to extract genomic 
DNA from venous blood. Participants participating in the in vitro study were genotyped 
for the IL1B rs16944 C>T and IL6 rs1800795 G>C polymorphisms. Restriction fragment 
length polymorphism (RFLP) analysis was used for IL1B rs16944 (AvaI)4 while custom 
designed fluorescence-based Taqman PCR assays (Applied Biosystems, Foster City, 
CA, USA) were used to genotype IL6 rs1800795. Several controls were included in 
the genotyping protocols which included repeated controls and negative controls. 
Two independent researchers scored genotype results obtained from RFLP analysis. If 
no consensus was reached, or genotyping was not possible, samples were re-analysed. 
TaqMan PCR determines genotype calls automatically, however were manually checked 
by a researcher. In general, all samples were analysed only once. Based on their genotypes, 
participants were either classified in the high-risk or low-risk profile group. More 
specifically, the IL1B TT and CT genotypes were considered as low-risk, whereas the CC 
genotype was considered as high-risk. Additionally, the IL6 CC and GC were classified in 
the low-risk group, and the GG-genotype was classified in the high-risk group.
Participants for the genetic association study were additionally screened for COL5A1 
rs12722 C>T and IL6R rs2228145 A>C. Genotyping of all four single nucleotide 
polymorphisms (SNPs) was conducted in the current study on all samples in both the 
Swedish (n=195) and the South African cohort (n=198). It should be noted that the DNA 
samples of the South African cohort were previously collected17. Restriction fragment 
length polymorphism (RFLP) analysis was used for the COL5A1 rs12722 (BstuI), and 
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IL6R rs2228145 (HindIII) SNPs. All SNPs: COL5A1 rs12722 C>T, IL1B rs16944 C>T, 
IL6 rs1800795 G>C and IL6R rs2228145 A>C were selected based on their previously 
reported genetic associations with risk of ACL ruptures and Achilles tendinopathy19, 20.
To establish primary fibroblast cultures, skin biopsies were processed according to 
a modified Baumgarten protocol21. Human dermal fibroblasts were cultured to 70% 
confluency in Dulbecco’s modified Eagle medium (DMEM, Gibco, Carlsbad, CA, USA) 
with 200 units/mL penicillin, 100 μg/mL streptomycin, 3.97 mM GlutaMAX (Gibco) 
and 10% FBS. Cells were serum-starved for 8h in DMEM and subsequently treated with 
10ng/ml human recombinant (hr) IL-622, 20ng/ml hrIL-1β23 or 10ng/ml hrTNF-α22 (all 
from Peprotech, Rocky Hills, NJ, USA). After 24h, cells were washed twice in ice-cold 
Dulbecco’s phosphate-buffered saline (DPBS, Sigma-Aldrich, Saint Louis, MO, USA) and 
frozen at -80°C until ready for RNA extraction, using the RNAeasy kit (Qiagen, Venlo, 
The Netherlands). Subsequently, a cDNA synthesis kit including a recombinant RNAse 
inhibitor (Thermo Scientific) using oligo (dT)s as primers was used.
A SYBR green-based buffer (Thermo Scientific), 10ng of cDNA, and primers specific for 
the transcript of interest, to a final concentration of 500nM each were mixed. PCR cycles 
were as follows: (2’30’’ at 50°C: 2’30’’ at 95°C) x1, (15’’ at 95°C: 30’’ at 60°C) x50 followed 
by melt-curve analysis (95°C-60°C-95°C). RT-PCR analyses were performed using 
a Quantstudio3 real-time PCR machine (Thermo Scientific). The mRNA expression 
levels of structural matrix components, such as COL5A1, COL1A1, DCN and BGN were 
assessed for each sample including components of the inflammatory pathway, namely 
IL1B, IL6R1, IL6, IL6R and TNFRSF1A (Invitrogen, Carlsbad, CA, USA) (Supplementary 
Table 1). Cofilin (Invitrogen) was previously found stable and linearly correlated with 
RNA quantity (data not shown), and was therefore used to normalize qPCR data. Both 
positive and negative controls were always included.
Statistical analyses were performed with the programming environment R (R Development 
Core Team). In the cytokine stimulation experiments, statistics were performed using 
Unpaired, two-tailed Student’s t-test. Power analysis was performed using QUANTO 
v.1.2.4 (http://biostats.usc.edu/software) to calculate sample size for the Swedish cohort. 
Assuming minor allele frequencies between 0.1 and 0.5 a sample size of 79 cases would 
be adequate to detect an allelic odds ratio (OR) of 2.3 and greater at a power of 80%. Basic 
descriptive statistics were compared using the one-way analysis of variance to detect 
significant differences between characteristics of the SWE-CON group and the SWE-
NON group. The R package genetics24 and SNPassoc25 were used to analyse differences 
in genotype and allele frequencies between the groups and to calculate Hardy-Weinberg 
equilibrium probabilities. Inferred allele constructs were created for COL5A1-IL1B-IL6-
IL6R genes from both the Swedish and South African genotype data respectively using 
the haplo.stats package in R26. The analysed models were based on previously reported 
associations3, 4.
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RESULTS
Fibroblasts derived from 8 donors had a high-risk genetic profile for either IL1B rs16944 
C>T or IL6 rs1800795 G>C (Supplementary Table 2). No significant differences in basal 
expression were observed in any of the ECM genes when fibroblasts were classified based 
on IL1B genotypes (Figure 2A). A reduced (p=0.012) COL5A1 expression was noted in 
IL6 high-risk fibroblasts compared to low-risk fibroblasts. As for the cytokine-related 
genes, we found that TNFRSF1A was less (p=0.003) expressed in the untreated IL6 high-
risk fibroblasts (Supplementary Figure 1A, B).
In IL1B high-risk fibroblasts, COL5A1 (p=0.012) and BGN (p=0.020) expression were 
reduced following hrIL-1β. Additionally, treatment with hrTNF-α resulted in decreased 
COL5A1 (p=0.042) levels (Figure 2G). In untreated IL6 high-risk fibroblasts, COL5A1 
was reduced (p=0.012) compared to IL6 low-risk fibroblasts (Figure 2B). No stimulation 
of the fibroblasts with hrIL-6 (Supplementary Figure 1C, D), hrIL-1β(Supplementary 
Figure 1E, F) or hrTNF-α (Supplementary Figure 1G, H) did not significantly alter the 
expression of any of the cytokine-related genes analysed.
Polymorphisms within IL1B and IL6 alter the expression of structural and fibril-associated 
ECM components and herewith possibly modulate the susceptibility of ligament injuries. 
Therefore, these associations were further investigated in other population groups from 
(i) Sweden and (ii) an indigenous mixed ancestry population from South Africa.
The South African population was previously described in detail17. Swedish participants 
were matched for height, body mass and body mass index (BMI) (Supplementary Table 
3). However, participants in the SWE-CON group consisted of significantly less men 
(34.5%, n=40) than the SWE-NON group (54.4%, n=43, p=0.014) and were significantly 
older (44.7 ± 11.9, n=114) than participants in the SWE-NON group (36.5 ± 13.7, n=78, 
p<0.001). Differences in medical and family history are displayed in Supplementary Table 
4. No significant genotype effects were noted on age, sex, height, body mass or body mass 
index for the investigated polymorphisms (Supplementary Table 5).
No significant differences in genotype or allele frequency distributions were observed 
for either COL5A1 rs12722 C>T, IL1B rs16944 C>T and IL6 rs1800795 G>C in both the 
South African and Swedish cohorts (Table 1). However, for the South African cohort the 
IL6R rs2228145 A>C CC genotype was significantly overrepresented (p=0.028) in the 
SA-CON group (13%, n=12) compared to the SA-ACL group (3%, n=3). Although not 
significant (p=0.054), a similar trend was observed when comparing the SA-CON group 
(13%, n=12) to the SA-NON subgroup (11%, n=6). Furthermore, the genotype and allele 
frequency distributions significantly differed between the South African and Swedish 
cohorts (Supplementary Table 6) for all the polymorphisms tested. Therefore, cohorts 
could not be combined for further analysis.
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Figure 2: mRNA expression of extracellular matrix genes in stimulated and unstimulated fi broblasts.
Primary human fi broblasts were obtained from 8 healthy volunteers and classifi ed in high-risk or low-risk for ligament 
injuries based on IL1B rs12722 C>T (A, C, E, G) and IL6 rs1800795 G>C (B, D, F, H). Fibroblasts were treated with ve-
hicle (PBS) to evaluate basal levels (A, B)or hr-IL-6 (C, D), hrIL-1β (E, F) or hrTNF-α (G, H) to evaluate fold-response 
to the treatment, compared to vehicle of the expression of extracellular matrix genes type I collagen α1 (COL1A1), type 
V collagen α1 (COL5A1), decorin (DCN), biglycan (BGN). Data is presented as (A, B) 2-ΔCt to assess gene expression 
compared to CFL1 (housekeeping gene) or (C-H) fold to vehicle (dotted lines). Data is presented as mean with standard 
deviation (SD). Unpaired two-tailed Student’s t-test. P-values in bold typeset indicate signifi cance (p< 0.050).
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Table 1. Genotype and minor allele frequency distributions, and p-values for Hardy-Weinberg exact test for 
the four selected polymorphisms in the control (SWE-CON and SA-CON), the anterior cruciate ligament 
(SA-ACL) rupture group and ACL subgroup with a noncontact (SWE-NON, and SA-NON) mechanism of 
injury within the South African and Swedish cohortsa.
South Africa Sweden
SA-CON SA-ACL p-valuea SA-NON p-valueb SWE-CON SWE-NON p-valueb
COL5A1
rs12722
C > T
n 96 93 48 109 77
CC 37 (36) 27 (25) 0.866 35 (17) 0.793 22 (24) 23 (18) 0.773
CT 49 (47) 52 (48) 54 (26) 43 (47) 47 (36)
TT 14 (13) 22 (20) 10 (5) 35 (38) 30 (23)
T allele 38 (73) 47 (88) 0.851 38 (36) 1.000 56 (123) 53 (82) 0.617
HWE 0.829 0.824 0.367 0.241 0.648
IL1B
rs16944
C > T
n 98 93 48 112 78
CC 24 (24) 27 (25) 0.530 27 (13) 0.923 39 (44) 44 (34) 0.799
CT 47 (46) 52 (48) 44 (21) 41 (46) 40 (31)
TT 29 (28) 22 (20) 29 (14) 20 (22) 17 (13)
T allele 52 (102) 47 (88) 0.411 51 (49) 0.971 40 (90) 37 (57) 0.542
HWE 0.549 0.836 0.395 0.120 0.224
IL6
rs1800795
G > C
n 98 98 51 113 77
GG 72 (71) 64 (63) 0.445 67 (34) 0.339 22 (25) 26 (20) 0.606
GC 26 (25) 31 (30) 27 (14) 59 (67) 52 (40)
CC 2 (2) 5 (5) 6 (3) 19 (21) 22 (17)
C allele 15 (29) 20 (40) 0.185 20 (20) 0.369 48 (109) 48 (74) 1.000
HWE 1.000 0.539 0.373 0.060 0.821
IL6R
rs2228145
A > C
n 95 95 49 112 76
AA 54 (51) 58 (55) 0.028 55 (27) 0.054 53 (59) 46 (35) 0.618
AC 34 (32) 39 (37) 43 (21) 37 (41) 46 (35)
CC 13 (12) 3 (3) 2 (1) 11 (12) 8 (6)
C allele 29 (56) 23 (43) 0.161 23 (23) 0.346 29 (65) 31 (47) 0.779
HWE 0.082 0.385 0.257 0.253 0.599
Genotype and allele frequencies are expressed as a percentage with the number of participants (n) in parentheses.
aCON vs. ACL (unadjusted p-value).
bCON vs. NON (unadjusted p-value).
P-values in bold typeset indicate significance (p< 0.050).
Allele combinations were inferred for COL5A1-IL1B-IL6 and COL5A1-IL1B-IL6R. For 
each of the two allele combinations, eight possible constructs were inferred at a frequency 
above 4%. For the South African cohort, no significant differences in the frequency 
distributions of these combinations were observed when all participants were evaluated 
or when only male or only female participants were compared (Supplementary Figure 2).
The frequency distributions for the COL5A1-IL1B-IL6 and the COL5A1-IL1B-IL6R allele 
combinations were similar between the control and cases when all participants or only 
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the female participants in the Swedish cohort were compared (Supplementary figures 
3A and 3C). However, for the COL5A1-IL1B-IL6 allele combination, when only males 
participants were evaluated, the T-C-G combination was significantly underrepresented 
(p=0.034 Haplo-score: 2.1) in the SWE-CON (7.7%, n=3) compared to the SWE-NON 
(18.0%, n=8) group (Supplementary Figure 3B). Furthermore, the frequency distributions 
for the COL5A1-IL1B-IL6R allele combinations, showed the T-C-A combination to be 
significantly underrepresented (p=0.044, Haplo-score: 2.0) in the SWE-CON (28.0%, 
n=11) compared to the SWE-NON (14.0%, n=6) group when only the male participants 
were compared in the Swedish cohort.
DISCUSSION
Considering the ligament as an integrative part of the knee joint, it is plausible that the 
ACL is subjected to cues derived from its surrounding anatomical structures, such as the 
synovium or synovial fluid. It is proposed, that as a response to repetitive mechanical 
overloading, macrophages might infiltrate tissues surrounding the ligaments27. Thereby, 
potentially exposing the ligamentocytes to an additional amount of specific inflammatory 
cytokines as part of the matrix remodeling mechanism. It is interesting, that some of the 
genetic susceptibility loci implicated in tendon and ligament injuries encode proteins 
involved in the homeostatic regulation of ECM components of both tendon and 
ligament, and components of the proinflammatory pathway20. This study, therefore used a 
hypothesis-based approach to evaluate the potential impact of the inflammatory pathway 
on modulating susceptibility to ligament injuries using an in vitro risk associated model, 
complimented with a genetic association approach.
For the functional IL1B rs16944 polymorphism, treatment with hrIL-β resulted in a 
1.3-fold decrease (p=0.020) of BGN and a 2.1-fold (p=0.012) decrease of COL5A1 in a 
genetic risk associated dependent manner. In addition, hrTNF-α treatment displayed a 
2.0-fold (p=0.042) reduction in COL5A1 mRNA levels in the fibroblasts with an IL1B 
rs16944 CC genotype. We suggest that, given an inflammatory micro-environment where 
these cytokines are abundant, matrix production is differently affected in IL1B high-risk 
compared to IL1B low-risk genetic profiles.
The IL6 rs1800795 G-allele increases IL-6 mRNA expression levels, inducing apoptosis28 
which might decrease the production of ECM components. Our experiments indirectly 
support this hypothesis since fibroblasts having the IL6 rs1800795  GG genotype 
displayed a 2.8-fold reduction (p=0.012) in COL5A1 mRNA. Although not significant, a 
similar trend (p=0.07) was observed for other associated ECM components such as DCN. 
This is an important finding, since both  COL5A1  and  DCN  are required for normal 
fibrillogenesis29.
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At basal levels, the expression of proinflammatory genes was relatively low for all 
groups. However, with the exception of TNFRSFA1 mRNA expression, mRNA levels 
of all the investigated cytokines were increased on average between 1.03 and 6109 fold 
in all the groups after treatment with hrIL-1β (Supplementary Figure 1C, D), hrIL-
6 (Supplementary Figure 1 E, F) and TNF-α (Supplementary Figure 1G, H). More 
specifically, treatment with hrIL-1β significantly upregulated IL1B and IL6 mRNA levels 
3690 and 3948-fold respectively, although no statistically significant differences in their 
expression were noted between the high- and low-risk groups. This is in agreement with 
the hypothesis as shown in Figure 1 and with previous work11.
These results support the proposal that polymorphisms within IL1B and IL6 alter the 
expression of structural and fibril-associated ECM components and herewith possibly 
modulate the susceptibility to ligament injuries. This holds true in specific cohorts where 
these loci were implicated in risk models for the susceptibility to tendon and ligament 
injuries3, 4. These associations were therefore evaluated in two independent population 
groups from different ancestries, one from Sweden and the other from South Africa in an 
attempt to identify the susceptibility significance of these genetic loci in different populations.
In the South African cohort, the IL6R rs2228145 CC genotype was significantly 
overrepresented (p=0.028) in the controls, compared to individuals that sustained 
an ACL injury. Although the CC genotype frequencies appeared to be similar in our 
Swedish cohort and in a previously reported South African Caucasian cohort3, it did 
not reach the level of significance. As shown previously, the COL5A1-IL1B-IL6 T-C-G 
and the COL5A1-IL1B-IL6R T-C-A allele combinations were found to be associated 
with an increased susceptibility to sustain an ACL rupture in the Swedish cohort when 
only male participants were evaluated3, 4. These associations were not reproduced in the 
South African cohort evaluated in this study, which might be explained by the different 
genetic background of the cohorts, as illustrated by the significant differences in genotype 
frequencies. Based on our power analysis, the sample size in this study is adequate to 
detect an allelic odds ratio (OR) of 2.4 at approximately 80% statistical power for Type 
1 error detection. Although the study is underpowered to detect smaller effects, it is 
unlikely to reflect false positive data. In addition, it is important to note the current study 
used an a priori hypothesis and that reported associations are in line with previous ones. 
However, the findings should be cautiously interpreted and require confirmation in a 
larger cohort. We believe that all genetic data should be interpreted in the context of an 
individual’s ancestral background. More important, all risk factors should be considered 
in a complex multifactorial disease, such as ACL injuries, to inform susceptibility. Risk 
susceptibility is most likely a combination of the interaction between a variety of extrinsic 
and intrinsic risk factors, including genetics.
A finely balanced inflammatory response is required for remodeling of the ECM30 and that 
genetic polymorphisms potentially affect the production of inflammatory cytokines12, 31. 
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The specific identity of these biological key role players however still remains unknown, 
including the threshold number and the time course of when they are required to direct 
the remodeling process within tendon and ligament. Therefore, future research should 
focus on the identification and quantification of inflammatory factors and on their time 
courses in tendon and ligament injuries. This may provide insights for biology-based 
therapies, such as anti-cytokine antibodies or cytokine antagonists and the most effective 
treatment period. Another approach might be to target cells that are responsible for the 
production of inflammatory cytokines, such as macrophages.
The in vitro experiments used dermal fibroblasts of eight individuals. Although dermal 
fibroblasts might have similar characteristics as tenocytes or ligamentocytes, their 
function and exact composition differ, possibly influencing their response to stimuli. In 
addition, a tissue-specific culture model applying a tensile force is required to study the 
effect of polymorphisms on matrix remodeling in more detail. Future research should 
aim to increase the number of donors. The difference in sex distribution in the genetic 
association study is explained by the fact that females participate less frequently in 
pivoting sports and therefore males and females were both tested together and separately 
for potential genetic associations with susceptibility for ACL injury.
In conclusion, this study describes specific polymorphisms within the inflammatory 
pathway to modulate the synthesis and degradation of structural and fibril-associated 
ECM components and thereby potentially contributing to an increased susceptibility to 
ACL injuries. This provisional evidence improves our understanding of the underlying 
mechanism for the genetic susceptibility to ACL ruptures and might lead to early 
identification of individuals who are of increased susceptibility to ACL injury and the 
potential application of personalized preventive or therapeutic interventions.
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SUPPLEMENTARY FIGURES AND TABLES
Supplementary Table 1. Primers used for RT-PCR analysis.
Gene Forward primer (5’ à 3’) Reverse primer (5’ à 3’)
COL5A1 GACAAGAAGTCCGAAGGGGC TAGGAGAGCAGTTTCCCACG
COL1A1 TGAAGGGACACAGAGGTTTCAG GTAGCACCATCATTTCCACGA
DCN CAGACCAAGCACGCAAAACA TCACAACCAGGGAACCTTGC
BGN CACCGGACAGATAGACGTGC CATGGCGGATGGACCTGGAG
IL6 GGATTCAATGAGGAGACTTGCC GGGTCAGGGGTGGTTATTGC
IL1B TTGCTCAAGTGTCTGAAGCAGC CTTGCTGTAGTGGTGGTCGG
IL6R CACGCCTTGGACAGAATCCA TCCAGCAACCAGGAATGTGG
IL1R1 GGTAGACGCACCCTCTGAAG GCATTTATCAGCCTCCAGAGAAGA
TNFRSFA1 ATTGGACTGGTCCCTCACCT GTAGGTTCCTTTGTGGCACTT
CFL1 ATAAGGACTGCCGCTATGCC CGGGGGCCCAGAAGATAAAC
Supplementary Table 2. Genetic risk profiles of the participants based on their (A) IL1B rs16944 C>T and 
(B) IL6 rs1800795 G>C genotypes.
A. Participant
ID
IL1B
rs16944
Sex B. Participant
ID
IL6
rs1800795
Sex
Low risk 5 CT F Low risk 3 CC M
7 CT M 5 GC F
8 CT F 22 GC M
11 CT M 24 GC F
22 TT M High risk 7 GG M
High risk 3 CC M 8 GG F
10 CC M 10 GG M
24 CC F 11 GG M
M, male; F, female.
Supplementary Table 3. Patient characteristics of the control (SWE-CON) group and the anterior cruciate 
ligament group with a noncontact (SWE-NON) mechanism of injury in a Swedish cohorta.
SWE-CON (n=116) SWE-NON (n=79) p-value
Age (years)b 44.7 ± 11.9 (114) 36.5 ± 13.7 (78) <0.001
Sex (% male) 34.5 (116) 54.4 (79) 0.014
Height (cm) 172.3 ± 10.1 (108) 173.4 ± 8.6 (71) 0.438
Body mass (kg)b 72.1 ± 13.6 (107) 75.0 ± 12.8 (71) 0.149
Body mass index (kg/m2)b 24.4 ± 2.9 (107) 24.7 ± 2.9 (70) 0.466
aValues are presented as mean ± standard deviations except for sex, which is expressed as a percentage. The number 
of participants (n) with available data for each variable is in parenthesis.
bSelf-reported values at the time of recruitment for the SWE-CON group, and at time of ACL rupture for the SWE-
NON group.
P-values in bold typeset indicate significance (p< 0.050).
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Supplementary Table 4. Medical history and family injury for the control (SWE-CON) and non-contact 
(SWE-NON) anterior cruciate ligament rupture group of the Swedish cohorta.
Male Female
SWE-CON
(n=40)
SWE-NON
(n=42)
p-valueb SWE-CON
(n=76)
SWE-NON
(n=37)
p-valueb p-valuec
Previous ligament injury 88.6 (35) 100.0 (35) 0.114 73.5 (68) 81.8 (33) 0.458 0.035
Previous joint injury 35.1 (37) 51.3 (39) 0.235 37.5 (72) 41.7 (36) 0.834 0.230
Family history of ACL injury 15.2 (33) 24.3 (37) 0.384 17.4 (69) 33.3 (33) 0.121 0.093
•	 Grandparent	 0.0 (33) 0.0 (37) - 0.0 (69) 3.0 (33) 0.323 0.407 
•	 Parent	 0.0 (33) 2.7 (37) 1.000 7.2 (69) 12.1 (33) 0.466 0.531 
•	 Sibling	 12.1 (33) 10.8 (37) 1.000 2.9 (69) 6.1 (33) 0.593 0.551 
•	 Child	 3.0 (33) 10.8 (37) 0.361 7.2 (69) 6.1 (33) 1.000 0.551 
•	 Other	 0.0 (33) 0.0 (37) - 0.0 (69) 6.1 (33) 0.103 0.164 
Family history of joint injury 59.5 (37) 69.2 (39) 0.516 47.2 (72) 72.2 (36) 0.024 0.014
•	 Parent	 21.6 (37) 46.2 (39) 0.031 31.9 (72) 47.2 (36) 0.181 0.018 
•	 Sibling	 43.2 (37) 48.7 (39) 0.804 15.3 (72) 44.4 (36) 0.002 0.003 
•	 Child	 27.0 (37) 17.9 (39) 0.415 20.8 (72) 19.4 (36) 1.000 0.608 
aValues are expressed as percentages with the number of participants (n) with available data in parentheses.
bSWE-CON vs. SWE -NON, p-values in bold typeset indicate significance (p< 0.050).
cSWE-CON (male + female) vs. SWE-NON (male + female).
P-values in bold typeset indicate significance (p< 0.050).
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Supplementary Table 5. Genotype effects per patient characteristic in the Swedish cohort.
A. Genotype effects COL5A1 rs2228145 C>T.
C/C (n=42) C/T (n=83) T/T (n=61) p-value
Age (years) 40.2 ± 12.6 (40) 39.9 ± 13.2 (83) 44.0 ± 13.5 (60) 0.145
Sex (% male) 50.0 (21) 43.3 (36) 34.4 (21) 0.197
Height (cm) 174.7 ± 11.0 (38) 172.1 ± 9.0 (78) 171.9 ± 8.6 (55) 0.308
Body mass (kg) 74.1 ± 11.8 (38) 77.3 ± 13.8 (77) 73.3 ± 13.2 (55) 0.782
Body mass index (kg/m2) 24.0 ± 2.7 (37) 24.6 ± 2.8 (77) 24.7 ± 3.1 (55) 0.536
B. Genotype effects IL1B rs16944 C>T.
C/C (n=78) C/T (n=77) T/T (n=35) p-value
Age (years) 42.2 ± 13.2 (77) 39.8 ± 13.3 (75) 42.2 ± 13.5 (35) 0.483
Sex (% male) 50.0 (39) 31.1 (24) 48.6 (17) 0.091
Height (cm) 173.8 ± 9.3 (72) 171.2 ± 9.1 (72) 173.7 ± 9.5 (30) 0.203
Body mass (kg) 75.7 ± 12.2 (70) 71.6 ± 12.8 (72) 73.0 ± 16.0 (31) 0.172
Body mass index (kg/m2) 24.9 ± 2.8 (70) 24.3 ± 2.7 (72) 24.7 ± 3.2 (30) 0.360
C. Genotype effects IL6 rs1800795 G>C.
C/C (n=45) C/G (n=107) G/G (n=38) p-value
Age (years) 44.8 ± 12.5 (38) 40.8 ± 13.7 (104) 40.2 ± 12.7 (45) 0.211
Sex (% male) 47.4 (18) 37.4 (40) 46.7 (21) 0.536
Height (cm) 172.7 ± 8.3 (36) 172.3 ± 9.7 (96) 173.0 ± 9.7 (43) 0.927
Body mass (kg) 73.1 ± 11.5 (72) 73.5 ± 14.6 (96) 73.1 ± 12.1 (43) 0.983
Body mass index (kg/m2) 24.5 ± 2.6 (35) 24.7 ± 3.0 (95) 24.3 ± 2.7 (43) 0.679
D. Genotype effects IL6R rs2228145 A>C.
A/A (n=94) A/C (n=76) C/C (n=18) p-value
Age (years) 41.4 ± 13.2 (93) 40.9 ± 14.2 (75) 42.9 ± 8.0 (17) 0.850
Sex (% male) 42.6 (40) 36.8 (28) 55.6 (10) 0.882
Height (cm) 172.2 ± 9.7 (84) 172.5 ± 8.6 (70) 174.6 ± 9.6 (18) 0.610
Body mass (kg) 72.4 ± 11.7 (85) 73.5 ± 14.4 (69) 75.4 ± 12.4 (17) 0.653
Body mass index (kg/m2) 24.2 ± 2.6 (84) 24.8 ± 3.0 (69) 24.7 ± 2.6 (17) 0.407
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Supplementary Table 6. Genotype and minor allele frequency distributions, and p-values for Hardy-Wein-
berg exact test of the four selected polymorphisms within the South African (SA) and Swedish (SWE) 
cohort for asymptomatic controls (CON), the anterior cruciate ligament (ACL) rupture group and the ACL 
subgroup with a noncontact (NON) mechanisma.
CON ACL
SA-CON SWE-CON P-valueb SA -ACL SWE -ACL P-value1 SA -NON P-valuec
COL5A1
rs12722
C > T
n 96 109 93 71 48
CC 38 (36) 22 (24) <0.001d 41 (38) 23 (18) 0.019d 35 (17) 0.021d
CT 49 (47) 43 (47) 45 (42) 47 (36) 54 (26)
TT 14 (13) 35 (38) 14 (13) 30 (23) 10 (5)
T allele 38 (73) 56 (123) <0.001d 37 (68) 53 (82) 0.003d 38 (36) 0.022d
HWE 0.829 0.241 0.824 0.648 0.367
IL1B
rs16944
C > T
n 93 112 93 78 48
CC 24 (24) 39 (44) 0.033d 27 (25) 44 (34) 0.033d 27 (13) 0.095
CT 47 (46) 41 (46) 52 (48) 40 (31) 44 (21)
TT 29 (28) 20 (22) 22 (20) 17 (13) 29 (14)
T allele 52 (102) 40 (90) 0.019d 47 (88) 37 (57) 0.058 51 (49) 0.033d
HWE 0.549 0.120 0.836 0.224 0.395
IL6
rs1800795
G > C
n 98 113 98 77 51
GG 72 (71) 22 (25) <0.001d 64 (63) 26 (20) <0.001d 67 (34) <0.001d
GC 26 (25) 59 (67) 31 (30) 52 (40) 27 (14)
CC 2 (2) 19 (21) 5 (5) 22 (17) 6 (3)
C allele 15 (29) 48 (109) <0.001 20 (40) 48 (74) <0.001d 20 (20) <0.001d
HWE 1.000 0.061 0.539 0.821 0.373
IL6R
rs2228145
A > C
n 112 95 76 95 49
AA 53 (59) 54 (51) 0.996 46 (35) 58 (55) 0.165 55 (27) 0.886
AC 37 (41) 34 (32) 46 (35) 39 (37) 43 (21)
CC 11 (12) 13 (12) 8 (6) 3 (3) 2 (1)
C allele 29 (65) 29 (56) 1.000 31 (47) 23 (43) 0.108 23 (23) 0.256
HWE 0.082 0.253 0.385 0.599 0.257
aGenotype and allele frequencies are expressed as a percentage with the number of participants (n) in paren-
theses.
bSA vs. SWE cohort (unadjusted p-value).
cSA with non-contact mechanism vs. SWE cohort (unadjusted p-value).
dP-values in bold typeset indicate significance (p< 0.050).
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Supplementary Figure 1: mRNA expression in unstimulated fi broblasts (A, B) and fi broblasts stimulated 
with IL-1β (C, D), IL-6 (E, F) or TNF-α (G, H). mRNA expression levels of the cytokine-related genes, IL6, 
IL1B, IL6R, IL1R1 and TNFRSF1AR in fi broblasts classifi ed in high-risk or low-risk for ACL injuries based on 
(A) IL6 rs1800795 G>C or (B) IL1B rs12722 C>T. Data is presented as 2-ΔCt to assess gene expression compared 
to CFL1 (housekeeping gene). Data is presented as mean with standard deviation (SD). Unpaired two-tailed 
Student’s t-test, P-values in bold indicate signifi cance (p<0.050).
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A. All participants (males and females).
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B. Male participants.
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Supplementary Figure 2: Frequency distributions in the South African cohort for the COL5A1 rs12722 
C>T, IL1B rs16944 C>T, IL6 rs1800795 G>C or IL6R rs2228145 A>C polymorphisms in the control group 
(CON; black bars) and the anterior cruciate ligament rupture group (ACL; white bars) for (A) all partici-
pants (males and females), (B) the male participants and (C) female participants. The number of partici-
pants (n) in each group is in parentheses.
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Supplementary Figure 3: Frequency distributions in the Swedish (SWE) cohort 
for the COL5A1 rs12722 C>T, IL1B rs16944 C>T, IL6 rs1800795 G>C or IL6R 
rs2228145 A>C polymorphisms in the control group (SWE-CON; black bars) and 
the non-contact anterior cruciate ligament rupture group (SWE-NON; white bars) 
for (A) all participants (males and females), (B) male participants and (C) female 
participants in the Swedish cohort. The number of participants (n) in each group is 
in parentheses. P-values in bold typeset indicate significance (p< 0.050). 
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Supplementary Figure 3: Frequency distributions in the Swedish (SWE) cohort for the COL5A1 rs12722 
C>T, IL1B rs16944 C>T, IL6 rs180079  G>C or IL6R rs2228145 A>C polymorphisms in the control group 
(SWE-CON; black bars) and the non-contact anterior cruciate ligament rupture group (SWE-NON; white 
bars) for (A) all participants (males and females), (B) male participants and (C) female participants in 
the Swedish cohort. The number of participants (n) in each group is in parentheses. P-values in bold typeset 
indicate significance (p< 0.050).
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ABSTRACT
Synovial inflammation plays an important role in the pathological process of osteoarthritis 
(OA). This study determines phosphorylation levels of signal transducer and activator 
of transcription (STAT) proteins in osteoarthritic synovium and investigates whether 
inhibition of STAT signaling pathways modulates the inflammatory phenotype of OA 
synovium. To examine this, STAT1, 3, and 6 phosphorylation were determined in OA 
synovium using Western blot analysis. This was done either directly after harvest or after 
treatment with 50 μM NSC118-218, 100 μM S3I-201, or 100 nM AS1517499, compounds 
known to inhibit STAT phosphorylation, for 24 hours with or without the presence of 
synovial fluid. Different STAT1 and STAT3 phosphorylation levels were observed in 
OA synovium among the donors. Phosphorylated STAT6 was only detectable when 
explants were cultured in synovial fluid. NSC118-218 and AS1517499 inhibited STAT1 
phosphorylation, although only treatment with AS1517499 also resulted in decreased 
IL1B and IL6 gene expression. S3I-201 inhibited STAT3 phosphorylation, resulting in less 
IL6 expression and increased TNFA expression. These data indicate that donor dependent 
STAT1, 3, and 6 phosphorylation patterns are found in OA synovium. Inhibition of 
STAT1 phosphorylation had an anti-inflammatory effect, whereas the inhibition of 
STAT3 phosphorylation enhanced the inflammatory phenotype. Inhibition of STAT1 
phosphorylation might be a potential therapy to diminish synovial inflammation 
eventually to slow down or prevent the pathogenesis of OA.
Key words: Inflammation; modulation; JAK-STAT signalling; osteoarthritis; synovium.
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INTRODUCTION
Inflammation of the synovial membrane is a common feature of osteoarthritis (OA) 
with an accumulation of infiltrating immune cells, such as macrophages10. Cells within 
the inflamed synovial membrane produce factors known to have catabolic effects, 
such as interleukin (IL) 1β and IL629, 35. The pathophysiological process that occurs in 
the osteoarthritic joint is largely mediated by pro-inflammatory cytokines and other 
mediators35. However, OA also results in elevated levels of the anti-inflammatory cytokines 
IL4 and IL10 in the serum or synovial fluid16, 22, 33. Therefore, a targeted approach is 
required to specifically modulate the inflammatory phenotype of the synovial membrane.
The intracellular Janus kinase (JAK)/signal transducers and activators of transcription 
(STAT) signaling pathways are a principal signaling mechanism for a wide array 
of cytokines and growth factors. Signaling through this pathway is mediated by 
phosphorylation of STAT proteins. It is known that when cells, including fibroblasts 
and macrophages, are stimulated with interferon (IFN) γ, STAT 1 is phosphorylated17, 19. 
Similarly, IL4 in general results in activation of STAT6, whereas stimulation with IL10 
leads to activation of STAT31, 25. Once phosphorylated, STAT proteins form dimers 
and subsequently regulate gene expression8. More specifically, phosphorylated STAT1 
regulates transcription of IL1B 19, whereas phosphorylated STAT3 targets the IL6 and 
IL10 genes11, 15. The anti-inflammatory gene IL4 is targeted by phosphorylated STAT618. 
Although previously investigated in rheumatoid arthritis, it is currently unknown which 
JAK-STAT pathways are activated in OA synovial tissue and whether modulation of JAK-
STAT pathways affects the inflammatory phenotype of the synovium.
The main cell types in synovial explants are fibroblasts and macrophages. Macrophages 
can become activated by environmental cues, resulting in different phenotypes ranging 
from pro-inflammatory to anti-inflammatory or repair macrophages. In vitro, pro-
inflammatory or M1-like macrophages can be obtained by stimulation with IFNγ and/
or TNFα4 among others. Macrophages induced by stimuli such as IL4 or IL13 obtain a 
repair-phenotype and are often referred to as M2-like macrophages. M2-like macrophages 
induced with IL10 or glucocorticoids obtain a predominant anti-inflammatory 
phenotype27. These subtypes represent the extremes of a spectrum and are a simplified 
version of the range of phenotypes that can appear in vivo. As macrophages are one of the 
sources for pro-inflammatory cytokines in the knee joint during OA, macrophages were 
completely depleted from the knee joint prior to OA induction. Indeed, macrophages 
contributed to the onset and progression of osteoarthritis31, 32. However, depleting all 
synovial macrophages is a non-specific approach and might therefore also abolish some 
of their beneficial effects. Another approach is to neutralize specific cytokines, but this 
did not seem to be completely effective in every patient suffering from OA5. Targeting 
proteins involved in intracellular signal transduction pathways might therefore be 
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an interesting new strategy as it is more specific than depleting cells and it affects the 
production of multiple cytokines at once.
The aim of the present study was to determine STAT activation in OA synovium and 
to investigate whether inhibiting STAT signaling pathways modulates the inflammatory 
phenotype of osteoarthritic synovium. In addition, as macrophages are key role players in 
inflammation, we determined presence of macrophage phenotypes in OA synovium and 
their respective STAT activation levels.
METHODS
Modulating synovial tissue
Synovial tissue was obtained from 17 patients with gonarthrosis undergoing total knee 
replacement at Erasmus MC, University Medical Center, Rotterdam. Consent was given 
in accordance with the guidelines of the Federation of Biomedical Scientific Societies 
(www.federa.org) after approval by the local ethical committee (#MEC2004-322). The 
synovium was washed twice with 0.9% NaCl (Sigma-Aldrich, Saint Louis, Missouri, 
USA), separated from the surrounding tissue and cut in to 5mm2 pieces.
To examine initial activation of STAT proteins, synovial explants were not cultured, but 
immediately stored at -80°C (n=4, male: 1, mean age: 64). To inhibit STAT phosphorylation, 
explants were cultured for 24 hours with or without 50µM NSC118-218, 100 µM S3I-201 and 
100 nM AS1517499 in medium (Dulbecco’s Modified Eagle Medium, low glucose (DMEM; 
Gibco, Carlsbad, USA) complemented with 10% FCS (n=5, male: 2, mean age: 61) with or 
without additional 50% synovial fluid from the same donor as the synovial tissue was obtained 
(n=4, male: 3, mean age: 79). After the culture period, synovial explants were harvested and 
stored at -80°C until evaluation using Western Blot analysis and gene expression analysis. 
The medium was harvested and stored at -80°C for cytokine measurements. Doses were 
chosen based on the current literature. Dimethyl sulfoxide (DMSO; Sigma-Aldrich) was 
used as vehicle for all inhibitors with a final DMSO concentration in cultures of <0.01%.
RNA isolation and quantitative RT-PCR
Frozen synovial samples were processed using a Mikro-Dismembrator S (B. Braun Biotech 
International GmbH, Melsungen, Germany) and consecutively samples were dissolved in 
350µl Trizol. A RNeasy Micro Kit (QIAGEN, Venlo, The Netherlands) was used to extract 
RNA and procedures were performed according to the manufacturer’s instructions. RNA 
was quantified using Nanodrop ND-1000 Spectrophotometer (NanoDrop ND1000 UV-
VIS, Isogen Life Science B.V., the Netherlands). A total of 250 ng RNA per sample was 
reversed transcribed into cDNA using RevertAidTM First strand cDNA synthesis Kit (MBI 
Fermentas, St. Leon-Rot, Germany). Quantitative real-time PCR was performed on an ABI 
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Prism 7000 Sequence detection system (Applied Biosystems, Foster City, Ca) using either 
TaqMan Universal PCR mastermix (Applied Biosystems) or SybrGreen (Eurogentec). 
Gene expression of IL1B, TNFA, CCL18, Cluster of Differentiation 206 (CD206) and CD163 
was evaluated. Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH), Hypoxanthine 
Phosphoribosyltransferase 1 (HPRT1) and Beta-2-microglobulin (B2M) were all tested 
as housekeepers, where GAPDH was found the most stable (data not shown) and was 
therefore further used as normalization for the genes of interest. Relative quantification 
of PCR signals was performed by comparing the threshold cycle value (Ct) for the gene of 
interest in each sample with the Ct value for the housekeeping gene23.
Quantification of cytokine production
Quantification of IL6, CCL18 and soluble CD163 (sCD163) in the medium of synovium 
cultures was performed by enzyme-linked immunosorbent assays (ELISAs) according 
to the manufacturer’s instructions of human IL6 ELISA Development Kit (PeproTech), 
human CCL18 DuoSet Development Kit (R&D Systems) and human soluble CD163 
DuoSet Development Kit (R&D) systems.
Western blotting
Sample’s protein concentrations were measured using a bichinchoninic acid assay 
(BCA assay) according to the manufacturer’s instructions (Thermo Scientific). For 
immunoblot detection of phosphorylated STAT proteins, 10 – 20 μg of the samples were 
electrophoresed on 10% SDS-polyacrylamide gels (Thermo Scientific, or Invitrogen, 
Carlsbad, CA USA), electrotransferred onto nitrocellulose membranes and blocked with 
5% non-fat dried milk for two hours. Membranes were incubated overnight at 4°C with 
primary antibodies against phosphorylated STAT1 (Cell Signaling Technology, Danvers, 
MA, USA), phosphorylated STAT3 (Cell Signaling Technology), phosphorylated STAT6 
(Cell Signaling Technology) and α-Tubulin (Cell Signaling Technology).
After washing, the membranes were incubated with horseradisch peroxidase (HRP) 
–conjugated anti-rabbit IgG secondary antibody (Cell Signaling) for 1.5 hour at room 
temperature. Antibody detection was performed using SuperSignal West Pico Luminol 
Enhancer Solution and SuperSignal West Pico Stable Peroxide Solution (Thermo 
scientific). Western blot analyses were quantified using Image J (U.S. National Institutes 
of Health, Bethesda, Maryland, USA).
Immunohistological analysis
Synovial samples from 3 different donors (n=3, male: 1, mean age: 70 years) were collected 
and 6 µm thick cryosections were cut. Sections were fixed in acetone for 10 minutes and 
subsequently washed with PBS. Following blocking with 10% goat serum (Southern 
Biotech #0060-01) for 30 minutes, sections were incubated for 1 hour at room temperature 
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with an antibody against CD68 (Abcam, clone KP-1 ready-to-use) as pan-macrophage 
marker, CD86 (Genetex, clone EP1158Y; 0.45 µg/ml) as M1 marker, CD206 (Abcam, 
#64693; 2.5 µg/ml) as M2a marker, and CD163 (Abcam, #182422; 1.6 µg/ml) as M2c 
marker. Sections were incubated for 30 minutes with either second antibody biotinylated 
goat-anti-mouse Ig link (BioGenex, HK-325-UM) or a biotinylated goat-anti-rabbit Ig 
link (Biogenex, HK-326-UR) diluted with PBS/1%BSA. This was followed by incubation 
with a third antibody: alkaline phosphatase-conjugated streptavidin label diluted 1:50 in 
PBS/1%BSA (BioGenex, HK-321-UK). After a final wash step in Tris-HCl, sections were 
incubated in freshly prepared substrate mixture of Neu Fuchsin (Chroma Gesellschaft, 
1g/25ml 2M HCl), Sodiumnitrate (Sigma, #S2252) and Naphtol AS-MX phosphate (Sigma, 
#N5000) that was dissolved in di-methylformamid (Sigma, D4551). Subsequently tissue 
sections were counterstained with Haematoxylin Gill’s (Sigma, #GHS232) to evaluate the 
overall staining pattern better. An isotype-matched control antibody; either monoclonal 
mouse IgG1 (Dako Cytomation #X0931) or rabbit IgG1 antibody (Dako Cytomation 
#X0903) was used as negative control for each staining. Sections were dried overnight 
and mounted with VectaMount (Vector Laboratories, #H5000).
Human monocyte isolation and culture
Monocytes were isolated from human buffy coats of healthy male donors (Sanquin Blood 
bank, Amsterdam, the Netherlands) by Ficoll density gradient separation and CD14+ 
selection as described before14. Isolated monocytes plated in 24-well plates (Corning 
Incorporated, NY, USA) at a density of 500,000 cells/cm2 in X-VIVO 15 medium (Lonza, 
Verviers, Belgium) supplemented with 20% heat-inactivated fetal calf serum (FCS, 
Lonza), 50 µg/mL gentamycin and 1.5 µg/mL fungizone. Monocytes were differentiated 
towards different macrophage phenotypes using 10 ng/mL IFNγ (Peprotech, Rocky Hill, 
NJ, USA) and 10 ng/mL TNFα (Peprotech) to obtain M(IFNγ + TNFα), 10 ng/mL IL4 
(Peprotech) to obtain M(IL4) or 10 ng/mL IL10 (Peprotech) to obtain M(IL10).
Activated macrophages were harvested 30, 60, and 90 minutes after plating. These cells 
were suspended in 180 µL M-PER (Thermo Scientific, Rockford, USA) with 0.1% HALTTM 
– Protease Inhibitor Single-Use Cocktail (100x) (Thermo Scientific) and 0.1% Phosphatase 
Inhibitor (Thermo Scienitific) and stored at -80°C until Western Blot analysis was performed.
After 24 hours, the medium of macrophages was collected, centrifuged at 200x g and 
the supernatants were stored at -80°C for cytokine measurement. Harvested cells were 
resuspended in PBS/0.1% Triton X-100 (Sigma-Aldrich, St. Louis, USA) for DNA 
quantification or in TRIzol Reagent (Ambion, Carisbad, CA, USA) for mRNA isolation.
Statistical analysis
All statistical analyses were performed using IBM SPSS statistics for Windows (version 
21.0, IBM Corp., Armonk, NY). A mixed linear model with a Bonferroni post-hoc test 
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was used aft er log transformation to statistically analyze the data and to take into account 
donor variability between diff erent donors. In all experiments, an individual experiment 
was considered as a random factor. For macrophages cultured in monolayers, polarization 
states were considered as a random factor. In the experiments with synovial explants, 
treatment with an inhibitor was considered as a random factor.
Diff erences were considered to be statistically signifi cant if p< 0.05.
RESULTS
STAT phosphorylation in end-stage OA synovium
Phosphorylated STAT1 was detectable in synovial explants obtained immediately aft er 
surgery in 3 of the 5 OA donors evaluated. pSTAT3 could be detected in synovial tissue of 
all donors, although the levels of expression seem variable. No pSTAT6 could be detected 
in the collected synovial explants, only when the explants were stimulated with IL4 (as a 
control) (Figure 1).
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Figure 1. Presence of phosphorylated STATs in OA synovial tissue.
Western Blots analysis of OA synovial tissue in 5 donors. The dotted line indicates 
grouping of images from different parts of the same gel.
Therefore, presence of phosphorylated STATs was examined in explants that were 
cultured in synovial fluid (SF).  Indeed, in the presence of synovial fluid, pSTAT6 was 
detectable in all explants in variable degrees (Figures 2A, D and G), next to pSTAT1 
and pSTAT3.
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Figure 1. Presence of phosphorylated STATs in OA synovial tissue.
Western Blots analysis of OA synovial tissue in 5 donors. Th e dotted l ne indicat s grouping of images from diff erent 
parts of the same gel.
Th erefore, presence of phosphorylated STATs was examined in explants that were cultured 
in synovial fl uid (SF). Indeed, in the presence of synovial fl uid, pSTAT6 was detectable 
in all explants in variable degrees (Figures 2A, D and G), next to pSTAT1 and pSTAT3.
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Figure 2. Modulation of STAT phosphorylation in OA synovial tissue cultured in synovial fluid.
A, D, G) Western Blot analysis of synovial tissue after treatment with the STAT inhibitors. The dotted line indicates 
grouping of images from different parts of the same gel, whereas the continuous line indicates grouping of different 
parts from different gels. -; control, +; treated with STAT inhibitor. B, E, H) Quantification of the Western Blots 
relative to α Tubulin. C, F, I) Gene expression corrected for GAPDH and relative to the untreated control, which is 
represented by the dotted line. Data is shown as mean (as indicated by line) for n=4 analysed in 2-fold.
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Modulation of OA synovial tissue with STAT-inhibitors
After determining STAT phosphorylation in human OA synovium, the effect of STAT1, 
3, and 6 inhibition on the inflammatory profile was assessed in the tissue. Since especially 
STAT6 phosphorylation seems only detectable in OA synovium when certain stimuli 
are present, we decided to culture all the explants in the donor’s own SF. Culturing 
synovial explants with 50 μM NCS118-218, known as STAT1 inhibitor, did not affect 
STAT1 phosphorylation, nor did it affect pSTAT3 or pSTAT6 levels (Figure 2A and B). 
100 μM S3I-201, known as STAT3 inhibitor, did not influence STAT3 phosphorylation in 
explants cultured in SF, nor did it affect STAT1 or STAT6 phosphorylation (Figure 2D and 
E). 100 nM AS1517499, chosen as STAT6 inhibitor, decreased STAT1 phosphorylation 
levels, without affecting pSTAT6 levels (Figure 2G and H). This decrease in STAT1 
phosphorylation levels was accompanied by a significant decrease of IL1B and IL6 levels 
(Figure 2I).
The effect of the STAT1 and 3 inhibitors was also tested in cultures without synovial fluid. 
Here, NSC-118218 did result in a significant decrease of pSTAT1 levels (Figure 3A and 
B), without affecting gene expression levels (Figure 3C) or secreted protein production 
(Figure 3D). Treatment of synovial explants with S3I-201 decreased phosphorylated 
STAT3 levels in 4 of the 5 donors, and increased pSTAT3 in one of the donors (Figure 
3E and F). This treatment led to a significant upregulation of TNFA and a significant 
downregulation of IL6 and CD163 (Figure 3G). S3I-201 treatment also did not alter 
protein secretion after 24 hours of culture (Figure 3H). As pSTAT6 is not present at 
detectable levels in OA synovial tissue in absence of the corresponding environmental 
cues, STAT6 phosphorylation levels were not determined in synovial explants in culture 
medium nor was AS1517499 tested under these conditions.
Characterization of human macrophage phenotypes and their presence in OA 
synovial tissue
Using immunohistochemistry, the presence of macrophages was analysed in OA 
synovium. CD68 used as pan-macrophage marker, was mainly found in the lining of OA 
synovium explants. The presence of CD86, indicating pro-inflammatory macrophages, 
and CD206, indicating tissue repair macrophages, was mainly seen in the lining of OA 
synovium explants. CD163, a marker indicating anti-inflammatory cells, was present in 
the synovial lining of donor 1 and in the sublining of donor 2 and 3. Isotype controls were 
negative for all stainings (Figure 4A).
To investigate the activity of the different STATs related to different macrophage subtypes 
and cytokine expression, we stimulated macrophages towards specific phenotypes in vitro. 
pSTAT1 was abundant in M(IFNγ+TNFα) at all three time points after activation and not 
detectable in M(IL10) and M(IL4). pSTAT3 was highly present in M(IL10). pSTAT6 was 
only detected in M(IL4), but not in M(IFNγ+TNFα) or M(IL10), and phosphorylation 
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Figure 3. Modulation of STAT phosphorylation in OA synovial tissue cultured in medium.
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Figure 3. Modulation of STAT phosphorylation in OA synovial tissue cultured in medium.
A, E) Western Blot analysis of synovial tissue after treatment with the STAT inhibitors. The dotted line indicates 
grouping of images from different parts of the same gel, whereas the continuous line indicates grouping of differ-
ent parts from different gels. -; control, +; treated with STAT inhibitor. B, F) Quantification of the Western Blots 
relative to α Tubulin. C, G) Gene expression corrected for GAPDH and relative to the untreated control, which is 
represented by the dotted line. D, H) Protein production of IL6, CCL18 and sCD163. Data is shown as mean (as 
inidcated by the line) for n=5 donors analysed in 2-fold.
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rapidly decreased aft er stimulation (Figure 4B). M(IFNγ+TNFα) had signifi cantly higher 
gene expression levels of TNFA, IL6 and IL1B, than the other macrophage phenotypes. 
M(IL4) expressed the highest levels of CCL18 and CD206. M(IL10) expressed signifi cantly 
more CD163 than M(IFNγ+TNFα) (Figure 4C). Although not signifi cant, IL6 protein 
was the highest in culture medium of M(IFNγ+TNFα), CCL18 was the highest in M(IL4) 
and sCD163 in M(IL10) (Figure 4D).
To examine whether the analysed pSTATs in synovium are diff erentially activated in 
diff erent macrophage phenotypes, we analysed pSTAT1, 3, and 6 in diff erent in vitro 
obtained macrophage phenotypes. Samples were taken at diff erent time points aft er 
stimulation since STAT activation can be very dynamic.
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Figure 4. Diff erences in macrophage phenotypes in OA synovium and characterization of primary hu-
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Figure 4. Differences in macrophage phenotypes in OA synovium and 
characterization of primary human macrophage phenotypes, stimulated with 
IFNγ and TNFα (M (IFNγ + TNFα)), IL4 (M(IL4)) or IL10 (M(IL10))
A) Immunohistochemistry for markers indicating different macrophage phenotypes in 
OA synovium. B) Western Blot analysis of in vitro differentiated macrophages, at 
three time points after the start of differentiation. C) Gene expression corrected for 
GAPDH in the differentiated macrophages 24 hours after the start of stimulation, and 
D) Protein production by differentiated macrophages after 24 hours of IL6, CCL18 
and sCD163 corrected for amount of DNA. Data is shown as mean (indicated by line) 
for n=3 donors analysed in 3-fold.
DISCUSSION
In the current paper, we show that STAT1 and STAT3 phosphorylation levels differ 
among the OA synovial donors and that pSTAT6 is only detectable in presence of 
corresponding stimuli. Although NSC118-218 is the known STAT1 inhibitor, STAT1 
phosphorylation was only inhibited by AS1517499 (known as STAT6 inhibitor) in 
presence of synovial fluid and resulted in a significant decrease of IL1B and IL6 gene 
expression levels. In absence of synovial fluid, the STAT3 inhibitor S3I-201 inhibited 
STAT3 phosphorylation and resulted in more TNFA, and less IL6 and CD163. Since 
macrophage phenotypes had specific STAT1, 3, and 6 phosphorylation levels and 
presence of the macrophage phenotypes was confirmed in OA synovium, the 
targeting of phosphorylated STAT proteins within macrophage phenotypes might be 
a potential new approach to modulate synovial inflammation. 
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Figure 4. Differences in macrophage phenotypes in OA synovium and characterization of primary hu-
man macrophage phenotypes, stimulated with IFNγ and TNFα (M (IFNγ + TNFα)), IL4 (M(IL4)) or IL10 
(M(IL10))
A) Immunohistochemistry for markers indicating different macrophage phenotypes in OA synovium. B) Western 
Blot analysis of in vitro differentiated macrophages, at three time points after the start of differentiation. C) Gene 
expression corrected for GAPDH in the differentiated macrophages 24 hours after the start of stimulation, and D) 
Protein production by differentiated macrophages after 24 hours of IL6, CCL18 and sCD163 corrected for amount 
of DNA. Data is shown as mean (indicated by line) for n=3 donors analysed in 3-fold.
DISCUSSION
In the current paper, we show that STAT1 and STAT3 phosphorylation levels differ among 
the OA synovial donors and that pSTAT6 is only detectable in presence of corresponding 
stimuli. Although NSC118-218 is the known STAT1 inhibitor, STAT1 phosphorylation 
was nly inhibi ed by AS1517499 (known as STAT6 inhibitor) in presence of synovial 
fluid and resulted in a significant decrease of IL1B and IL6 gene expression levels. In 
absence of synovial fluid, the STAT3 inhibitor S3I-201 inhibited STAT3 phosphorylation 
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and resulted in more TNFA, and less IL6 and CD163. Since macrophage phenotypes 
had specific STAT1, 3, and 6 phosphorylation levels and presence of the macrophage 
phenotypes was confirmed in OA synovium, the targeting of phosphorylated STAT 
proteins within macrophage phenotypes might be a potential new approach to modulate 
synovial inflammation.
Nowadays, many anti-inflammatory compounds are being tested as potential new 
strategies for OA, focusing on complete suppression of inflammation, either via 
macrophages or via directly inhibiting cytokines. However, this approach may be too 
aspecific as sometimes a certain level of inflammation is required for a proper healing20 
and the composition of macrophage phenotypes in the synovium can differ at different 
stages of OA3 and even between patients12. Many cytokines use JAK-STAT signaling 
pathways to transduce intracellular signals. As phosphorylated STAT proteins are found 
in the synovial membrane of patient with rheumatoid arthritis9, 34, 36, modulation of 
intracellular signaling pathways have shown to be a promising intervention2. Compounds 
used in the current study share a comparable mechanism of action, as NSC-118218 and 
AS1517499 are known to inhibit tyrosine phosphorylation and S3I-201 binds to SH2 
binding sites6, 13, 21, 26. This prevents STAT proteins to get phosphorylated and detached 
from its receptor. Ultimately resulting in an inability to form STAT dimers and therefore 
an inability to bind DNA recognition sequences. To our knowledge, this is the first study 
showing modulation of the inflammatory phenotype of osteoarthritic synovial tissue 
using STAT phosphorylation inhibitors.
Different culture set-ups were used when testing the effect of the inhibitors. Since 
pSTAT6 was only detectable when stimuli were present, we cultured synovial explants 
with synovial fluid while adding the three STAT-inhibitors. Here surprisingly enough 
only AS1517499, chosen as STAT6 inhibitor, decreased the phosphorylation of STAT1 
but not STAT6. When the synovial explants were cultured in medium without synovial 
fluid, no STAT6 was detectable and thus no STAT6 inhibitor was tested. Without the 
presence of synovial fluid, NSC-118218 decreased STAT1 phosphorylation, but without 
changing expression of the analysed genes and S3I-201 decreased STAT3 phosphorylation 
in 4 of the 5 synovial explants donors in the presence of S3I-201. Upregulation of TNFA 
in response to inhibition of STAT3 phosphorylation may be explained by the action of 
different STATs: selective blockade of one STAT molecule might be compensated by 
more activation of another STAT molecule7, although we did not see this for the analysed 
STATs. Another explanation for the increase of TNFA when STAT3 phosphorylation is 
inhibited might be that inhibition of anti-inflammatory markers abolishes a more pro-
inflammatory response, as has been shown in previous work30. The loss of inhibitory 
function of NSC-118218 and S3I-201 in the presence of synovial fluid might be explained 
by a continuous presence of JAK-STAT pathway-activating stimuli in the synovial fluid24, 
such as the STAT1 activators IL-1β and IL-6 or the STAT3 activator IL-10.
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Our study showed that different macrophage phenotypes had specific STAT 
phosphorylation patterns in vitro. Presence of these corresponding macrophage 
phenotypes in OA synovium was confirmed and in line with previous reports12, 28. The 
levels of phosphorylated STAT proteins that could be detected in OA synovium appeared 
to be strongly donor dependent. This suggests that the stage of inflammation of the 
synovial tissue and possibly also the different macrophage phenotypes residing in the 
synovium varies among patients. Differences in the response to treatment with STAT-
inhibitors might be explained by these findings.
A potential approach to modulate synovial inflammation might be via modulation of 
macrophages with high STAT1 phosphorylation levels, as these phosphorylated proteins 
are predominantly found in pro-inflammatory macrophages. On the other hand, one 
should avoid the modulation of macrophages with high pSTAT3 or pSTAT6 levels, 
since these phosphorylated STATs are associated with macrophages that have an anti-
inflammatory phenotype. Therefore, modulating synovial inflammation by targeting 
phosphorylated STAT proteins in macrophages might be a suitable approach to delay the 
progression of OA.
To quantify the effect of the compounds on STAT phosphorylation we semi-quantitated 
the Western blot data. Besides, using total protein measurements to load an equal amount 
of protein per sample, we used α-tubulin as an extra control for normalization. We 
specifically chose to use α-tubulin for this purpose because we were interested in the 
total amount of pSTAT1, 3, and 6 irrespective of how much unphosphorylated STAT was 
present in the cell.Moreover, since phosphorylation of STATs might result in an altered 
ratio between STAT and pSTAT, unphosphorylated STATs cannot be used as control 
protein for equal loading.
In conclusion, different macrophage phenotypes have specific STAT phosphorylation 
levels. OA synovium contains these macrophage phenotypes but has varying STAT 
phosphorylation levels among the donors. This suggests that the composition of synovial 
macrophages and herewith the degree of synovial inflammation is strongly donor 
dependent. In addition, this study shows that inhibition of STAT phosphorylation 
in OA synovium modulates its inflammatory phenotype. Considering the varying 
STAT phosphorylation levels in OA synovium among patients, inhibition of STAT 
phosphorylation is a potential personalized therapeutic approach to direct the synovial 
inflammation seen in OA.
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The anterior cruciate ligament (ACL) is an important stabilizing ligament of the knee and 
commonly injured in pivoting sports. When surgical intervention is needed to restore knee 
stability, autogenous hamstring tendons are the graft of choice for ACL reconstructive 
purposes. The surgical harvesting of one or two hamstring tendons is required and 
subsequently used to reconstruct the ruptured ligament. In the light of potential donor 
site morbidity and functional deficits, both patients and orthopaedic surgeons voice 
concerns about the harvest of healthy and functional tendon tissue. However, in 1992 
Cross et al. were the first to describe the potential of hamstring tendons to regenerate 
following harvesting procedures21. If regeneration takes place and regenerated tendons 
resemble the native ones, the post-harvest morbidity might be limited.
Therefore, the general aim of this thesis was to improve the outcome following harvest 
of the hamstring tendons through a better understanding of tendon regeneration. This 
might contribute to the identification of new (therapeutic) targets and ultimately result 
in an improved outcome after ACL reconstruction procedures entailing the hamstring 
tendons.
THE REMARKABLE CAPACITY OF HAMSTRING TENDONS TO 
REGENERATE
Despite the efforts to use synthetic materials or allografts, autografts remain the first 
choice for ACL reconstruction purposes53, 56. Today, the hamstring tendons are the 
most commonly used autograft to reconstruct the torn ACL34, 56. More specifically it 
requires the surgical resection of either the semitendinosus tendon only, or both the 
semitendinosus and gracilis tendon to prepare the graft. Another popular and widely 
used tendon autograft is the bone-patellar tendon-bone (BPTB) graft entailing the central 
third of the patellar tendon34, 56. Although the quadriceps tendon and iliotibial band are 
less frequently used as autografts, these are suitable alternatives too. Regardless the choice 
of autograft, surgical resection of healthy and functional tissue is needed. Both patients 
and surgeons raise concerns about the potential donor site morbidity and lack of this 
tendon for functional deficits.
What are the regeneration rates for hamstring tendons?
In 1992, Cross et al. were the first authors describing the remarkable regeneration 
capacity of the hamstring tendons after being entirely resected21. In our systematic 
review we showed that regeneration of the semitendinosus and gracilis tendons occurs 
in 70% within the first year following harvesting procedures (Chapter 2). Studies 
reporting about hamstring tendon regeneration used different imaging techniques, such 
as computed tomography (CT), magnetic resonance (MR) imaging and ultrasound. 
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In addition, various definitions were used to assess (in)complete regeneration of the 
hamstring tendons, regeneration was assessed dichotomously and evaluated only after a 
single follow-up period. This does not reflect a dynamic and continuous process such as 
regeneration of the hamstring tendons. Therefore, we described regeneration rates both 
one and two years after harvest using MR imaging (Chapter 3). In line with previous 
findings, we found that the semitendinosus tendons regenerated in 65.7% of the cases 
and that the gracilis tendons regenerated in 82.9% of the cases. Interestingly, regeneration 
rates in the second year after harvest were found to be lower compared to the regeneration 
rates one year after surgical resection. This might be explained by the observation that 
the initial structure is predominately fibrous with only a few collagen fibers27. Over time 
the regenerated tendon starts the remodeling process and becomes similar to the native 
tendon with longitudinally oriented collagen fibers that appear to be of appropriate 
orientation and dimension33, 67, 80. In line with these findings, biomechanical properties 
of regenerated tendons improve over time54. Therefore, regenerated structures might be 
most prone to rupture within the first period following harvest and result in a decline 
in the regeneration rates over time. Patients with a rupture of the regenerating structure 
often experience a sudden, persistent and sharp pain at the posterior thigh63.
Hamstring tendons are not the only tendons that are frequently harvested for 
reconstructive purposes. Another often-used graft for ACL reconstruction procedures 
is the BPTB autograft, involving the harvest of the middle-third of the patellar 
tendon. Previous studies reported similar regeneration rates for the patellar tendon as 
aforementioned for the hamstring tendons7, 88. Another tendon that is harvested for 
ligamentous reconstruction tendon interposition of the carpometacarpal joint is the 
flexor carpi radialis tendon. Reported regeneration rates for this tendon reach up to 79% 
4 years after surgery5.
Regenerated hamstring tendons are thicker and longer compared to the native 
tendons
Tendons are important for the transmission of skeletal muscle forces to bone. Appropriate 
regeneration of the tendon is therefore important to withstand mechanical loads, resulting 
in an increase of cross-sectional areas (CSA)38, 48. In line with these findings, regenerated 
semitendinosus and gracilis tendons show a doubling of the CSA of compared to the 
CSA of the native tendons (Chapter 3). A similar increase of the CSA is observed after 
tendon resection for the BPTB autografts4, 6, 7, 20, 45. There are several feasible hypotheses 
that explain the increased CSA of regenerated tendons. First of all, the organization and 
composition of the extracellular matrix (ECM) in regenerated tendons might be inferior 
to the original tendon, causing diminished biomechanical properties. Therefore, more 
tissue is required to withstand the same mechanical forces as before. Secondly, the 
tendon is exposed to more mechanical stress per unit and therefore increases its CSA. A 
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third feasible explanation is that the increase in CSA serves as a protective mechanism 
to strengthen vulnerable tendons, as seen in Achilles tendinopathy and after Achilles 
tendon rupture46, 74.
In line with the first hypothesis, it has been observed that in the first months after resection 
the regenerated structure is predominately fibrous with only a few collagen fibers27. 
Over time the regenerated tendon starts the remodeling process and becomes similar 
to the native tendon with longitudinally orientated collagen fibers33, 67, 80. Along with this 
improved organization of the ECM, the biomechanical properties of the newly formed 
structure ameliorate with the passage of time54. However, the ultimate load, stiffness and 
the modulus of the regenerated structure do not become identical compared to the native 
tendons. These inferior biomechanical properties may be partially due to the decreased 
cross-sectional diameter of the collagen fibers in the regenerated tendons33. This all fits 
within the first hypothesis and explains our observation that regenerated tendons have 
increased CSA compared to the native tendons.
The musculotendinous junctions (MTJ) of regenerated hamstring tendons appear to be 
found more proximal compared to the MTJ of native tendons, resulting in an increase 
of the semitendinosus and gracilis tendon length (Chapter 3). The average length of this 
proximal shift ranges from 3.1 to 7.3 cm17, 62. On the contrary, it is interesting to note 
that the patellar tendon is significantly shortened between 0.4 and 1.8 cm after harvest of 
the middle third of the tendon7, 12.The opposite post-harvest remodeling of the patellar 
tendon and the hamstring tendon length might be explained by the different anatomic 
situations after surgical intervention. The hamstring tendons are harvested from insertion 
to the MTJ, leaving a free anatomic space between the fascial planes of the medial thigh. 
However, a BPTB graft requires a longitudinal incision directly over the patellar tendon, 
involving harvest of the middle third and leaving two thirds of the native tendon in situ. 
In addition, some surgeons close the harvest gap. This surgical approach might result 
in formation of exaggerated pathologic fibrous hyperplasia causing a shortening of the 
patellar tendon and a subsequent tendon shortening69.
Recently, Laako et al. described a surgical technique in which the distal head of the 
harvested semitendinosus and/or gracilis muscle is drawn towards its anatomical 
location and attached to the semimembranosus muscle50. This technique could be of 
value in patients with increased lengths of the semitendinosus and gracilis tendons, 
since increased tendon lengths might cause symptoms such as posterior thigh pain. 
Alternatively, one could choose to only harvest 75% of the tendons, leaving the other 
25% in situ. Another, relatively rare, symptom caused by the altered thickness and 
length of regenerated tendons is a snapping syndrome. Gali et al. proposed a method of 
percutaneous lengthening of regenerated tendons alleviating symptoms and resulting in 
minimal morbidity30.
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The work in this thesis emphasizes that tendons regenerate and that regenerated 
hamstring tendons are thicker and longer than the native ones, altering the anatomy and 
biomechanics. Therefore, patients may experience symptoms that are related to this new 
situation. Orthopaedic surgeons should be aware of the potential of the semitendinosus 
and gracilis tendons to regenerate, their altered morphological properties and the 
potential accompanying clinical symptoms. If needed, surgical interventions should be 
considered.
Should hamstring tendons be reconsidered as graft of choice for ACL reconstruction 
purposes?
Patients often express their concerns regarding potential muscle strength deficits 
following tendon harvesting procedures. Previous studies measuring the peak torque of 
knee flexion reported a full recovery of hamstring strength19, 55, 87. This recovery might be 
attributed to a functional restoration of muscle-tendon-bone complex of the hamstring 
tendons. Alternatively, it might also be caused by compensatory hypertrophy of the 
remaining knee flexors, such as the biceps femoris and semimembranosus26, 42. Since 
the semitendinosus and gracilis muscles insert at the pes anserinus and are therefore 
more important for higher angles of knee flexion (beyond 75 degrees)65, strength deficits 
might be found in deep knee flexion. In line with this hypothesis, three studies reported 
strength deficits ranging from 20 to 30% at knee flexion angles beyond 75 degrees17, 64, 82. 
However, the clinical relevance of this limited strength deficit is debatable (Chapter 4).
Orthopaedic surgeons worldwide have not reached consensus yet regarding the selection 
of the best graft to reconstruct ruptured ACLs. Based on several studies, hamstring 
tendons and bone-patellar tendon-bone are the most frequently used autograft1, 34, 56. 
However, BPTB autografts result in significantly more donor site morbidity and lower 
patient reported outcome measurements and hence hamstring tendons are the graft 
of choice for ACL reconstructions1, 34, 56, 57. However, the semitendinosus and gracilis 
tendons are primarily internal rotators of the tibia, withstanding excessive external 
rotation and protecting the (reconstructed) ACL3, 68, 75. Patients without hamstring 
tendon regeneration have impaired internal tibial rotary strength2, 3 and might therefore 
be at increased risk for ACL re-ruptures3. Preoperative identification of patients that are 
likely to lack regenerative capacity of the hamstring tendons might alter the graft choice. 
Since there is currently no literature available that supports this hypothesis, future studies 
should investigate if regeneration indeed decreases the risk of ACL re-rupture.
Another interesting aspect of regenerated hamstring tendons is their potential to 
be re-harvested. Although it has been reported that the semitendinosus and gracilis 
tendons have been reharvested for ACL89 and medial patella-femoral ligament (MPFL)80 
reconstructions, the re-use of these tendons is still very questionable for several reasons. 
First of all, tendon regeneration does not occur in every patient and therefore harvesting 
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is not always possible. Given the morphological features of the remodeled tendons and 
the importance of graft thickness and graft length, newly formed tendons could be 
considered as potential interesting candidates for reharvesting procedures. However, it 
is important to address that the strength and stiffness of the newly formed tendons is 
expected to be inferior to the native tendons. In addition, histological studies revealed 
that the remodeled tendons show areas of scar tissue that could be expected to alter graft 
strength25, 27, 67.
Taken together regenerated tendons resemble the native tendons, but are not identical 
in terms of morphology, histology and biomechanical features. It would be helpful to 
identify key role players of tendon regeneration and remodeling because it contributes 
to the identification of targets to direct and improve these processes. Ultimately, this 
knowledge might be used to improve treatments for tendon-related diseases.
MODULATORS FOR THE INFLAMMATORY RESPONSE
Tendon repair is a complex and multistage process, which is initiated after tissue damage 
and ultimately results in function restoration. Although numerous cells are involved 
in the process of tendon repair, macrophages are thought to be key role players in this 
process35, 49.Various in vitro studies showed that the different macrophage phenotypes 
produce distinct factors, having different effects on tendon repair. Considering the specific 
effects of the specific macrophage phenotypes, it is not surprising that macrophage subsets 
are differently recruited during the process of tendon repair58, 73. More specifically, it has 
been shown that M1-like macrophage are recruited first and stimulate tenocytes to produce 
catabolic enzymes, such as matrix metalloproteinases73. In addition, M1-like macrophages 
typically produce factors such as IL-1β, IL-6, and TNF- α84. In Chapter 5, we describe 
that pro-inflammatory cytokines negatively influence the production of structural and 
fibril-associated ECM components. Then, M2-like macrophages are recruited resulting 
in higher ECM densities and increased collagen I expression presenting an orientation 
along the longitudinal axis of the tendon58. This macroscopically resembles a normal and 
healthy tendon. Together, these findings emphasize the pivotal role of macrophages in the 
tendon repair process. However, it is important to note that both pro-inflammatory and 
anti-inflammatory macrophages/cytokines are highly required for optimal tissue healing: 
inhibition of pro-inflammatory factors and stimulation of anti-inflammatory factors 
will not necessarily result in proper tissue healing. Tissue healing strongly depends on 
the finely regulated balance between pro- and anti-inflammatory factors. The question 
remains whether aging and smoking that are known to negatively influence regeneration 
chances (Chapter 4) also affect macrophages and/or their phenotypes.
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Aging
Aging is associated with decreased chances for regeneration of the hamstring tendons 
(Chapter 4). In general, it is known that aging negatively affects the function of the 
immune system61.
Currently, it is unclear whether the generation of macrophages from monocytes is 
impaired with age39, 66, 85. Regarding macrophage polarization, it has been reported 
that more M2-like macrophages are found in a mouse-model of age-related macular 
degeneration47. These ocular macrophages had decreased levels of TNF-α and IL-12, 
whereas the anti-inflammatory cytokine IL-10 was upregulated. In addition, an increase 
in M2-like macrophages was observed with aging in spleen, lymph nodes and bone 
marrow43.
Aging influences the cytokine secretion patterns by macrophages. Compared to cytokine 
production in young mice, peritoneal macrophages from old mice secrete less pro-
inflammatory cytokines, such as IL-1β, IL-6, and TNF- α, and more anti-inflammatory 
cytokines such as IL-109, 14, 72. Microarray analysis further investigated the molecular 
basis for this decrease and revealed signal transduction genes were specifically reduced in 
macrophages from old mice15. First of all, decreased expression of toll-like receptor (TLR) 
4 has been suggested as a reason for the observed age-related alterations72. However, 
other studies indicated that TLR4 remains unchanged with age9. Another explanation 
might be alterations in the JAK-STAT signaling pathway. As shown in Chapter 6, 
macrophage phenotypes have a characteristic STAT phosphorylation pattern. Previous 
studies showed that STAT1 phosphorylation levels are decreased in macrophages from 
old mice, compared to young mice23. Since STAT1 phosphorylation is mainly found in 
M1-like macrophages, decreased phosphorylation levels might therefore contribute to 
reduced production of pro-inflammatory cytokines.
Taken together, aging impacts on macrophage function and potentially disturbs the 
highly regulated balance between pro- and anti-inflammatory factors, which is required 
for optimal tendon healing. A failure to repair the ECM of tendons might therefore be 
caused by an impaired macrophage function.
Smoking
Smoking has been shown to have deleterious consequences for several orthopaedic 
conditions, such as higher rates of hip fracture, nonunion of fractures and osteomyelitis. 
In addition, smoking is also associated with impaired regeneration of the hamstring 
tendons (Chapter 4).
M1-like macrophages play a central role in defending the human body against invading 
pathogens and foreign material. Cigarette smoking reduces the phagocytic ability of 
macrophages40 and decreases levels of molecules that are needed for intracellular killing, 
such as nitric oxide (NO) and reactive oxygen species (ROS)90. This finding suggests that 
127
General discussion
7
cigarette smoke induces macrophage polarization towards a M2-like phenotype. This 
hypothesis is further strengthened by the activation of STAT3 pathways in macrophages 
after exposure to cigarette smoke32. Activation of this pathway is seen in M2-like 
macrophages (Chapter 6) and needed for the production of anti-inflammatory cytokines. 
In addition, low levels of cytokines that are typically produced by M1-like macrophages 
are found in response to cigarette smoke16. Therefore, STAT3 is considered to be a pivotal 
signaling molecule for macrophage polarization towards an M2-like phenotype.
Similar to the effect of aging, the exposure to cigarette smoke influences the tightly 
regulated equilibrium between pro- and anti-inflammatory factors and herewith 
potentially affects the repair capacity of the ECM.
Genetics
The aforementioned factors only partially explain the interindividual variation in tendon 
repair. Today, there is mounting evidence suggesting that genetics has a pivotal role in the 
healing tendency of tendons70, 76.
Tendons are subject to mechanical loads that reach up to ten times an individual’s body 
mass. Therefore, the ECM of tendons continuously needs to undergo remodeling in order 
to withstand these loads and maintain homeostasis. It has been described that tendons 
are able to respond to these mechanical loads by initiating several matrix remodeling 
pathways52, 86. Previous studies showed that inflammatory gene expression profiles of 
tenocytes are modulated in response to mechanical loading triggering tenocyte apoptosis 
and ECM degradation. Therefore, it is reasonable to hypothesize that polymorphisms 
within genes encoding for inflammatory proteins modulate risk of tendinopathy.
Previous studies showed that genes encoding several interleukin proteins including 
interleukin-1β (IL1B rs16944 C>T), interleukin-6 (IL6 rs1800795 G>C) and interleukin-6 
receptor (IL6R rs2228145 A>C) modulate risk of Achilles tendinopathy in cohorts from 
South Africa77, Australia77 and the United Kingdom10. All these polymorphisms are located 
at the promotor site, affecting the produced amounts of the respective interleukines12, 28, 31, 51. 
It has been shown that IL1B rs16944 is independently associated with an increased risk 
of acute Achilles tendon ruptures10. For chronic Achilles tendinopathy, no independent 
associations were noted77. However, IL1B and IL6 variants were associated with increased 
risk of Achilles tendinopathy in inferred gene-gene interactions models77. Although it 
has been well described that IL-1β and IL-6 are responsible in the activation of many 
downstream signaling cascades, it remained unclear how these polymorphisms contribute 
to tendinopathy70, 76. The work in this thesis indicated that polymorphisms within genes 
encoding IL-6 and IL-1β modulate the production of structural and fibril-associated ECM 
components (chapter 5) and herewith potentially contribute to an impaired capacity to 
repair the ECM.
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It is interesting to note that additional associations were found between polymorphisms 
within genes encoding for IL1B and IL6, and other soft musculoskeletal injuries. In line 
with the findings for acute rupture of the Achilles tendon, the IL1B rs16944 promotor 
polymorphism independently increases the risk of ACL rupture71. In addition, inferred 
allele combinations of IL1B, IL6 and IL6R were found to be associated with risk of ACL 
ruptures, both two independent South African cohorts71 and a Swedish cohort (chapter 
5). The risk of developing carpal tunnel syndrome has also shown to be modulated 
by polymorphisms within IL6R11. Collectively, these results underline the potential 
implication of interleukin signaling pathways in the underlying mechanism that 
predisposes for both acute and chronic soft musculoskeletal injuries. The investigated 
polymorphisms were found to be associated with increased risk for ACL rupture in a 
Swedish cohort (Chapter 5), and other cohorts71. In addition, these polymorphisms 
were previously associated with increased risk of chronic Achilles tendinopathy70, 76, 77. 
Therefore, it might be suggested that these polymorphisms negatively affect the odds for 
hamstring tendon regeneration.
Personalized medicine is a central dogma in current clinical practice, proposing the tailor 
made clinical assessment of an individual patient based on their extrinsic and intrinsic risk 
factors18. Tendon healing is based on a poorly understood complex interaction between 
a variety of extrinsic and intrinsic risk factors. Clinicians should be aware of this when 
considering any clinical application of genetic testing and prevent the use of terms such 
as diagnostic, prognostic or preventive. Instead, clinicians should rather consider injury 
susceptibility through the identification of both known intrinsic and extrinsic risk factors 
(Figure 1). Individuals who are at increased risk to develop a soft musculoskeletal injury 
should then be referred to a sports-trained physiotherapist to be managed personally by 
appropriate prehabilitation exercises to reduce risk.
Athletes Predisposed athletes Susceptible athletes Injured athlete 
Intrinsic factors Extrinsic factors Inciting event 
Figure 1: Schematic overview of the complex relationship between intrinsic and extrinsic factors, as well as 
the role of the inciting event. Future multifactorial models could be of great value to distinguish low-risk 
(black), predisposed (grey) and susceptible (blue) athletes.
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FUTURE PERSPECTIVES
Remaining uncertainties about tendon regeneration
The work in the current thesis shows that the semitendinosus and gracilis tendons 
regenerate in 70% of patients within the first two years following tendon harvest for 
reconstructive purposes. It appears that these tendons regenerate in a proximal to distal 
fashion, and that regenerated tendons are longer and have increased cross-sectional 
areas compared to the native tendons. However, the exact mechanism that underpins 
hamstring tendon regeneration remains unclear. In the field of Developmental Biology 
and Cancer, lineage tracing is currently the golden standard to determine a cell’s origin. 
In this technique, a single cell is labeled in such a way that the mark is transmitted to the 
cell’s progeny. The advantage of this approach is that it can be performed without any 
prior knowledge of what genes or markers should be expressed. However, a disadvantage 
this technique requires to physically stop the development process to see how cells look. 
Therefore, more recent developments have enabled in vivo barcode generation, targeting a 
locus for rearrangement or mutagenesis such that a different set of outcomes is generated 
in different cells44. The barcodes are generated over a limited amount of time resulting 
in a deep and precise lineage tracing. A great advantage of this strategy is the ability to 
continuously record a cell’s development. Another more indirect method to identify the 
origin of the cells residing in the newly formed tendon tissue is to compare its methylome 
with the methylomes of cells derived from the surrounding tissues, such as fat, muscle 
and tendon sheets. A methylome is the methylation of cytosines, contributing to the 
epigenetic layer and defining the transcriptional and regulatory potential of genomic 
DNA41.
Mid- and long-term follow-up of patients with harvested hamstring tendons is necessary 
to further evaluate the clinical implications of tendon regeneration. The semitendinosus 
and gracilis tendons withstand excessive external tibial rotation protecting the ACL. 
An impaired repair capacity of the hamstring tendons following harvesting procedures 
might therefore impact ACL reconstruction survival rates. Although there is currently 
no literature available on this topic, hamstring tendon regeneration is potentially of 
importance for the clinical outcome after ACL reconstruction procedures. Additionally, 
complete hamstring tendon regeneration theoretically re-establishes a functional muscle-
tendon-bone complex. This hypothesis is supported by the current literature, suggesting 
that tendon regeneration would result in no or limited loss of muscle strength. However, 
it remains unclear whether this is caused by high-quality regeneration or compensatory 
hypertrophy of other (posterior) thigh muscles. In this light, it would be highly valuable 
to evaluate the volumes of all thigh muscles following harvesting procedures. Next to this, 
the quality of the regenerated tendons might be indirectly measured by the radiologic 
appearance of the hamstring muscles. Previously tendon-related disorders of the rotator 
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cuff have been described to cause a myriad of changes in the cuff musculature on MR 
imaging, such as fatty infiltration, atrophy and fibrosis. In line with these observations, 
one might hypothesize that impaired regeneration of the hamstring tendons causes 
similar deviations of the semitendinosus and gracilis muscles.
Improved understanding of tendon- and ligament related injuries
ACL injuries are often associated with knee instability, take up to 9 months to rehabilitate 
and lead to gonarthrosis in 40% of the patients 10 years after injury59. In addition, treatment 
of ACL injuries is costly and only 50% of the athletes successfully return to preinjury 
levels29, 59. Therefore, the current focus of musculoskeletal research is the identification of 
factors associated with increased susceptibility to ACL injuries. Independent associated 
factors with ACL injury include anatomical variations, neuromuscular control, sex, 
female sex hormone concentrations, genetic polymorphisms and previous injuries78, 79. 
To date, studies that evaluated risk of ACL injury using combinations of risk factors by 
developing multivariable models are limited36, 83. These models exclusively focus on the 
anatomic features and do not provide a full understanding of ACL injury risk. However, 
it is probable that tendon- and ligament related injuries depend on multiple risk factors. 
Therefore, it is important to focus on creating comprehensive and clinically applicable 
risk models identifying individuals with increased susceptibility to both tendon- and 
ligament-related injury. Besides, the models should provide more direction for preventive 
programs, as well as appropriate counseling for those who are at increased risk.
The healing process of tendons involves an inflammatory phase. Macrophages are 
considered to be pivotal in the onset and perpetuation of tendon diseases22, 60, 81. Some 
studies indicate that macrophage depletion improved morphological and biomechanical 
properties in injured Achilles tendons or following ACL reconstruction procedures24, 37. 
On the other hand, other studies reported that aspecific inhibition of macrophages is 
detrimental to ECM formation and tensile strength8, 13. In line with these findings, aspecific 
targeting of inflammation by common anti-inflammatory drugs including diclofenac, 
celecoxib and naproxen seem to have deleterious effects on tendon healing. These findings 
emphasize the functional role of macrophages in the tendon-healing process but suggest 
the need for further clarification on the interplay between macrophages and tenocytes. In 
vitro studies are limited but suggest that different macrophages have different effects on 
tenocyte behavior58, 73, 81. Given these different effects of the different macrophage subsets, 
it might be interesting to specifically target macrophages in order to improve the tendon 
remodeling process. This can either be done by using specific antibodies to specifically 
target a monocyte or macrophage subset, or by modulating specific intracellular signaling 
proteins, such as STAT proteins.
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When surgical intervention is needed to reconstruct a ruptured anterior cruciate ligament 
(ACL), the hamstring tendons are often harvested and subsequently used as autograft. 
The harvested hamstring tendons have the potential to regenerate. The main of this thesis 
was therefore to improve the clinical outcome following harvest of the hamstring tendons 
through a better understanding of the process of hamstring tendon regeneration.
Chapter 2 summarized the available literature on hamstring tendon regeneration and 
showed that 70% of the patients have the potential to regenerate their harvested tendons. 
However, the included studies assessed hamstring tendon regeneration dichotomously, 
used multiple definitions for tendon regeneration and only evaluated regeneration at a 
single follow-up period. Therefore, Chapter 3 evaluated hamstring tendon regeneration 
rates both 1 and 2 years after harvest using magnetic resonance (MR) imaging. We found 
that the semitendinosus tendons regenerated in 65.7% and that the gracilis tendons 
regenerated in 82.9% of the cases. In addition, regenerated hamstring tendons were found 
to have significantly increased cross-sectional areas and lengths compared to the original 
tendons. Failure to regenerate and the altered morphological properties might cause 
clinical symptoms such as posterior thigh pain, cramping and weakness. In this light, it 
might be interesting to preoperatively identify individuals with poor chances of complete 
regeneration of the hamstring tendons. Chapter 4 revealed that aging and smoking were 
negatively associated with regeneration chances. In addition, it revealed that patients without 
regeneration reported higher pain scores compared to those with regenerated tendons.
Another well-known factor involved in tissue repair processes is inflammation. Chapter 5 
revealed that polymorphisms within genes encoding inflammatory proteins such as IL6 and 
IL1B affect the production of structural and fibril-associated extracellular matrix components 
in a risk-dependent manner. In addition, it was found that these polymorphisms contribute 
to risk of ACL injuries. Taken this together, these results suggest that IL6 and IL1B might be 
important factors during the process of hamstring tendon regeneration. In order to direct 
the inflammatory process, Chapter 6 focused on the modulation of inflammation using 
activated STAT-signaling pathways in macrophages. Specific inhibition of activated STAT 
proteins modulated the inflammatory phenotype, potentially via modulating macrophage 
phenotypes.
CONCLUDING REMARKS
To conclude, the work in this thesis described the regenerative capacity of hamstring 
tendons following harvesting procedures. In the future, clinicians should preoperatively 
inform patients about tendon regeneration, its clinical consequences and possibly alter 
the choice of graft. Furthermore, this thesis identified potential targets to improve tendon 
regeneration. Future studies on the role of infl ammation and tendon repair could focus 
on the role and impact of macrophages.
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A
NEDERLANDSE SAMENVATTING
De voorste kruisband speelt een essentiële rol bij de stabilisatie van het kniegewricht. Een 
ruptuur van de voorste kruisband is een van de meest voorkomende sport-gerelateerde 
letsels van de knie, waarbij in de helft van de patiënten een hersteloperatie geïndiceerd 
is. Tijdens een operatie worden veelal twee hamstringpezen, de semitendinosus en 
gracilis pees, gebruikt om de gescheurde kruisband te reconstrueren. Deze pezen worden 
chirurgisch verwijderd vanaf de spier-pees overgang tot op de aanhechting aan het 
onderbeen. Opvallend genoeg blijken sommige patiënten in staat om deze geoogste pezen 
te regenereren. Het doel van dit proefschrift is derhalve ook om de klinische uitkomst 
na het oogsten van hamstringpezen te verbeteren door het proces van hamstringpees-
regeneratie beter te begrijpen.
In Hoofdstuk 2 werd de beschikbare literatuur met betrekking tot hamstringpees-
regeneratie samengevat. Hierin werd aangetoond dat 70% van de patiënten beschikt over 
de capaciteit om de hamstringpezen te regenereren. Echter, het werd ook duidelijk dat in 
de huidige literatuur een eenduidige definitie van hamstringpees-regeneratie ontbreekt. 
Daarnaast werden verschillende technieken gebruikt om regeneratie in beeld te brengen 
en werd de regeneratiestatus altijd louter op één moment bepaald.
Derhalve werd in Hoofdstuk 3 met behulp van MRI beelden hamstringpees-regeneratie 
geëvalueerd op zowel 1 als 2 jaar na het chirurgisch verwijderen van de oorspronkelijke 
pezen. Hieruit bleek dat de semitendinosus in 65,8% en de gracilis in 82,9% van 
de patiënten geregenereerd is in het tweede jaar na chirurgie. In vergelijking met het 
eerste jaar had 10,5% van de patiënten een veranderde regeneratiestatus, waarbij zowel 
verbetering als verslechtering van het regeneratieproces werd gezien. Daarnaast werd 
beschreven dat geregenereerde pezen een toegenomen oppervlakte en lengte hebben 
in vergelijking met de originele pezen. Zowel het falen van het regeneratieproces, als 
de veranderde morfologische peeseigenschappen kunnen leiden tot symptomen als 
spierkramp, pijn en zwakte in de achterzijde van het bovenbeen. Het is daarom ook 
klinisch relevant om voor de operatie de patiënten te identificeren die mogelijk een 
verminderde kans hebben op succesvolle regeneratie, zodat de operatieve behandeling 
eventueel kan worden aangepast. Hoofdstuk 4 liet zien dat oudere mensen en rokers 
een verminderde kans hebben op regeneratie van de pezen. Bovendien werd duidelijk 
dat patiënten zonder regeneratie hogere pijnscores rapporteerden dan patiënten met 
geregenereerde pezen in het tweede jaar na de operatie.
Een andere factor waarvan bekend is dat die een rol speelt bij het herstel van weefsels 
is ontsteking. In Hoofdstuk 5 werd duidelijk dat varianten in genen die coderen voor 
ontstekings-gerelateerde eiwitten, zoals interleukine (IL) 1B and IL6  de productie van 
extracellulaire matrix componenten beïnvloeden. Daarnaast werd duidelijk dat deze 
genetische varianten het risico op het scheuren van de voorste kruisband beïnvloeden. 
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Het is daarom aannemelijk dat IL1B en IL6 belangrijke factoren zijn voor het proces 
van hamstringpees-regeneratie. Om het regeneratieproces te beïnvloeden werd in 
Hoofdstuk 6 onderzocht of het mogelijk is het ontstekingsproces te moduleren door het 
remmen van specifieke processen in macrofagen, ontstekingscellen die een rol spelen in 
weefselherstel. Door specifieke STAT-eiwitten te remmen konden we de eigenschappen 
van het ontstekingsproces beïnvloeden, mogelijk via macrofagen.
Concluderend heb ik in dit proefschrift de regeneratieve capaciteit van hamstringpezen 
beschreven. Dit maakt het in de toekomst mogelijk dat artsen patiënten voor de operatie 
beter informeren over hamstringpees-regeneratie, de klinische gevolgen hiervan en 
de operatietechniek hierop aanpassen. Bovendien laat het werk in dit proefschrift 
nieuwe potentiële aangrijpingspunten zien om peesregeneratie te beïnvloeden. Nieuw 
wetenschappelijk onderzoek naar de rol van ontsteking en peesherstel zou zich kunnen 
concentreren op de interactie tussen peescellen en macrofagen.
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‘If I have seen further, it is by standing on the shoulder of Giants’
Isaac Newton (1643-1727)
Hoewel het schrijven van een proefschrift een individuele prestatie lijkt, is niets minder 
waar. Ik heb de afgelopen jaren veel bijzondere mensen ontmoet en het genoegen 
gehad met sommigen van hen samen te werken. Met behulp van hun kennis, hulp en 
betrokkenheid is dit proefschrift tot stand gekomen. Graag wil ik iedereen bedanken die 
direct of indirect een bijdrage heeft geleverd aan dit proefschrift. Een aantal personen wil 
ik hierbij in het bijzonder noemen.
Allereerst wil ik het woord richten tot mijn promotor, professor dr. van Osch. Beste Gerjo, 
waar moet ik beginnen je te bedanken? Het moet geen gemakkelijke opgave geweest zijn 
om een student, coassistent en later orthopaed in opleiding te begeleiden, maar wat ben 
ik blij dat je die uitdaging bent aangegaan. Jouw wetenschappelijke betrokkenheid, maar 
ook je persoonlijke interesse heb ik altijd erg gewaardeerd en zijn veelzeggend over jou 
als persoon. Het is indrukwekkend, en soms toch ook een tikkeltje frustrerend, om te zien 
hoe een manuscript significant verbetert naar aanleiding van jouw razendsnelle feedback. 
Gerjo, ik ben trots en dankbaar jou als promotor te hebben.
Aan mijn copromotoren dr. Meuffels en dr. Bastiaansen-Jenniskens ben ik eveneens veel 
dank verschuldigd. Beste Duncan, je hebt me de kans en het vertrouwen gegeven om aan 
dit avontuur te beginnen. De daaropvolgende jaren van intensieve samenwerking waren 
een geweldige ervaring, waarin ik alle ruimte kreeg om mezelf op zowel persoonlijk als 
wetenschappelijk niveau te ontwikkelen. Dankzij jouw gedrevenheid, inspanningen en 
optimisme is dit proefschrift nu afgerond. Ik vind het ontzettend inspirerend om te zien 
hoe het enthousiasme voor de orthopaedie en de wetenschap van je af straalt! Ik kijk er 
nu al naar uit om ook in de kliniek van je te leren!
Beste Yvonne, jij nam me onder je vleugels toen ik in het lab kwam, terwijl ik op dat 
moment nog nooit een pipet had vastgehad. In de loop der jaren heb je me laten zien wat 
de meerwaarde is van fundamenteel onderzoek in de klinische praktijk. Daarnaast heb 
je me geleerd hoe ogenschijnlijk teleurstellende resultaten toch informatief en waardevol 
kunnen zijn. Dankjewel voor al je adviezen, positiviteit en motiverende woorden na 
‘tegenvallende’ resultaten.
Professor dr. Verhaar, ik wil u graag bedanken dat u mij de kans heeft gegeven om 
ervaring op te doen in de wetenschap op uw afdeling.
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Professor dr. Kleinrensink, professor dr. Zwerver en dr. van Lieshout, hartelijk dank 
voor het plaatsnemen in de leescommissie en voor de tijd die u genomen heeft om mijn 
proefschrift te beoordelen.
Graag wil ik ook alle coauteurs bedanken die allemaal een onmisbare bijdrage leverden 
aan dit proefschrift. Graag richt ik een speciaal woord van dank aan dr. van Meer. 
Beste Belle, met het verzamelen en structuren van de KNALL-data heb je een belangrijk 
fundament gelegd voor mijn proefschrift. Ondanks je eigen drukke programma was je 
altijd bereikbaar om mijn vragen te beantwoorden, en manuscripten van feedback te 
voorzien. Dankjewel voor alle hulp. Dr. Reijman, beste Max, ik kon altijd iedere vraag aan 
je stellen en rekenen op een vlotte reactie. Dankzij jouw kritische vragen en prikkelende 
suggesties gaf je me steeds weer een duwtje in de juiste richting. Dr. Oei, beste Edwin, 
je hebt me een aantal belangrijke radiologische principes geleerd bij het bestuderen en 
beoordelen van de MRI-beelden. Dank hiervoor!
I have had the unique opportunity to perform part of my Ph.D. research at the University 
of Cape Town (UCT), South Africa. Therefore, I would like to express my gratitude 
to all my South African colleagues. In particular, I would like to thank professor dr. 
Collins. Dear Malcolm, thank you for giving me the opportunity to visit the division of 
Exercise Science and Sports Medicine at UCT. I feel privileged to have been part of your 
research group. I also would like to thank professor dr. September. Dear Alison (alias 
Lady F), you opened my eyes for the intriguing world of genetics and its applications 
in Orthopaedics and Sports Medicine. I really admire your optimism, creativity and 
craziness. I feel humbled and honored that you are part of my doctoral committee. I 
hope we can continue our collaboration in the future! Baie dankie! An Italian and a 
Dutch having steak in Cape Town? That is where it all started in 2018. Dear Marco, our 
collaboration has been really fruitful. Good luck with finishing your own thesis! Last, 
but certainly not least, dr. Rahim. Dear Masouda, you showed me around in the lab and 
made me familiar with all the techniques. In addition, you were there to answer so many 
of my questions during my stay. Thank you for your patience!
Of course, I would like to thank all other members of the team who made my stay an 
unforgettable experience.
Aan de basis van dit Kaapse avontuur stond dr. van der Eerden. Beste Bram, je 
begeleiding voorafgaand, tijdens en na de uitwisseling naar Zuid-Afrika in het kader van 
het RUBICON project, zijn van grote waarde geweest.
Nicole, Wendy en Janneke, jullie hielpen me altijd met al mijn praktische en technische 
problemen in het lab. Soms was zelfs de vragende blik in mijn ogen al genoeg om me 
te hulp te schieten. Jullie maken dat het voelt als thuiskomen wanneer ik weer eens in 
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het lab ben! Sandra, zonder jouw hulp bij allerlei administratieve verplichtingen was dit 
proefschrift nu niet af geweest. Dank ook voor je begrip als ik weer eens ongeduldig was, 
en je bestookte met allerlei mails.
Lizette, al snel bleek dat we het goed met elkaar konden vinden. De lange dagen in het lab 
waren hierdoor erg gezellig, maar ook op congressen heb ik veel met/om je moeten lachen. 
Wu, toen jij me als student onder je hoede nam, heb je mijn interesse voor fundamenteel 
onderzoek geprikkeld. We gaan elkaar in de kliniek zeker weer tegenkomen! Andrea, 
(even without asking) I could always count on you when my work or ideas needed a 
critical view. I will try to remember some of your advices in the clinics! Shorouk, you 
have a great sense of humour, and you always made me smile. I will miss your company 
during conferences! Panithi, I still remember our late nights in the lab, when we 
worked and sang together. It’s been a long time without you, my friend! Roberto, your 
help with all my Western Blot experiments has been of great value. Thank you for your 
advices! Serdar, during my work in the clinics you were willing to take over some of my 
experiments. Thank you!
Verder wil ik graag alle andere orthopaedisch chirurgen, aios en onderzoekers met 
wie ik de afgelopen jaren in het Erasmus MC heb gewerkt bedanken voor de prettige 
samenwerking en interesse in mijn onderzoek. Ik heb genoten van de gezellige sfeer en 
goede discussies tijdens alle maandagochtend besprekingen, de lab-kliniek bijeenkomsten, 
maar ook tijdens de wetenschapsdagen en congressen. Ik kijk er nu al naar uit om terug 
te keren naar Rotterdam!
Marc, Jeroen, Rogier, Jurgen en Cas, ik voel me bevoorrecht met jullie vriendschap. 
Wat kan ik genieten van onze uitstapjes en jullie gezelschap. Dankjulliewel voor jullie 
oprechte interesse in mijn werk en de nodige afleiding! Fieke, ik heb veel bewondering 
voor de manier waarop jij in het leven staat en steeds probeert het maximale uit jezelf te 
halen. Ymke(s), samen hebben we de afgelopen jaren heel veel ballonnetjes kapot geprikt. 
Door jouw gevoel voor humor en sarcasme heb ik vaak lachend naar het scherm van mijn 
telefoon gekeken.
Birgit, Michelle, Martijn en Cleo, het is heerlijk om met jullie te zijn en te lachen om 
allerlei flauwe grappen en grollen. Nu mijn proefschrift is afgerond hoop ik dat we vaker 
van dit soort avondjes zullen hebben!
Beste collega’s van de chirurgie in Breda, ik ben bij de start van mijn klinische carrière in 
een warm bad terecht gekomen. Ondanks het feit dat ik ‘bottendokter’ word en ‘botten 
voor honden zijn’, ben ik blij dat ik mijn vooropleiding bij jullie mag doen!
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Mijn paranimfen, ik ben vereerd dat jullie vandaag naast mij willen staan. Thom, 
broertje, wat ben ik trots op je. Ik geniet ervan om te zien hoe je je ontwikkelt en je 
carrière vormgeeft. Ik hoop dat je me in de toekomst nog eens wil uitleggen hoe jouw 
levensmotto “don’t worry, be happy” in de praktijk gebracht dient te worden.
Thomas, onze rivaliteit op de baan heeft inmiddels plaats gemaakt voor een vriendschap. 
Ik ben daarom ook erg blij dat je vandaag (in rokkostuum!) naast me staat, ondanks de 
aanwezigheid van dokters en wetenschappers.
Lieve pap en mam, dankzij jullie ben ik waar ik nu ben. Jullie hebben ons opgevoed met 
een onvoorwaardelijke steun, liefde en vertrouwen. We hebben door jullie geleerd dicht 
bij onszelf te blijven, dromen te realiseren door hard te werken en altijd het maximale 
uit ons zelf te halen. Wat ben ik jullie ontzettend dankbaar voor alles wat jullie voor mij 
gedaan en betekend hebben.
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